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ABSTRACT 
p53 is a pleiotropic protein that is mutated in many types of cancers. It is involved 
in regulating various distinct cellular pathways including apoptosis, cell cycle arrest, 
senescence, autophagy, angiogenesis, and most relevant to this dissertation, cellular 
metabolism. While extensive research has been conducted on p53 in cancer biology, the 
role of this protein in modulating mitochondrial function in skeletal muscle has only been 
recently investigated. Thus the aim of this dissertation was to assess the mechanisms by 
which p53 induces and controls aerobic metabolism in skeljtal muscle, and the 
subsequent impact it carries on exercise-mediated pathways that elicit an increase in 
mitochondrial bioenergetic capacity. 
First, we examined the effect of p53 on mitochondrial protein import and complex 
IV assembly. Using subsarcolemmal (SS) and intermyofibrillar (IMF) mitochondria 
isolated from p53 wildtype (WT) and knockout (KO) mice, we discerned no effects of 
p53 on the rate of protein import. However, the expression of sever~ proteins involved in 
the import process was reduced in the KO mice. Assembly of comllex IV was impaired 
in the IMF mitochondria, along with the assembly co-factor Surfl, which may facilitate 
the previously documented attenuation of mitochondrial function in the p53 KO mice. 
Next we evaluated whether p53 is recruited in response to etdurance exercise. To 
assess this, we subjected C57Bl/6 mice to an acute run at 15m/min for 90 minutes± 3 
hours recovery, and subsequently measured alterations in conJnt, and sub-cellular 
localization of p53. The nuclear p53 content decreased steadily wib acute exercise and 
post-recovery, in sharp contrast to the increase in p53 abundlce .in SS and IMF 
- IV -
mitochondria. Concomitantly, higher levels of mitochondrial p53 rere complexed with 
Tfam, the mitochondrial DNA (mtDNA) transcription factor, and with mtDNA at the D-
loop with exercise and recovery. We identified putative p53 respJse elements in the D-
I 
loop, and hypothesized that p53 could be mediating mtDNA transcription in collaboration 
with Tfam. Further support for this was derived from the observJon that the exercise-
induced increase in mtDNA-transcribed protein COX-I was compl~tely abrogated in p53 
KO mice. 
Lastly, we sought to determine the necessity of p53 to the exercise-induced 
changes that transpire within the muscle upon an imposed metab,lic and physiological 
challenge such as a bout of endurance exercise. p38 MAPK actirtion was abolished, 
whereas AMPK and CaMKII signalling was attenuated with exercise in p53 KO mice. 
This occurred in tandem with lower levels of PGC-1 a translocation I into the nucleus, and 
subsequently attenuated the increase in mRNA content of genes involved in 
mitochondrial biogenesis. While non-exercised p53 KO mice displayed an impaired 
ability to undergo autophagy during basal conditions, there was lno difference in the 
activation of autophagic proteins post-exercise in p53 KO vs. WT mice. 
Collectively, our data illustrate that p53 is integral to mainJining baseline levels 
I 
of mitochondrial content and function, and is intimately involved in, and necessary for 
h . l" . . . d d . h Id" . h d . 1 t e s1gna mg process m1tiate upon acute en urance exercise t at me iates mitoc on na 
I 
biogenesis. 
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CHAPTER 1: 
INTRODUCTION 
Individuals over the age of 65 years represent one of the fastest growing segments 
of the North American population. In elderly population, cancer is fast becoming an 
epidemic as approximately 40% of men and women in Canada will oevelop some form of 
this disease, and and approximately 1 out of 4 Canadians will die fr&m cancer. (Canadian 
I 
Cancer Statistics, 2009). The increasing costs associated with the dare and management 
I 
of cancer and associated co-morbidities are financially unfeasible and overburden our 
healthcare system. It is thus imperative that the molecular biology and pathology of 
cancer is studied to re-define and fine-tune potential therapeutic Jategies available for 
cancer treatment and management. 
The importance of the tumor suppressor protein p53 protein can be gleaned from 
the fact that over 50% of all human cancers carry a mutation in the p53 gene. Re-
introduction of p53 or restoration of its activity is sufficient to subpress the growth of 
I 
tumors, both in vitro and when transplanted into mice (95; lp9; 155). Following 
genotoxic stress, p53 is recruited within minutes to either induce icell cycle arrest and 
coordinate DNA repair, or depending on the extent of the damage, initiate cell death 
I 
(141 ). Recent research has shed light on the ability of p53 to respond to more 
physiological stressors as well (141 ). p53 regulates cellular Lti-oxidant defence, 
angiogenesis, fertility, autophagy, and orchestrating a balance betjf!en the anabolic and 
I 
catabolic pathways within the cell (141). Additionally, in the last fel years, research has 
I 
demonstrated that p53 also plays a vital role in controlling cell mJtabolism. Since it is 
I 
1 
commonly accepted that metabolic perturbations are a hallmark of c
1
ancer progression ( 45; 
145), metabolism is thus being studied as a possible therapeutic tarJet in cancer treatment, 
I 
making p53-mediated regulation of cellular energetics a hot topic oTnvestigation. 
Increasingly sedentary lifestyles coupled with excess caloriG intake have resulted 
I 
in the emergence of inactivity-related chronic diseases and co-lorbidities. Utilizing 
endurance exercise as a viable therapeutic modality for the treatmelt and management of 
. d hr . d" . . . "d b h I d" I . age-associate c omc 1seases ts ga1mng wt e acceptance y t 9 me tea commumty 
(146). In addition to improving metabolic performance, a pletho,a of epidemiological 
studies have shown that regular physical activity extends life expectancy and reduces 
morbidity. Elucidating the underlying causes and molecular signalijg events, such as the 
role of p53 in the adaptive response to endurance exercise, carries ~reat significance for 
I 
the treatment of physical inactivity- and impaired metabolism-reldted diseases such as 
obesity, insulin resistance, type 2 diabetes, cancer and cardiovasculL diseases. Since the 
primary adaptation to a regimen of endurance exercise is an increlse in mitochondrial 
"d . . . . . . . h h d di. f h . 1 ox1 attve capacity, 1t 1s imperative to gam a t oroug un erstan mg o t e canomca 
pathway of initiation and regulation of this process. 
2 
CHAPTER2: 
LITERATURE REVIEW 
2.1. Overview of exercise-mediated mitochondrial biogenesis 
A highly malleable tissue, skeletal muscle exhibits a rmarkable range of 
plasticity in response to a number of physiological and pathophysiological stimuli. With 
d . . . h . h . b b 11. . . en urance exercise trammg, t ere is a c ange m su strate meta <i> ism, an increase m 
mitochondrial content, and an improved exercise tolerance. Since this was first noted 
many years ago ( 58), many researchers have confirmed and extendeld these observations. 
Exercise-mediated enhancement of muscle mitochondrial content is now a well 
established phenomenon in exercise physiology (59), and this incr1ase in mitochondrial 
content per gram of tissue with exercise is termed mitochondrial biogenesis. This is 
evident in both subsarcolemmal (SS) mitochondria, those loJted underneath the 
sarcolemma membrane, and in intermyofibrillar (IMF) mitochondrila, those interspersed 
between the myofibrils (89). 
Cellular mediators of metabolic adaptations that respond to endurance exercise 
stimuli are complex, and are subject to multiple facets of regulation lt the transcriptional 
and translational level. The exercise-mediated increase in mitochonJal content is largely 
due to an extension of the existing reticulum rather than de novJ organelle synthesis 
(132). Notwithstanding being a main focus of research in exercise physiology, it is of 
great importance to continue to explore and delineate the underlying mechanisms of 
3 
mitochondrial biogenesis in order to complement the new data that emerge continually 
and further our understanding of this process. 
The process of mitochondrial biogenesis is complex, requiring the coordinated 
induction of over 1,500 proteins encoded by both the nuclear and jtochondrial genomes 
as recently reviewed (124). Control over this process is medialed by a number of 
transcriptional regulators, including the members of the peroLsomal proliferator-
activated receptor (PP AR) y coativator-1 (PGC-1) family, nuclear lespiratory factor 112 
. I (NRF-1/2), cAMP response element binding protein (CREB), initiator element binding 
factor (YYl), estrogen-related receptor (ERR) a/y, thyroid hormoJ receptor family, and 
I 
myocyte-enhancing factor 2 (MEF2), among several others. Of the numerous studies 
I 
devoted to defining the transcriptional regulation of mitochondrial biogenesis, an exciting 
and emerging role for p53 has surfaced (see below). However, of tLs myriad of factors, 
the lion's share of the attention has been given to the transcriptional L-activator, PGC-la. 
The process itself begins much before the activation of these translription factors, with 
the recruitment of cellular signalling kinases. 
2.1.1. Signalling pathways regulating exercise-mediated mitochondrial adaptations 
It is generally accepted that the increase in contractile actif ity, and subsequent 
metabolic demands during acute exercise, trigger various signalling cascades that 
converge to augment mitochondrial and metabolic gene transcri~tion (27; 71). The 
I 
cumulative effects of these repeated changes in gene transcription result in the 
I 
incorporation of new skeletal muscle proteins to constitute the adaptive response over the 
4 
course of training. The precise signal transduction pathways are not completely 
understood, but evidence suggests that adenosine monophosphate (AMP), calcium, and 
reactive oxygen species (ROS)-induced activation of AMP-actJated protein kinase 
(AMPK), calcium/calmodulin-activated protein kinase (CaMK), and p38 mitogen-
activated protein kinase (MAPK), respectively, are key molecular events linked with 
muscle adaptation ( 60-62; 89). Activation of each of these signallinJ pathways in skeletal 
muscle is associated with increased mitochondrial content, likel1 through direct and 
indirect activation of regulatory transcription factors (5; 112; 154)[ Furthermore, these 
kinases increase their activity in response to exercise in a dose-dependent (intensity and 
duration of contractile activity) manner, and also based on the fiberltype composition of 
the muscle (88). More recently, a growing body of work has provided evidence for 
myokines, muscle-derived factors secreted upon exercise that can Jbsequently act in an 
• • .&: h. . d . d . J . autocrme or paracrme ias ion to m uce systemic a aptatlons suusequent to exercise 
training (107). 
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Figure 1. Overview of key intracellular signaling pathways hypothesized to mediate 
exercise-induced mitochondrial biogenesis in a skeletal muscle! cell. (a) Upon motor 
unit recruitment, the action potential travels down a neuron and at the neuromuscular 
junction (NMJ), causes acetylcholine to be released into the synapt~c cleft. Acetylcholine 
binds to its receptors on the post-synaptic muscle membrane, jcausing ligand-gated 
sodium (Na+) channels to open and allow three Na+ molecules in fm every two potassium 
(K+) molecules out of the cell thereby depolarizing the cell. A~ the action potential 
propagates across the sarcolemma membrane, it causes the release olr calcium (Ca2+) from 
the sarcoplasmic reticulum (SR). Calcium allows the cell to undergd contraction, while at 
the same time activating a series of kinases including Ca2+/calmodu[in-dependent protein 
kinase (CaMK). (b) Calcium binds to troponin and potentiates the irlteraction of actin and 
myosin, causing adenine triphosphate (ATP) to be broken dowJ to produce adenine 
diphosphate (ADP) which is further processed to produce monoph~sphate (AMP). This 
results in the activation of AMP-dependant protein kinase (AMPK) via allosteric 
modulation by AMP. (c) ADP is also responsible for initiating thel process of oxidative 
phosphorylation in the mitochondria, wherein oxygen is consumed along with ADP to 
produce ATP and water by the electron transport chain· (ETC). Apbroximately 2-5% of 
the oxygen consumed is diverted to produce reactive oxygen species (ROS) which can 
either be quenched by the resident mitochondrial anti-oxidants, or \exit the organelle to 
activate stress-responsive proteins or kinases such as p38 mitogen-activated protein 
kinase (p38 MAPK). (d) Lastly, exercise has been shown to result in the release of 
myokines, or muscle-derived humoral factors that are released into jthe blood to act in a 
paracrine or autocrine manner to induce systemic, or local mitochondrial biogenesis, 
respectively. 
7 
2.1.1.1. CaMK 
Contractile activity or exercise results in an elevation in intracellular cytosolic 
Ca2+ concentration in skeletal muscle. Resting Ca2+ concentrationj of 10-30 nM can be 
I 
increased up to 100-300 nM in slow-twitch fibers, and 1-2 µM in fast-twitch fibers upon 
exercise (54). Augmented Ca2+ levels can mediate gene expressif n by activating key 
Ca2+ -depedent enzymes such as calcineurin, protein kinase C (PKC) and 
I 
calcium/calmodulin-depedent protein kinase II, and IV (CaMKII, CaMKIV; (26). 
I 
Support for Ca2+ -mediated increase in mitochondrial biogenesis is p~imarily derived from 
I 
cell culture, where myocytes treated with calcium ionophores suchl A23187, ionomycin, 
I 
I 
or with caffeine, display a subsequent increase in mitochondrial epzymes and proteins, 
and regulatory transcriptional factors at the mRNA and protein 1Le1 (26). Transgenic 
mice with constitutively active form of CaMKIV display increled muscle PGC-1 a 
I 
expression, and mitochondrial biogenesis (154 ), however CaMKIV ~ockout mice do not 
differ from wild-type littermates in the response to endurance training, including an up-
regulation of PGC-1 a ( 6). Furthermore, since CaMKIV is primlly found in neural 
tissue, its contribution to adaptations in mitochondrial biogenesis in skeletal muscle is 
thought to be limited. This indicates that other CaMK isoforms and Ca2+ -activated 
1 . 1 1 . 1 . . h d . 1 b. I . . enzymes may p ay a vita ro e m regu atmg m1toc on na 10genes1s m response to 
exercise. CaMKII has been shown to respond to both acute and chrlnic exercise, and its 
. . . . . 1 1 d . h . d .d . . I . k 1 1 1 activation 1s positive y corre ate wit mcrease ox1 ative capacity m s e eta muse e. 
While less is known about CaMKII in translating the metabolic adiptations, it has been 
I 
illustrated to play a role in stimulating glucose uptake by regulatibg the expression of 
I 
I 
I 
I 
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GLUT4 (154). CaMKII is primarily regulated by autophosphorylation, and is thought to 
be activated by Ca2+ levels in a dose-dependent manner (29; 36). 
2.1.1.2. AMPK 
During contractile activity, there is a concurrent reduction in the ATP/ADP ratio 
and an elevation in AMP levels ( 46). AMPK functions as a mjtabolic stress sensor 
protein and can be allosterically activated by AMP up to 10-fold, Jd phosphorylation at 
Thr-172 in the kinase domain by upstream protein kinases causes > 100-fold activation 
(22; 46; 50). Together with the allosteric effect of AMP, AMPK can be activated up to 
1000-fold over baseline levels upon nutritional or oxidative stress. AMPK is 
phosphory lated at Thr-1 72 by the upstream tumor suppressor protein kinase LKB 1, and 
also by CaMK-~, the latter activating AMPK even in the absenL of an increase in 
AMP/ATP ratios (51). AMPK is a heterotrimeric complex, consistilg of the catalytic a 
subunit (containing Thr-172) and two regulatory ~ and y (containing the site for allosteric 
modulation by AMP) subunits ( 46). AMPK has been shown to be ac~ivated in response to 
exercise in humans, animals and in cell culture ( 62) and is responsiile for acute, as well 
I . 
as chronic adaptations to endurance exercise. AMPK promotes GLUT 4 translocation to 
the sarcolemma membrane and thus increases glucose uptake. It al1o initiates fatty acid 
oxidation by phosphorylating and inactivating Acetyl-CoA carboxylase (ACC)2, which 
produces malonyl-CoA, an inhibitor of carnitine-palmitoyl transfelase-1 (CPT-1), the 
enzyme in the outer mitochondrial membrane responsible for faJ acid uptake ( 150; 
I 
151). With respect to long-term adaptations to exercise, AMP~ increases GLUT4 
expression (158), directly phosphorylates PGC-la, a main regulatoJ protein involved in 
9 
mitochondrial biogenesis (68), and enhances Sirtuin 1 (SIRTI) activity which 
subsequently promotes the deacetylation of the PGC-la leading lo its activation (21). 
Furthermore, AMPK activation by 5-aminoimidazole-4-carboxamit riboside (AI CAR), 
a well-known pharmacological drug that specifically triggers ~MPK by mimicking 
AMP, elicits an increase in PGC-la mRNA, protein and promoter Ltivity, accompanied 
b . l"fi . . . h d . 1 . . . I h . h y concomitant amp i icatlon m mitoc on na enzyme activities sue as citrate synt ase, 
cytochrome c oxidase and malate dehydrogenase in skeletal muscle (60; 66; 149). These 
data illustrate the important role of AMPK in mediating exercise-induced adaptations. 
2.1.1.3. ROS 
Mitochondria are the main source of reactive oxygen species (ROS) production in 
the cell, and ROS are generated when an electron is inappropriately honated to an oxygen 
molecule in the electron transport chain at complex I and III. At baseline conditions, 
approximately 2-5% of oxygen is converted to ROS (17; 90). Accumulation of ROS 
damages cellular macromolecules such as proteins, lipids and DNA. The damage accrued 
by a lifetime of oxidative damage has been stipulated as the underlying cause for many 
degenerative diseases including aging, cancer and diabetes (67). However, evidence 
indicates a beneficial role for ROS in the cell as well. Exercise has been shown to 
increase formation of ROS in the muscle (28; 109), and ROS-activated downstream 
signals have been implicated in inducing mitochondrial biogenesis ( 61; 65; 125). ROS 
have been illustrated to induce mitochondrial reticulum formatir, enhance mtDNA 
levels and mitochondrial mass. This increase was mediated specifically by the expression 
of NRF-1 and PGC-la, which was enhanced following exogJous ROS treatment 
10 
indicating a positive role for ROS in mediating mitochondrial biogresis (125; 129). Our 
lab has previously demonstrated that ROS enhance PGC-1 a promoter activity in both an 
AMPK-dependent and independent manner ( 65). 
Additionally, ROS are known to boost kinase activatir (mainly mitogen-
activated protein kinases or MAP Ks) and reduce the activity of Jl>hosphatases such as 
calcineurin (23; 85; 135). MAPKs include c-Jun N-terminal kinaJ (JNK), extracellular 
signal-regulated kinase (ERK) and p38 MAPK, of which p38 MAPK has a well-
documented role in modulating the oxidative capacity of skeletal muscle (75). p38 
MAPK is readily phosphorylated upon exercise (5; 40), and its downstream targets 
include p53, myocyte-enhancing factor 2 (MEF2) and activating transcription factor-2 
(ATF-2) among others. p38 MAPK adaptively upregulates glucose transport in a MEF2 
dependent manner (101), and is causally linked to elevations in PGC-la promoter activity 
via engagement of ATF-2 (5). 
2.1.1.4. Myokines 
The last decade has witnessed an expanding appreciation of the role of skeletal 
muscle as an endocrine organ, replete with muscle-specific productif n of myokines that 
are secreted by the contracting skeletal muscle into the blood. The list of myokines 
produced by the muscle is growing steadily and includes myostatJ interleukin (IL )-6, 
IL-7, IL-8, IL-15, brain-derived neurotrophic factor (BDNF), leukelia inhibitory factor 
I (LIF), fibroblast growth factor (FGF)-2, insulin-like growth factor (IGF)-1, follistatin-like 
1 (FSTL-1 ), oncostatin M, and irisin to name a few (I 07). TheJ myokines exact a 
di verse effect on muscle and other organs. Myostatin, LIF, IL-7 Jd IL-15 act on the 
11 
muscle in an autocrine manner and are involved in regulating muscle hypertrophy (19; 
I 
48; 56). BDNF, traditionally involved in ensuring neuronal cell growth, maturation, 
differentiation and survival, has been shown to increase fatty acid oxidation in an AMPK-
dependent manner and enhance brown fat thermogenesis (98; 107; 108). IL-6 and IL-15 
have been illustrated to play a role in lipid and glucose metaJolism (103), insulin 
sensitivity (12) and increasing endurance capacity (33; 104; 116)l IGF-1 and FSTL-1 
I 
promote osteogenesis (3; 74), and FGF-21 has been stipulated ih improving glucose 
I 
metabolism (96). Oncostatin M has been shown to inhibit mamn\ary cell growth and 
I 
induce apoptosis (57). The PGC-la-dependent myokine irisih drives brown-fat 
I 
I 
development and improves glucose homeostasis (16). IL-6, IL-15, BDNF, oncostatin M 
I 
and irisin increase at the mRNA, and protein level in muscle upbn exercise, and are 
secreted into the blood by the contracting muscle (107). It is indeed !exciting to speculate 
I 
whether lack of exercise leading to an altered myokine expre~sion profile is the 
d 1 · l"nk b · · · d · · · 1 d hr · d. I un er ymg 1 etween mactiv1ty an mactiv1ty-re ate c omc 1seases. 
I 
2.1.2. Mitochondrial Protein Import 
I 
I 
I 
I 
Mitochondrial synthesis is a highly regulated process I that involves the 
coordination of both the nuclear and the mitochondrial genomes. mtDNA itself encodes 
I 
for only 13 proteins, which implies that the rest of the protein dontent, about 1500 
nuclear-transcribed proteins, must be imported into the mitoctndria after being 
I 
transcribed and translated in the cytoplasm (142). Proteins destined ~o become a part of 
I 
the mitochondria must interface with the protein import machinery fhat spans the outer 
I 
I 
I 
12 
I 
I 
I 
and inner mitochondrial membranes, and increases in mitochondrial reticulum must be 
I 
accompanied by an enhanced rate of protein import (89). I 
The protein import machinery consists of the translocases of the outer membrane 
. I (TOM) complex, and the transclocases of the inner membrane (Tl~) complex (8). The 
I 
TOM complex serves as the entry point for all mitochondrial f estined protein and 
includes receptor proteins such as Tom20, Tom22 and Tom70 that interact with the 
I 
I 
precursor proteins that have been delivered to the mitochondria thrdugh the assistance of 
I 
cytosolic chaperones such as heat shock protein (Hsp )90, Hsp7~ and mitochondrial 
I 
import stimulation factor (MSF). While Tom20 and Tom22 recbgnize the precursor 
proteins with an N-terminal presequence (!), Tom70 shows affini, for proteins with an 
internal targeting sequence (86; 87). The receptors transport the precursor proteins 
through the 400 kDa general import pore formed by the ~-barrel Jrotein Tom40. Once 
through the TOM complex, the preproteins can follow one of thrJ major pathways: I) 
preproteins with a presequence are transferred to the translocase ofl the inner membrane 
(TIM)23 complex for import into the matrix (14; 15); 2) proteins destined for the inner 
membrane rely on chaperone-like components of the intermemJrane space and the 
protein insertion machinery of the inner membrane or TIM22 complex (127); 3) 
precursor proteins fated for outer membrane incorporation are integrated therein by the 
sorting and assembly machinery (SAM) complex (I I). This revieL will focus on the 
. I 
import of matrix-destined mitochondrial proteins. I 
The TIM23 complex consists of Tim23, Tim50, and Timl 7. iThe matrix-destined 
I 
proteins translocate through the import channel formed by Tim23 (136). This 
I 
13 
translocation requires mitochondrial membrane potential (~'Jim) and ATP (15). ~'Jim 
activates the channel itself, as well as providing an electrophoretic effect that drives the 
positively charged presequence of the preprotein into the matrix (10; 136). ATP drives 
I 
the mitochondrial chaperone, mitochondrial Hsp70 (mtHsp70), which forms the core of 
the presequence translocase-associated motor (PAM), to liaise wil the preprotein and 
I 
pull it into the matrix (148). Mitochondrial processing peptidase (MPP) then removes the 
presequence from the preproteins, and mitochondrial chaperones sLh as mtHsp60 and 
mtHsplO help fold the protein into its final conformation (47; 134). Studies have shown 
that the enhancement in mitochondrial function is closely related to improved rates of 
protein import. Several components of the import machinery subh as Hsp70, MSF, 
mtHsp70, mtHsplO, Tom20, Timl 7, Tim23, Tom22 and other memtrs of the TOM and 
TIM complex display increased levels of expression in response to L exercise stimulus 
( 42; 70; 131 ). Furthermore, import and assembly of tom40 incleases upon chronic 
exercise (70), whereas denervation yielded a net reduction in the rJte of protein import 
into the mitochondria ( 126). While the regulation of protein import ito the mitochondria 
and its response during exercise remains enigmatic, it is clear that j improved ability to 
import more proteins would allow for a more streamlined procet of mitochondrial 
assembly and therefore improve organelle function. 
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Figure 2. Mitochondrial Protein Import Pathway. Upon . translation, many 
mitochondrial matrix-destined proteins are synthesized as precursor proteins with a 
cleavable N-terminal presequence. Other mitochondrial proteins may be bound for 
insertion into the outer or inner mitochondrial membranes. l'hese proteins are 
translocated to the mitochondria with the help of cytosolic chaperones such as Hsp70, 
Hsp90 and MSF. At the outer mitochondrial membrane (OM), the precursor interacts 
with the translocases of the outer mitochondrial (TOM) receptor proteins such as Tom20. 
a) The translocases of the inner mitochondrial membrane (TIM23): complex assists in 
targeting the precursor protein to the matrix. The mitochondrial heat shock protein 70 
(mtHsp70) drives the import of precursor proteins into the matrix in an ATP- and 
mitochondrial membrane potential (~'!')-dependent manner. The mitochondrial 
processing peptidase (MPP) cuts off the presequence and the protein1 is then folded and 
configured to its mature form. The mature form of the protein cap then execute its 
function in the mitochondria (e.g. binding to mtDNA and regulating mtDNA-driven 
transcription). b) Proteins targeted to be incorporated into the IM of the mitochondria are 
directed to the TIM22 complex, and those that need to be inserted into:the OM are sent to 
the sorting and assembly machinery (SAM) complex. 
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2.1.3. Autophagy/Mitophagy 
Macroautophagy, hereafter referred to as autophagy, is the selective 
removal of damaged organelles and subcelluar structures, and includes the select 
elimination of mitochondria (mitophagy), endoplasmic reticulum (reticulophagy), 
I 
peroxisomes (pexophagy), ribosomes (ribophagy), granules (crinophagy), and pathogens 
(xenophagy) through the lysosomal pathway (43; 73). A basal lLel of autophagy is 
maintained to perform general housekeeping of cell by turning ovJ long-lived/damaged 
organelles arid pfoteins. Decreased rates of autophagy are ijplicated in various 
neurological and metabolic disease. On the other hand, the process of autophagy can be 
adaptively increased upon metabolic stress, such as endurance exercise (123), to aid in 
cell survival. Autophagy is activated primarily through a surge in lJels of Ros, and by 
amino acid restriction ( 43). 
To maintain a healthy and bioenergetically competent pool of mitochondria in the 
cell, mitochondrial biogenesis must be complemented with mJophagy to remove 
dysfunctional mitochondrial units. It is presumed that mitochondria Le turned over as an 
intact unit as the half-lives of mtDNA, cardiolipin, and inner meLbrane proteins are 
reportedly similar ( 41; 113). The process of mitophagy is initiated uJon a loss of ~ljlm or 
an elevation in ROS levels, which recruits PTEN-induced putative lase 1 (PINKl) and 
E3 ubiquitin ligase Parkin to the outer mitochondrial membrane (39). Parkin ubiquitinates 
mitochondrial fusion protein 1/2 (Mfnl/2), and mitochondrial outer membrane GTPase 
called mitochondrial rho (Miro, involved in mitochondrial transport) effectively delinking 
the dysfunctional mitochondria from the healthier reticulum (39j 144). Autophagic 
I 
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I 
proteins p62 then bind to the ubiquitinated outer membrane mitochondrial proteins and 
engage the autophagosome (77). The autophagasome is inducted upon recruitment of 
Beclin-1, and is assembled by a series of conjugation reactions catalyzed by various 
autophagy related genes (Atgs) that result in the lipidation, and thus biochemical 
cleavage, of microtubule-associated light chain 3 (LC3) to LC311 (72; 99). Increase in 
LC311 expression is commonly used as a biomarker for activation 0£ autophagy. Once the 
mitochondrion is enveloped by the autophagosome, it is delivered to the lysosome and 
subsequently broken down by the various resident lysosomal hydrolases. The 
macromolecules recycled are then released back into the cell to maijtain energy balance. 
In addition to triggering the synthesis of mitochondria, exeJise has recently been 
recognized to play a part in the removal of damaged or dysfunltional mitochondria, 
thereby maintaining mitochondrial homeostasis (44; 44; 52; 52; 19; 69). Much work 
needs to be done to fully elucidate the intensity, frequency and duration of exercise 
required to initiate optimal autophagy/mitophagy in skeletal muscle, and to 
comprehensively document the exercise-mediated changes autophagjc flux. 
2.1.4. Role of PGC-la in mitochondrial biogenesis 
The PGC-1 family consists of PGC-1 a, PGC-1 ~' and PGC- ~ related co-activator 
(PRC). PGC-1 u is a transcriptional co-activator and a critic1 regulator of the 
transcription of nuclear genes encoding mitochondrial proteinsl, and it has been 
implicated as a key mediator of the adaptive response to exerciJ in skeletal muscle 
(110). 
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Many of the putative signals triggering exercise-induced araptations in skeletal 
I 
muscle are activators of PGC-la. For example, p38 MAPK can phosphorylate PGC-la 
I 
at three sites, releasing PGC-la from a repressor protein (34; 111). AMPK activates 
PGC-1 a by phosphorylating threonine-177 and serine-5 3 8 ~esidues, leading to 
mitochondrial biogenesis (68). Our lab has shown that AMPK activation by AICAR, a 
I 
well-known pharmacological drug that specifically triggers AMPK,I elicits an increase in 
I 
PGC-la promoter activity, as well as mRNA expression (66). \PGC-la function is 
inhibited by acetylation and the NAD+-dependent type III ~eacetylase, SIRTl, 
I 
deacetylates and activates PGC-la (102). Cellular reactive oxygen species (ROS) have 
also been identified as a stimulus regulating PGC-1 a in promoting mitochondrial 
I 
biogenesis and respiration. Our lab has also recently demonstrate~ that ROS augment 
PGC-1 a promoter activity and mRNA expression in murine myotub~s, an effect that was 
I 
abolished when the antioxidant, N-acetylcysteine was present (65). furthermore, current 
I 
work has shown that AMPK must phosphorylate PGC-la prior to :sIRTl deacetylation 
I 
for the full activation of PGC-1 a and its downstream target gene~, indicating that the 
different signaling pathways work in concert to activate PGC-la (21J 
The post-translational modifications of PGC-la lead to its 1tivation/repression, 
and its sub-cellular redistribution. In the nucleus, PGC- la coacf ivates transcription 
factors regulating mitochondrial biogenesis, including NRF-1/2, ERRa, PP ARs, and 
I 
MEF2 (137). These transcription factors regulate the promoters of genes involved in 
electron transport chain (ETC) function and fatty acid oxidation. Endurance exercise 
I 
facilitates this coactivator function by causing a shift in the subcel~lular localization of 
I 
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I 
PGC-la from the cytoplasm to the nucleus. This occurs prior to !any exercise-induced 
I 
increase in PGC-la protein expression (153). Moreover, it has recerttly been reported that 
endurance exercise mediates the translocation of PGC-1 a to the jitochondria where it 
I 
may serve as a co-activator for mitochondrial transcription factor A (Tfam) on 
I 
mitochondrial DNA (mtDNA; (120). PGC-la also increases the i expression of Tfam 
through the co-activation ofNRF-1/2. Tfam is required for mediatidg the transcription of 
i 
13 ETC subunits, 2 rRNAs and 22 tRNAs encoded by the mtDNk, and also controls 
I 
mtDNA copy number and maintenance (38). In this m~er, PGC-lla contributes to the 
I 
I 
coordinated regulation of the nuclear and mitochondrial genomes ciluring mitochondrial 
biogenesis. I 
Studies conducted using PGC-la transgenic and knock-1ut (KO) mice also 
support an important role for PGC-1 a in the regulation of mitochbndrial function and 
I 
exercise adaptations. Muscle-specific PGC-1 a over-expression results in similar 
adaptations as those seen with endurance exercise training~ including higher 
I 
mitochondrial content, enhanced fat oxidation and lower glycoge~ utilization during 
I 
exercise, as well as an increased endurance capacity (147). Research bonducted in our lab 
I 
has illustrated that mice deficient in PGC-1 a have reduced basal mitochondrial content 
I 
I 
and impaired respiratory function (4), yet the endurance exercise-induced adaptive gene 
I 
response is not abolished in these mice (82; 117). Using a cell cultJe model of chronic 
I 
contractile activity, we confirmed that PGC-1 a was necessary for mo~t, but not all, of the 
I 
I 
exercise-mediated changes culminating in mitochondrial biogenesis (138). Together, 
these data imply redundancy in the molecular mechanisms Jgulating metabolic 
i 
I 
I 
I 
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homeostasis, such that other members of the PGC-1 family, or novJl transcription factors 
I 
such as p53, play a vital part in exercise-induced mitochondrial synthesis. 
I 
2.1.5. Evidence for systemic effects of exercise I 
Endurance exercise is a powerful physiological induc~r of mitochondrial 
I 
oxidative capacity in skeletal muscle. The regulatory conduits that lead to mitochondrial 
I 
biogenesis with exercise have been studied extensively, and conside~able advances in our 
I 
understanding of how exercise mediates local muscular adaptatiJns have been made. 
I 
Since depleted oxidative capacity in skeletal muscle is associated Jth insulin resistance, 
I 
type 2 diabets, obesity and aging, it is intuitive to circumvent pathology by increasing 
! 
skeletal muscle mitochondrial quality and capacity, and thereby ifuproving organismal 
I 
health. More recently, there has been a growing appreciation for Jndurance exercise to 
I 
I 
induce mitochondrial adaptations in tissues beyond skeletal muscle, including adipose 
I 
tissue (130), liver (18), brain (18; 30), and kidney (18). [ 
There is ample evidence that endurance exercise has Jide-spread systemic 
metabolic effects, and confers cellular and phenotypic protection froL age-related disease 
in organs beyond skeletal muscle and the cardiovascular system. Enburance exercise has 
been shown to lower disability scores and all-cause mortality (14; 152), along with 
reducing death due to cancer (3 7) and improving glucose control in type 2 diabetes (7). In 
addition, long-term endurance exercise in the elderly appears to attlnuate a reduction in 
whole-body aerobic capacity, and completely preserve insulin sensiJity (49; 53; 79; 80). 
In support of human epidemiological data, exercise training in r+ents attenuates the 
I 
20 
effects of age on mitochondrial and antioxidant enzyme activities, and oxidative damage 
I 
in several non-muscle tissues (e.g. kidney, brain, liver; (18; 119). Additionally, exercise 
training in elderly induces the expression of mitochondrial and nuclear DNA repair 
proteins associated with aging (114; 115). While the protective efflt of exercise is afait 
accompli, the molecular mechanisms underlying the systemic effects of exercise remain 
unclear. Recent work stipulates the release of myokines from coltracting muscle as a 
possible means for achieving the systemic adaptations. 
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2.2. p53-mediated mitochondrial biogenesis 
2.2.1. Introduction to the tumor suppressor protein p53 
The tumor suppressor protein p53 is a master stress response factor well known 
for its pleiotropic effects on cell cycle arrest, apoptosis, pro- and anti-oxidant activity, 
angiogenesis, DNA repair, differentiation, fertilization, aging and senescence (83). In 
addition to serving as the "Guardian of the Genome" (78) under stressful conditions, 
mounting evidence indicates that p53 plays a vital role in the maintenance of energy 
I 
homeostasis in non-stressful environments. Notably, p53 has heed demonstrated to be 
involved in the maintenance of mitochondrial biogenesis (92). Jack of p53 impairs 
I 
aerobic capacity and exercise performance, and results in greater fatigue in p53 KO mice 
I 
highlighting a role for p53 in skeletal muscle health (122). rile the complex 
mechanisms underlying this effect have not been fully elucidated, tangible progress has 
been made in illustrating how p53 contributes substantially to le maintenance of 
mitochondrial content and function. 
2.2.2. Structure, activation and regulation of p53 
The p53 gene consists of eleven exons with two translation start sites in exons 2 
and 4 (105). Human p53 protein is composed of 393 amino acid residues. At the N-
terminus, the protein is composed of two transcriptional activation domains (TAD 1, 
T AD2) which are required for the transcriptional induction of the lget genes, and an 
overlapping proline-rich domain (PRD) necessary for protein-protel interactions (100; 
I 
105; 156). The central region of the protein houses the DNA binding domain (DBD), 
I 
22 
which is the most mutated site in the p53 protein (100; 105; 128; 156). The DBD is 
followed by the tetramerization motif (TET), which promotes the oligomerization of p53, 
I 
and the nuclear export signal (NES) (100; 105; 156). The TET motif allows p53 to exist 
I 
in its wild-type tetrameric conformation, made by two p53 homo-di~ers (100; 105; 156). 
I 
At the C-terminus, the protein has a C-terminal regulatory domain (CTD) which also 
contains three nuclear localization signals (NLS; (JOO; 156)). p5~ can undergo post-
1 
translational modifications at all of these domains leading to varia~le effects on protein 
I 
stability and degradation. 
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Figure 3. p53 protein domain structure and post-translatiinal modifications. 
Schematic illustration of the 393 amino acid domain structure of p53 showing important 
sites for post-translational modifications including phosphodlation, acetylation, 
ubiquitination, methylation, neddylation and sumoylation. Figure ada~ted from (91). 
I 
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p53 can be activated by mild, as well as by more severe genotoxic stress signals, 
leading to the understanding that p53 plays an important role duri~g normal health and 
I 
development. Studies of cells in culture subject to nutrient (i.e. I glucose) deprivation 
I 
demonstrated an increase in the activation of AMPK, leading! to the downstream 
phosphorylation of p53 at serine 15 (p53Ser15). This is a post-translational modification 
I 
associated with an increased stability and activity of p53 (32). Moreover, p53Ser15 is a 
I 
bona fide target of p38 MAPK under conditions of cellular stress (83). Interestingly, we 
I 
I 
have previously shown that an acute bout of contractile activity r~sults in concomitant 
I 
I 
increases in AMPK, p38 MAPK and p53Ser15 phosphorylation (122). This suggests the 
I 
I 
possibility that p53 may be involved in endurance exercise-inquced mitochondrial 
I 
biogenesis upon post-translational modifications induced by AMP:& and/or p38 MAPK 
· 1. d I s1gna mg casca es. \ 
I 
p53 can be regulated by numerous post-translational modifications including 
phosphorylation, acety lation, glycosy lation, ubiqutination, sumoJation, neddy lation, 
I 
ribosylation, 0-GlcNAcylation and lysine methylation (63; 64; 81; 105; 118; 140; 156). 
It has around 10 phosphorylation sites grouped together in the N-telinal part and a few 
more at the carobxy terminal (81; 156). Post-translational modificat1n of p53 fluctuates 
with the cellular stress levels and correlates with its downstream jffect. For example, 
phosphorylation of p53 lowers its affinity for mdm2, its negative regliator, consequently 
I 
reducing degradation (105; 140). Phosphorylation dominates th~ post-translational 
I 
I 
modification milieu as p53 can be targeted by a multitude of diffe~ent protein kinases 
I 
including ATM, ATR, the checkpoint kinases (Chkl, Chk2), Jun NHrterminal kinase 
I 
I 
I 
I 
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(JNK), p38, ERK (MAPK) and AMP-activated protein kinase (AMPK; (20; 81; 118)). 
I 
I 
Evidence suggests that acetylation of lysine residues near the GI-terminal region can 
improve DNA binding by p53 and acetylation of different lysine residues can have 
I 
differential effects on target gene expression (105; 140). I 
I 
In response to stress signals, p53 levels can be rapidly up-regulated. Evidence 
suggests that this occurs primarily via decreased protein degradation!rather than increased 
I 
I 
transcription (140). Subcellular localization of p53 plays a role in rfgulating its activity. 
I 
Mono-ubiqutination of p53 by mdm2, exposes its nuclear export signal (NES) and 
I 
promotes p53 to be shuttled out of the nucleus and to the cytoplas1* (63; 105). Once in 
thi: cytoplasm, monoubiqutinated p53 can undergo polyubiqutinatibn and consequently 
I 
I 
proteolytic degradation or it can be trafficked to the mitochondria (63). Moll UM recently 
illustrated in an elegant study that monoubiqutinated p53 can be targeted to the 
I 
mitochondrial outer membrane where it is rapidly deubiquitinated by the mitochondrial 
I 
herpesvirus associated ubiquitin-specific protease (HAUSP; (63; 94)). 
2.2.3. Mitochondrial function is dependent on p53 
A commonly used indicator of mitochondrial content is c~tochrome c oxidase 
(COX) activity. The COX complex, made up of thirteen subunits tllat are both nuclear-
1 
and mtDNA-encoded, plays a crucial role in aerobic respiration by dtalyzing the transfer 
of electrons from reduced cytochrome c to molecular oxygen. Abiltion of a functional 
p53 protein manifests as reduced COX activity (97; 122). This decrelse in COX enzyme 
I 
activity has been attributed to the transcriptional and post-transcriptipnal control exerted 
I 
i 
i 
I 
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by p53 on the expression of COX subunit I and COX subunit II €159) respectively. In 
addition, p53 transcriptionally regulates the synthesis of cytochromJ c oxidase 2 (SC02), 
a protein required for the assembly of mtDNA-encoded COX II srbunit into the COX 
complex (97). SC02 defects have been causally linked to aerobic respiratory failure and 
terminal cardioencephalomyopathy (97). The lower rate of mitolhondrial respiration 
observed in p53 KO cell lines was rescued by the transient transfLtion of SC02 (97), 
I 
indicating that this is an important pathway through which p5'3 promotes optimal 
mitochondrial biogenesis. 
A number of studies have also provided direct evidence forl the presence of p53 
response elements in the promoter regions of nuclear-encoded mitochondrial proteins 
related to metabolism, such as apoptosis inducing factor (AIF), hlat shock protein 70 
(hsp70) and hsp90, and Tfam. While AIF is known for its role in the induction of 
apoptosis, during basal conditions AIF contributes to efficient oxidative phosphorylation 
by promoting the proper assembly and function of mitochondrial Jspiratory complex I. 
Hsp70 and hsp90 are cytosolic chaperones that assist in the targetilg of mitochondrial-
destined proteins to the mitochondria. As well, Park and colleaguJ (106) demonstrated 
that the presence of p53 is a determinant of both Tfam expression Ld mtDNA content. 
I 
This suggests that p53 uses the regulation of Tfam as a conduit through which it can 
control the process of mitochondrial biogenesis. 
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2.2.4. p53 and mitochondrial DNA 
The small number of proteins encoded by the mtDNA are vrl for ETC function. 
Mutations in mtDNA have a range of pathological consequences, with ,..,,250 known 
disease-causing mutations now repo~ed. Furthermore, mutations t the nuclear DNA-
transcribed proteins affecting mtDNA mutations are even more frequent, thus increasing 
the genetic load of mtDNA dysfunction. p53 can be imported inL mitochondria, and 
I 
several studies have concluded that it may be involved in modulating mtDNA-encoded 
gene expression and stability (2; 76; 106; 157). The presence of a prtative p53 response 
element in mtDNA indicates the possibility that p53 could be directly involved in the 
I 
transcription of mtDNA (55). Indeed, p53 KO mouse embryos displayed a deficiency in 
mtDNA-encoded l 6S rRNA transcripts (31 ). p53 also promltes and maintains 
mitochondrial genomic stability directly 1) via its inherent 3' ~ 5' exonuclease activity 
(9), 2) by physically interacting with Tfam and regulating the binding of Tfam to 
damaged mtDNA (157), and 3) by enhancing the function ofmtDN~ polymerase gamma 
(poly), the only DNA polymerase in the mitochondria that is resJonsible for mtDNA 
replication and repair (2). Clearly, p53 has a validated and silnificant impact on 
maintaining mtDNA transcription and integrity. 
2.2.5. Effect of p53 on glycolysis 
Endurance exercise training is known to favor an increased reliance on aerobic 
metabolism, rather than glycolysis, as means of energy production in muscle. 
Coincidentally, along with its effect on promoting optimal mitochldrial function and 
I 
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mtDNA integrity, p53 appears to suppress glycolysis as well. A no'[el p53-transactivated 
gene called TP53-induced glycolysis and apoptosis regulator (TIGkR) lowers fructose-
2,6-bisphosphate levels in cells, resulting in an inhibition of glycolyJis (13). Additionally, 
I 
I 
p53 can induce the degradation of phosphoglycerate mutase, leading to decreased 
I 
glycolytic flux (92). As one of the hallmarks of cancer is a slft from aerobic to 
i 
I 
glycolytic metabolism, a process known as the Warburg effect (92), the p53-mediated 
I 
I 
suppression of glycolysis is in line with its role in cancer suppression. It remains to be 
I 
I 
seen whether the exercise-induced suppression of glycolysis, and dnhanced reliance on 
I 
I 
mitochondrial metabolism, is in part relayed by the recruitment and ~1ctivation of p53. 
I 
I 
2.2.6. p53, mTOR and autophagy I 
p53 is either a positive or a negative regulator of autophagy, depending on the 
I 
cellular localization of the protein and cellular stress conditions C93). During cellular 
I 
I 
stress when p53 is localized in the nucleus, it promotes the expressiotii of target genes that 
I 
I 
induce autophagy. Some of the genes identified include AMPK ~ubunits ~ 1 and ~2, 
I 
tuberous sclerosis complex 2 (TSC2), Sestrin2, damage-related a~tophagy modulator 
II 
(DRAM), and death-associated protein kinase 1 (DAPK-1; (93). Iri particular, AMPK, 
I 
TSC2 and Sestrin2 are able to exert a negative influence over the dlammalian target of 
I 
rapamycin (mTOR) complex 1 (mTORCl) pathway that participates in cell growth and 
metabolism, and negatively regulates autophagy (35; 93). Therefo~e, nuclear-localized 
p53 can increase autophagic flux by suppressing mTORCl, a blassic inhibitor of 
I 
I 
autophagy. 
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I 
I 
I 
' 
Conversely, during basal, non-stressful conditions, a large ftaction of p53 resides 
I 
in the cytoplasm. This cytoplasmic pool of p53 appears to inhibit ~utophagy (133). For 
I 
I 
example, an elevated basal content of autophagosomes is evident in p53 KO mice, 
I 
suggesting that autophagy is stimulated in the absence of p53, arid there is no further 
. . h h . 1 . . I 1 ·c. . WT mcrease m t ese autop agy ves1c es upon starvat10n, as 1s comm~n y mam1est m 
I 
mice (133). Thus, the absence of cytoplasmic p53 may allow autoJ?hagy to proceed at a 
I 
maximal rate. It therefore appears that p53 may serve as a rheostat of autophagic 
I 
signaling, inVolved in adjusting the rate of autophagy depending o* its localization, and 
I 
the presence of absence of cell stress. Further research on the toordinated interplay 
I 
I 
between p53 and mTORCl on the rate of autophagy, and the subsequent affect on 
I 
mitochondrial turnover, is warranted. I 
I 
I 
2.2.7. Role of p53 in mitochondrial fission and fusion I 
Mitochondria are dynamic organelles, capable of adapting to!energy perturbations 
within the cell. The maintenance of mitochondrial morphology de~ends on equilibrium 
between the states of fission and fusion (25). Fusion involves the Lerging of the inner 
and outer membranes, as well as the mixing of mitochondrial materill. On the other hand, 
fission divides the mitochondrial network into smaller organelles. Dtuptions in either of 
I 
these opposing processes can lead to developmental defects and disbase, suggesting that 
I 
proper maintenance of mitochondrial morphology is critical for nonJa1 cell function (25). 
I 
p53 has been linked to the regulation of both mitochondrJ1 fission and fusion 
I 
proteins. Knockdown of p53 has been reported to reduce mitochondrial fission, likely due 
I 
I 
I 
I 
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to the ability of p53 to transcriptionally upregulate the expression the fission protein 
Drpl (84). On the other hand, a consensus p53 binding site has been identified within the 
I 
promoter region of Mfn2, an important fusion protein. p53 ha~ been illustrated to 
i 
positively modulate the promoter activity, and protein expression of1Mfn2 (143). To date, 
there is no evidence that a net increase or decrease in mitochondrial network formation 
I 
occurs in the absence of p53. However, we have previously noted tJat lack of p53 results 
I 
in altered cristae formation in SS mitochondria, and reduced reticula~ network in the IMF 
I 
I 
mitochondria isolated from p53 KO mice (122). This alludes to the i*volvement of p53 in 
I 
determining muscle mitochondrial morphology, and further study 1 is required to fully 
understand the role of p53 in mitochondrial structural dynamics. 
I 
2.2.8. Role of p53 in modulating exercise-induced adaptations I 
The disruption of p53 expression carries significant physiological repercussions, 
as evident by the greater fatigability and reduced exercise capacity lbserved in p53 KO 
I 
animals (97; 106; 122). In order to implicate p53 in enduranfe exercise-induced 
mitochondrial adaptations, it is likely that: 1) p53 should be post-tratjslationally modified 
by contractile activity, and/or 2) its sub-cellular localization be modihed as a result of an 
I 
exercise stimulus. We have shown that contractile activity exercise idduces an increase in 
I 
p53Ser15 phosphorylation (122), classically linked to the increased ~tability and activity 
I 
I 
of the protein. This enhanced phosphorylation could be due to a coinbined effect of the 
I 
activation of p38MAPK and AMPK, both of which are canonical exercise-activated 
I 
kinases. This may confer a change in p53 cellular localization to ent~r the nucleus or the 
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mitochondrion, though this remains to be demonstrated. These clianges in localization 
could have a profound impact on the expression of nuclear and mitolhondrial genes. 
I 
p5 3 does appear to have an influence on the expression of ,GC-1 a, a coactivator 
which is important for normal mitochondrial adaptations to contractile activity. Our 
earlier work identified a putative p53 response element in the promdter region of PGC-la 
identified through in silico analysis ( 66). PGC-1 a protein expressiol was also reduced in 
muscle of p53 KO animals (122). Thus, this suggests that p53 is j positive regulator of 
I 
I 
PGC-1 a gene expression. In distinct contrast, a recent study has r~ported that telomere 
dysfunction elicits increased expression and activation of p53, whibh then consequently 
binds to the both the PGC-la and PGC-lP promoters, and repressL their expression in 
I 
mouse embryonic fibroblasts (MEFs, (121). Deleting germline p53 in these telomerase 
deficient mice restored PGC-1 a!P expression, and rescued the m1chondrial oxidative 
pathology present in these mice (121). These results are in compleL opposition to those 
I 
which indicate the importance of p53 for the maintenance of mitoJhondrial integrity. It 
may be that the effect of p53 on PGC-la/P expression observed J this study is tissue-
specific, or that the signaling millieu in cells from the telomere dlsfunctional animals 
varies significantly from a normal mouse. It is clear from studies Jing KO animals that 
the loss of p53 does not result in higher PGC-la!p expression, lor does it improve 
mitochondrial function. Thus, further work is clearly required to runl unravel the relation 
between p53 and PGC-la, and the resultant effects on mitochondrial biogenesis. 
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2.2.9. Integrative role of p53 in exercise-induced mitochondrial biogenesis - Future 
I 
Directions [ 
I 
Despite a growing appreciation for a widening role for p53 in mitochondrial 
I 
biogenesis and function, there is very limited literature available w~ich has analyzed the 
I 
necessity of p53 for endurance exercise-induced mitochondrial bio$enesis in muscle, as 
I 
most of the research on p53 has been conducted in cancer cell lines.I We have shown that 
I 
I 
in response to eight weeks of wheel running, p53 KO mice have a similar relative 
I 
I 
increase in COX activity ("'26%) as WT mice, despite running 5-fold lower distances, 
I 
suggesting that p53 may be important, but not required, for exercis~-mediated increases 
I 
in muscle oxidative capacity (122). Park et al. (106) reported that fir weeks of treadmill 
training improved peak oxygen consumption, work capacity and blbod lactate levels in 
WT and not p53 KO mice, underscoring the value of p53 for the accrued benefits of 
endurance exercise. 
As illustrated in figure 4, p53 affects mitochondrial biogenesi~ by exerting control 
i 
over a plethora of different cellular pathways. p53 can transcriptionally activate important 
I 
factors such as PGC-1, Tfam, AIF and SC02 that lead to mitochondrial biogenesis. p53 
I 
can also translocate to the mitochondrion and interact with mtDNA, Tfam and Poly, 
I 
contributing to mtDNA-mediated transcription and ensuring the integrity of the genome. 
Clearly, the cellular localization of p53 is important in determining 1he consequences of 
I 
its actions. Thus, it would be particularly interesting to deduce wheth~r exercise induces a 
I 
I 
I 
post-transcriptional modification in p53, culminating in its cellular ire-localization. The 
I 
presence of p53 in the nucleus or extranuclear regions also dittates its effect on 
I 
I 
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I 
autophagy. The autophagic destruction of dysfunctional or fragmented mitochondria is an 
I 
I 
important pathway for the maintenance of a constant mitochqmdrial content. We 
i 
I 
hypothesize that p53 may play an important role in the removal of damaged mitochondria 
I 
I 
with endurance exercise. Furthermore, it may be that an exercise-induced activation of 
i 
p53 could lead to the transcription of both Mfn2 and Drp 1, thus mai~taining optimal rates 
I 
of fission and fusion in the cell which are required to maintain a h~althy mitochondrial 
I 
pool. Further research in these areas is required to prove/disprove thdse hypotheses. 
I 
I 
I 
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modtftcatfon(s)? 
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Figure 4. Regulation of mitochondrial biogenesis by p53. As a I conventional nuclear 
transcription factor, p53 can induce the transcription of proteins involved in 
mitochondrial turnover (autophagy, fission and fusion) and mitoch~ndrial synthesis. p53 
transcribes pro-autophagic proteins such as AMP-activated pro,ein kinase (AMPK) 
subnits ~1 and ~2, tuberous sclerosis complex 2 (TSC2), and otl\lers (see the text) to 
induce autophagy. It also evokes the transcription of mitofusin 2 dMfn2) and dynamin-
related protein 1 (Drp 1) that contribute to mitochondrial fusion and: fission, respectively. 
Autophagy of dysfunctional mitochondria and mitochondrial fission/fusion flux may 
work in concert to ensure efficient mitochondrial turnover and m~intenance of healthy 
mitochondria. Furthermore, p53 also transcribes genes involved in controlling 
mitochondrial synthesis such as mitochondrial transcription factor~ (Tfam), synthesis of 
cytochrome c oxidase 2 (SC02) and apoptosis inducing factor (lAIF), among others. 
These proteins are subsequently imported into the mitochondria !where they perform 
specific functions. Tfam is responsible for mtDNA replication and t~anscription. SC02 is 
necessary for the proper assembly of subunit II in complex IV in the electron transport 
chain (ETC), and AIF contributes to the optimal assembly and filnction of complex I 
within the ETC. Lastly, p53 translocates into the mitochondria ahd positively affects 
I 
mtDNA transcription and genome integrity by interacting with Tfam and the mtDNA 
repair enzyme polymerase y (POLy). p53 also has inherent DNA reRair activity. Whether 
exercise causes post-translational modification(s), or changes I in the subcellular 
localization of p53 (?) to trigger the nuclear- and/or mitochondrialtspecific effects, has 
yet to be elucidated. I 
I 
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2.2.10. Conclusion 
I 
Regularly performed endurance exercise exerts a plethor~ of adaptive effects 
I 
leading to a multitude of health benefits, such as reduced risk of c1.diovascular disease, 
I 
I 
obesity, type 2 diabetes and cancer. These therapeutic effects are mediated by the 
I 
activation of various transcription factors and cellular signaling: pathways positively 
i 
regulating the overall health of the organism. p53 has emerged as a 'relatively new player 
I 
I 
in this field, as it is now established to have an important imp~ct on mitochondrial 
I 
I 
function and content. Several epidemiological studies have firmly iJndicated that regular 
I 
endurance exercise results in a reduced risk of cancer (146). Whethclr endurance exercise 
. h . . . f h I . 53 . 1 . I potent1ates t e systemic activation o t e tumor suppressor prot
1
em p m mu tip e 
tissues, and thereby retards cancer incidence/growth is not kn~wn. However, it is 
I 
intriguing to speculate that exercise-activated p53-dependent regula~ion of mitochondrial 
I 
function and content could rescue the loss of oxidative capaci~ in muscle wasting 
I 
conditions such as cancer cachexia. Clearly, the integration of p53 ~ithin the regulatory 
I 
network that contributes to endurance exercise-mediated metabolic and therapeutic 
I 
I 
adaptations in muscle is an exciting new avenue for study, and form ithe basis of my PhD 
dissertation. Further work in this area will significantly contribute tJ existing knowledge 
I 
on exercise-induced mitochondrial biogenesis, and provide impetus for future 
I 
investigations into the metabolic aberrations that underlie cancer p~ogression, with the 
I 
hope of deciphering innovative therapies. I 
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CHAPTER3: 
I 
I 
I 
I 
I 
I 
PhD DISSERTATION OBJECTIVES & HYPOTHESES 
i 
Based on the literature review, it is clear that endurance exercise-ihediated benefits are 
I 
manifold and ubiquitous, and modulated by a plethora of transcriptional- and non-
1 
transcriptional- regulators, of which the tumor suppressor protein 1[p53 is an important 
I 
player. Many questions remain unanswered including the mechanism(s) by which p53 
I 
I 
modulates endurance exercise-mediated adaptations in skeletal muscle and the scope of 
I 
I 
its activation and involvement in the signalling milieu post-exercise.: Since an increase in 
I 
mitochondrial content is one of the major adaptations to end~rance exercise, we 
I 
I 
specifically evaluated the role of p53 in the context of mitochondrial biogenesis. Thus, 
I 
the objectives of my dissertation were three-fold: i 
I 
OBJECTIVE #1 (Chapter 4): To investigate the role of p53 on Jitochondrial protein 
import and Complex IV assembly. 
Hypotheses: 
I 
I 
I 
I 
1) We hypothesized that mitochondria from p53 knockou~ mice will display 
I 
impaired import kinetics and reduced expression of p~oteins involved in 
I 
mediating the process. ! 
2) We posited that lack of p53 would impair the assembly or Complex IV since 
I 
p53 is previously shown to regulate an assembly factor of CoJplex IV. 
I 
53 
! 
I 
I 
I 
OBJECTIVE #2 (Chapter 5): To assess whether p53 is regulated by an acute bout of 
I 
endurance exercise at the level of mRNA, protein, post-translational! modification and 
sub-cellular localization. 
Hypotheses: 
1) We hypothesized that acute endurance exercise would activate p53 via post-
1 
translational modifications such as serine phosphorylation, and increase its 
I 
mRNA and protein content. 
I 
2) We also expected that acute exercise would lead to epb.anced nuclear and 
mitochondrial expression of p53, wherein it would ex~rt its pro-metabolic 
I 
I 
effect through nuclear and/or mtDNA transcriptional regulation. 
I 
I 
I 
I 
OBJECTIVE #3 (Chapter 6}: To delineate the importance of ~53 for the exercise-
induced alterations in cellular signalling with respect to mitochojdrial biogenesis and 
I 
I 
autophagy /mitophagy. \ 
~~~ I 
1) We expected that absence of p5 3 would ameliorate or dlpen the magnitude 
I 
I 
of the adaptive response to exercise when characterizihg changes in gene 
I 
expression and signalling involved in inducing mitochond~ial biogenesis. 
I 
2) Given the differential effects of p53 on autophagy we h~pothesized that lack 
I 
of p53 would impair both autophagy and mitophagy, !earing to the build up 
dysfunctional mitochondria characteristic of p53 knockouf mice. 
I 
I 
I 
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I 
~~ct i 
I The purpose of this study was to investigate whether p53 regulates mitochondrial 
I 
function by affecting mitochondrial protein import and complex IV ~ctivity and assembly. 
I 
I 
Mitochondrial fractions isolated from skeletal muscle of p53 )vild-type (WT) and 
I 
I 
knockout (KO) mice were probed for differences in the expression of proteins involved in 
i 
I 
import, in vitro rates of import, complex IV activity and assembly. I OCT import into SS 
I 
I 
or IMF mitochondria was unaffected in the absence of p53, despite protein- and 
I 
I 
mitochondrial subfraction-specific reductions in Tom20, Tim23, mt,Hsp70 and mtHsp60 
i 
in mitochondria from the KO mice. Complex IV (COX) activity in isolated mitochondria 
I 
I 
was also unchanged in KO mice. Using two-dimensional BN-PACiiE we measured the 
I 
I 
assembly of complex IV, and found it to be reduced in the IMF fractions from KO mice, 
I 
in tandem with lower levels of Surfl, a protein involved in the as~embly process. This 
I 
I 
observed defect in complex IV assembly may explain the previously documented 
I 
impairment in mitochondrial function in p53 KO mice. 
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I 
I 
Introduction 
The endosymbiont theory suggests that mitochondria I originated when a 
I 
I 
protobacterium was engulfed by a primordial eukaryotic cell about 11
1
.5-2 billion years ago 
I 
(11). If this were true, then the ancient eukaryotic cell made an adaptive transformation as 
I 
today mitochondria are the primary source of energy production ~n our cells, and are 
pivotal to a variety of cellular processes, such as fatty acid oxidation, amino-acid 
I 
I 
metabolism, calcium storage, iron-sulfur cluster synthesis, and apoptosis (30). A human 
I 
I 
cell can contain hundreds of mitochondria, and each mitochondri~:m contains multiple 
i 
copies of mitochondrial DNA (mtDNA), a circular 16,559bp large, dpuble-stranded DNA 
I 
I 
molecule. mtDNA transcribes 13 subunits of the electron transport chain (ETC), as well 
I 
I 
as the 22 tRNA and 2 rRNA species necessary for mtDNA-encodedi proteins translation. 
I 
The ETC is comprised of five complexes situated in the inner mitoqhondrial membrane, 
I 
and each complex is composed of both nuclear- and mtDNA-encod~d proteins, with the 
I 
I 
exception of complex II which is entirely nuclear DNA-transcribed. Since a single 
I 
I 
mitochondrion is comprised of nearly 1600 proteins, and mtDNA e~codes only < 1 % of 
I 
I 
the mitochondrial proteins (30), this necessitates the presence of a ful~y functional protein 
I 
import system. \ 
I 
Mitochondrially-destined proteins are synthesized by ribosomes in the cytosol and 
I 
I 
are guided to the mitochondrion by cytosolic chaperones such as h~at shock protein 70 
1 
I 
(Hsp70), Hsp90 and mitochondrial import stimulating factor (MSF, 1\(19; 20; 40). These 
I 
chaperones deliver the proteins directly to the translocase of the outer mitochondrial 
I 
I 
membrane (TOM) complex where the import process begins. TohuO is one of the 
I 
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I 
I 
I 
receptor proteins on the TOM complex that recognizes and binds to! cytosolic preproteins 
\ 
(3; 22; 25). Once through the TOM complex, the precursor proteins can be directed 
I 
towards different pathways depending on whether the protein is kgeted to the outer 
I 
I 
mitochondrial membrane, inner membrane, intermembrane space! or the matrix (30). 
I 
Precursor proteins destined for the matrix are imported by the trahslocase of the inner 
I 
I 
membrane (TIM) complex, through the channel-forming Tim23 protein (3; 22; 39), with 
I 
the assistance of the presequence translocase-associated motor (PA~). The core of PAM 
I 
I 
is composed of mitochondrial heat shock protein 70 (mtHsp70) whjch actively pulls the 
I 
I 
unfolded preprotein into the matrix in an ATP- and ~'¥-dependent 1manner (3; 22). The 
I 
. i 
precursor proteins undergo processing and are folded into their final configurations with 
I 
I 
the assistance of mtHsp60 and chaperonin 10 (cpnlO, (13). I 
I 
I 
Of the many factors that control mitochondrial function, p5B is a relatively new 
I 
I 
and important addition. It has been shown to be significant in baintaining optimal 
mitochondrial content and function, and absence of the proteij is detrimental for 
endurance capacity (26; 27). The tumor suppressor protein p53 wls first identified to 
I 
i 
affect oxidative capacity via its ability to transcriptionally regulate synthesis of 
I 
I 
cytochrome c oxidase (SC02), an important accessory factor in mitochondrial complex 
IV assembly (18). Subsequently, we and others demonstrated lower complex IV activity 
I 
in whole muscle homogenates, along with several impaired indic~s of mitochondrial 
I 
function evident in the p53 KO mice (24; 26). Like many other comp1lexes of the electron 
I 
I 
transport chain in the mitochondria, COX is made up of both mtDNA'.- and nuclear DNA-
1 
encoded proteins, rendering mitochondrial protein import as an important determining 
I 
I 
I 
I 
i 
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I 
I 
I 
I 
I 
I 
i 
i 
I 
I 
I 
I 
I , 
factor in the biogenesis of the complex. We therefore hypothesi~ed that the observed 
I 
I 
impairment in COX activity and mitochondrial respiration (24; 26) lin p53 KO mice may 
I 
be, in part, due to impaired mitochondrial import, in conjuncltion with decreased 
I 
I 
assembly of nuclear-encoded proteins into complexes such as compl'fx IV of the ETC. 
I 
I 
! 
i 
I 
Methods I 
Animal Breeding 
I 
I 
I 
I 
I 
p53 mice (9), were obtained from Taconic labs (New York, US~). Heterozygous p53 
I 
mice were bred and treated experimentally in accordance with principles of the York 
I 
Animal Care Committee. Each progeny of the breeding pair was g~notyped as follows. 
I 
An ear clipping obtained from each animal was used for a crdde DNA extraction. 
I 
Extracted DNA was added to a PCR tube containing DNA Taq I Polymerase (Sigma 
I 
I 
Jumpstart REDtaq Ready Mix PCR Reaction Mix) and forward anq reverse primers for 
I 
the wild-type (WT) p53 gene or the knockout (KO) p53 gene. Diffe1ences in the genome 
were detected using polymerase chain reaction (PCR) amplific~tion. The reaction 
II 
products were separated on a 2% agarose gel at 90 volts for 2-2.5 hours and visualized 
I 
with the use of ethidium bromide. 
Experimental Design 
I 
I 
I 
I 
I 
I 
I 
At around 3 months of age, p53 KO and their WT littermates\ (N=9/group) were 
cervically dislocated, and the quadriceps femoris, and gastrocnemius [muscle groups were 
I 
excised and placed in ice-cold buffer for cytosolic and mitochondrial fractionation. The 
I 
I 
I 
I 
I 
59 
protein content of cytosolic and mitochondrial extracts was d
1
etermined using the 
I 
I 
Bradford method (2). 1 
I 
II 
Mitochondrial and cytosolic fractionation I 
. I 
Freshly isolated quadriceps femoris, and gastrocnemius was minced, homogenized and 
II 
I 
subjected to differential centrifugation to isolate the subsareolemmal (SS) and 
I 
I 
intermyofibrillar (IMF) mitochondrial subfractions, as described pr
1
eviously (4; 17; 34). 
i 
Mitochondria were suspended in resuspension medium (100 mM KCl, 10 mM MOPS 
I 
i 
and 0.2% BSA). After the isolation procedure, SS and IMF mitochondria were used for 
I 
analyses of mitochondrial protein import, two-dimensional Blue N~~ive PAGE (2D BN-
i 
I 
PAGE), cytochrome c oxidase enzyme activity and immunoblotting. Cytosolic fractions 
I 
were prepared from freshly isolated skeletal muscle using a corhmercially available 
I 
extraction kit (Pierce NE-PER, Rockford, IL, USA). Briefly, 50-75 Jg of skeletal muscle 
I 
was minced and homogenized in CER-1 buff er containing protease inhibitor cocktail 
! 
Complete, EDTA-free (Roche Applied Sciences, Manheim, Germa~y). After a series of 
'1 
wash steps, the cytosolic fraction was obtained as the supemate foll0wing centrifugation 
I 
at 100,000 x g at 4 °C for 60mins. 
Cytochrome c Oxidase (COX) Enzyme Activity 
I 
I 
I 
i 
I 
COX activity was measured as previously detailed ( 6). Briefly, mif ochondrial extracts 
. were added to a test solution containing fully reduced cytochrome c. Tnzyme activity was 
i 
determined as the maximal rate of oxidation of fully reduced cytocln[ome c measured by 
I 
the change in absorbance at 550 nm in a Synergy HT microplate read~r at 30 °C. 
I 
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I 
I 
\ 
I 
DNA isolation and Jn vitro transcription I 
I 
The full-length cDNA clone for ornithine transcarbamylase (OCT), a matrix-bound 
I 
mitochondrial protein, was a generous gift from Dr. Gordon Shor~ (McGill University, 
I 
Montreal, Canada). The vector containing the OCT cDNA was lin~arized using Sac I at 
I 
3 7°C for 2hours. Plasmid DNA was subsequently phenol ex~racted and ethanol 
I 
I 
precipitated overnight at -80°C. The DNA was diluted to a concentration of 0.8 µg/µl, 
and was transcribed at 40°C for 90 min using SP6 RNA polyrrierase. The resulting 
I 
I 
mRNA pellet was resuspended to a final concentration of 2.8 µg/µl and aliquots were 
stored at -80C for use in import assays. 
I 
I 
I 
I 
I 
Jn vitro translation and import i 
The pOCT mRNA underwent in vitro translation in the presencJ of [35S]methionine 
I 
I 
I 
I 
within a rabbit reticulocyte lysate system. Briefly, isolated SS and IMF mitochondria 
I 
I 
were allowed to equilibrate by preincubation for 10 min at 30°C bef~re the import assay. 
I 
Translation mix (12 µl per 50 µg of mitochondrial protein) was added to the mitochondria, 
I 
and the import incubation was allowed to proceed at 30°C for 20 i min. After 20 min, 
I 
I 
I 
import was stopped by applying the mitochondrial translation mix to an ice-cold sucrose 
I 
I 
cushion (in mM: 600 sucrose, 100 KCl, 20 HEPES, and 2 MgCh).!
1 
Mitochondria were 
I 
pelleted by centrifugation for 15 min at 16,000 g (4°C) and resuspertded in 20 µl of ice-
1 
cold breaking buffer (600 mM sorbitol, 20 mM HEPES, pH 7.4).\ The samples were 
I 
denatured for 5 min and electrophoresed through a 12% SDS-polyacrylamide gel. Gels 
I 
I 
were processed and dried with a vacuum gel dryer. Radiolabelled ptecursor and mature 
. I 
I 
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I 
proteins were detected using phosphorimaging (Pharos FX, Bio-Ra4) and quantified with 
electronic autoradiography (Quantity One, Bio-Rad, Hercules, C~). The percentage of 
I 
I 
protein import was calculated based on the ratio of the intensity ofl the mature OCT and 
I 
I 
total OCT (sum of mature and precursor bands). A translation lane mixture was run on 
I 
each gel as a control for the in vitro translation and import reaction. 
Two-Dimensional Blue Native PAGE (2D BN-PAGE) 
I 
Separation of electron transport complexes was performed using Bl'f-PAGE according to 
I 
the protocol described by Schagger et al. (28; 29). Mitochondrial fractions (200 µg) were 
I 
I 
solubilized with I} dodecyl ~-D maltoside in a buffer composed of 1,750 mM E-amino-11-
caproic acid, 50 mM Bis-Tris, pH 7.0, at 4 °C. Following solubili1ation, samples were 
I 
centrifuged for 25 min at 100,000 g at 4 °C. Coomassie G-250 was ~dded to the resulting 
I 
supematants using a detergent-to-dye ratio of 4: 1 (w/w). The superhatants were applied 
I 
I 
on a 5-13% gradient BN PAGE gel and electrophoresed overnight lfor 16h at 4 °C and 
I 
23V. Blots were normalized for loading using VDAC in the first ditliension. To perform 
I 
! 
2D BN-PAGE, strips from the first dimension were cut, rotated 9p0 and subjected to 
I 
further separation in the second dimension on a 12% denaturihg SDS gel. After 
I 
I 
electrophoresis, proteins were electroblotted onto PVDF membran~s and subsequently 
probed with COX-I (complex IV) antibody as described below. 
lmmunoblotting 
I 
I 
I 
I 
I 
Mitochondrial and cytosolic extracts were separated by performi*g 10%-15% SDS-
1 
PAGE and subsequently transferred onto a nitrocellulose membratie, washed, blocked 
I 
I 
I 
! 
I 
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and immunoblotted overnight at 4°C with primary antibody directed against Tom20 
(Santa Cruz), Tim23 (BD Biosciences), mtHsp70, mtHsp60, cpjlO (Assay Designs), 
I 
hsp70, hsp90 (Stressgen Bioreagent), MSF-L (gift from Dr. IK. Mihara, Kyushu 
University), Surfeit locus protein 1 (Surf!), mitochondrial elJ
1
tron transport chain 
cocktail (Mitosciences), COX-I, porin (lnvitrogen) and aciculin. Membranes were 
washed 3x with tris-buffered-saline-tween-20 (TBST) solution conlaining 25 mM Tris-
1 
I 
HCl (pH 7.5), 1 mM NaCl and 0.1 % Tween 20. Membranes were\ then incubated with 
I 
appropriate secondary antibody coupled to horseradish peroxidase lat room temperature 
for 60 minutes. Following incubation, membranes were then Jashed 3x in TBST, 
developed using an enhanced chemiluminescence (ECL) kit and quantified via 
densitometric· analysis of the intensity of signal using Sigma Scan Pro v.5 software 
(Jandel Scientific, San Rafael, CA). 
Statistical analysis 
Data were analyzed using Graph Pad 4.0 software and values are reprrted as means± SE 
unless otherwise indicated. Mitochondrial protein import and fox activity were 
analyzed using a two-way ANOVA and Bonferroni post-tests. Ill other data were 
analyzed using Student's t-test. Significance levels were set at p < 0.05. 
Results 
Absence of p53 reduces the expression of several mitochondnial protein import 
machinery components. 
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I 
I 
I 
I 
Tom20, Tim23, mtHsp70, mtHsp60 and cpnlO are intimately assoliated with the import 
I 
and subsequent processing of matrix-destined proteins. ExpressioJ of these factors was 
I 
i 
determined in isolated SS (Fig. lA, C) and IMF (Fig. lB, D) mitochondrial fractions. In 
I 
i 
the SS mitochondria, lack of p53 induced a significant reduction in fom20 (39%), Tim23 
I 
I 
(36%), mtHsp70 (56%) and mHsp60 (32%) content, whereas cpnld expression remained 
I 
I 
unchanged (Fig. lA, C). We also observed a significant decrease ii} the protein levels of 
I 
Tim23, mtHsp70 and mtHsp60 by - 71 %, -56%, and -45%, resJ?ectively, in the IMF 
I 
I 
fractions isolated from p53 KO mice when compared to their WT ~ounterparts (Fig. 1 B, 
I 
D). Cpnl 0 and Tom20 expression were not altered in the IMF mitobhondrial pool in p53 
I 
I 
KO mice. VDAC was used as a loading control, and it was not affected by the absence of 
I 
I 
i p53. 
! 
i 
Expression of cytosolic chaperones involved in mitochondrial prbtein import remains 
I 
I 
unchanged in p5 3 KO animals. 
I 
Cytosolic chaperones are known to affect the import of mitochondri~l proteins with an N-
terminal pre-sequence or internal localization signal. We investigated the expression of 
I 
i 
I 
Hsp70, Hsp90 and MSF-L in cytosol isolated from p53 WT and K<:p mice. There was no 
alteration in the expression of the cytosolic chaperones in p53 KO muscle when 
I 
compared to WT counterparts (Fig. 2A, B). I 
I 
I 
Import of matrix-destined preproteins into SS and IMF mitochondha is not impaired in 
I 
p53 KO mice. 
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The import of the matrix-destined precursor protein pOCT into ~solated SS and IMF 
1. 
I 
mitochondria is illustrated as a representative autoradiogram with its quantification below 
I 
I 
(Fig. 3A, B). The rate of protein import was not significantly altere~ between SS or IMF 
I 
I 
mitochondria from p53 KO, when compared to WT mice (Fig 3A, ~). As has been shown 
I 
previously (34), the overall rate of pOCT import into SS mitochotidrial subfraction was 
I 
I 
lower than that observed in the IMF mitochondria. I 
I 
I 
Mitochondrial COX activity and expression of electron transport chain (ETC) machinery 
components were unaffected in muscle in the absence of p5 3. 
I 
I 
I 
I 
I 
Using isolated SS and IMF mitochondria from p53 WT and KO mjice, we measured no 
change in the rate of cytochrome c oxidase (COX) activity (Fig. f A). In addition, the 
I 
expression of components of the ETC machinery such as complbx V ATP synthase 
i 
subunit a (V), complex III subunit core 2 (III), complex IV subunit I (IV), complex II 
I 
I 
subunit 30 kDa (II), and complex I subunit NADH-ubiquinond oxidoreductase 1~ 
I 
subcomplex (I) did not differ between the two genotypes in ~ither mitochondrial 
II 
subfractions (Fig. 4B, C). I 
I 
I 
i 
I 
Impaired assembly of the cytochrome c oxidase (COX) complex i~ IMF mitochondria 
I 
I 
I 
I 
derived from p53 KO mice. 
We used a two-dimensional BN-PAGE technique to specifically analyze the assembly of 
complex IV (COX) in SS (Fig. 58) and IMF mitochondria (Fig. SD~ from p53 WT and 
I 
I 
KO mice. While assembly and synthesis of mature complex IV (S4~ was not altered in 
I 
I 
the SS fraction (Fig. 5B), it was decreased by 39% in the IMF mitdchondria (p < 0.05, 
l 
i 
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I 
I 
Fig. SD). This was accompanied by a significant 41 % decrease in t~e expression of Surfl, 
I 
(Fig. SC), an accessory assembly factor that facilitates the assembly of COX in 
! 
i 
mitochondria. Surfl expression was not different between the two genotypes in SS 
I 
mitochondria (Fig. SA). 
Discussion 
I 
I 
Mitochondrial synthesis is a highly regulated process\ that involves the 
I 
coordination of both the nuclear and the mitochondrial genonfos. Nearly 99% of 
I 
mitochondrial proteins are imported into the mitochondria, renderin~ this process crucial 
i 
for the synthesis and function of the organelle. Rates of mitochondri~l protein import can 
i 
be regulated by alterations in 1) mitochondrial respiration, 2) expression of protein 
I 
I 
import machinery (PIM) components, and 3) changes in mitoqhondrial membrane 
I 
potential (~'Pm). Our previous work has illustrated the adaptability ~f the protein import 
I 
I 
pathway in skeletal muscle mitochondria to various physiological perturbations such as 
1 
I 
denervation (32), chronic contractile activity (10), aging (8; 14~, thyroid hormone 
I 
treatment (S; 7; 31) and muscle differentiation (12). While the r~gulation of protein 
! 
import into the mitochondria and its response during exercise remains enigmatic, it is 
I 
clear that an improved ability to import more proteins would !, allow for a more 
I 
streamlined process of mitochondrial assembly, therefore improve or$anelle function. 
I 
The diverse effects of pS3 on mitochondrial function and oxic;Iative capacity have 
I 
only begun to be investigated in skeletal muscle. While no attempts i have been made to 
I 
assess the impact of pS3 in regulating the protein import process, the literature indicates 
I 
66 
that p53 affects the underlying determinative indices of protein impbrt such as respiration, 
I 
i 
and 'Pm (16; 26; 37). We have previously illustrated that respiratio~ was impaired in the 
! 
IMF mitochondrial sub-fraction from p53 KO muscle (26). This 1in tum likely affects 
I 
I 
ATP production, thus rendering an important conduit by which mitochondrial protein 
! 
import is regulated, to be defective in p53 KO mice. Others have also illustrated that 'Pm 
I 
i 
is dependent on the presence of p53 (16; 37). No prior studies exist that have examined 
I 
I 
the effect of p53 on the expression of protein import ma9hinery components. 
I 
Additionally, p53 transcribes SC02, an important assembly factor for complex IV of the 
I 
ETC (18). Thus we also determined if lack of p53 impairs i COX assembly in 
I 
mitochondria. 
First we investigated whether the protein levels of select PI~ components vital to 
i 
the import of matrix-destined proteins are dependent on p53 exprJssion. Our analyses 
I 
I 
revealed a protein- and mitochondrial fraction-specific effect on content. Tom20, Tim23, 
I 
I 
mtHsp70 and mtHsp60 were all significantly reduced in the SS rr}itochondria derived 
I 
from p53 KO mice when compared to WT controls. In contrast, only Tim23, mtHsp70 
I 
I 
and mtHsp60 levels were lower in the IMF mitochondria in p5] KO animals. We 
I 
I 
subjected the upstream 2000bp of the mus musculus promoter regions of these PIM 
I 
I 
components to promoter analysis using the Patch Software
1 
http://www.gene-
1 
regulation.com/cgi-bin/pub/programs/patch/bin/patch.cgi. Bioinfdrmatic analysis 
I 
revealed the presence of putative p53 response elements in the p1:romoter regions of 
I 
I 
Tom20 (at nucleotide positions +1158, +1872), Tim23 (-1824), cpnlO (-824, -1271, -
I 
I 
1422, -1663, -1965) and mtHsp60 (+35, -105, -240, -259, +480, -480,;-1495, +1812). No 
I 
I 
67 
putative p53 binding sites were observed in the promoter of rhtHsp70, which was 
I 
I 
nevertheless significantly reduced in the KO mitochondrial samples~ Likewise, the cpnlO 
promoter possessed several p53 response motifs, yet the expressiol was not affected in 
\ 
the KO mice. Further work is required to fully elucidate whe~her p53 affects the 
I 
expression of these proteins either directly via transcription, or indirectly via changes in 
I 
i 
post-transcriptional mechanisms. Alterations in the expression of IPIM components, in 
I 
I 
conjunction with impaired respiration and membrane potential, would theoretically limit 
I 
I 
mitochondrial protein import. Thus, we next determined the rate of import of a matrix-
-· . I 
destined protein in isolated mitochondrial sub-fractions. As shown breviously (34 ), IMF 
I 
i 
mitochondrial import rates were elevated when compared to SS mit0chondria, likely due 
I 
to the higher respiration kinetics of the IMF mitochondrial pool. iTo our surprise, we 
I 
I 
observed no difference in the percent import of mOCT in either subfraction between p53 
I 
WT and KO mice. In intact cells in vivo, mitochondrial preproteins also interact with 
i 
I 
cytosolic chaperones that primarily mediate the unfolding and i transport of newly 
I 
synthesized proteins. Thus, it is entirely plausible that within\ the intact cellular 
! 
environment, mitochondrial protein import rates in p53 KO skeletal inuscle maybe under 
I 
I 
another locus of regulation which could affect the rate of import. However, no changes 
I 
were observed in the expression of cytosolic chaperones (Hsp90, Hs~70 and MSF-L) that 
I 
coordinate the import of mitochondrial proteins. Clearly, the mitoc~ondrial capacity for 
I 
I 
protein import into the matrix is not impaired in the absence of p53 in skeletal muscle, 
I 
I 
despite a decrease in the expression of selected PIM components. It lis still possible that 
I 
import into other sub-mitochondrial localizations such as the interm~mbrance space, and 
68 
inner/outer membranes may still be affected. Further research ~s warranted to fully 
i 
elucidate the effect of p53 on mitochondrial import mechanics. I 
i 
i 
We next explored mitochondrial complex IV activity and t~e expression of ETC 
I 
components in mitochondria from WT and KO mice. COX acti~ity was not different 
I 
between the two genotypes in SS or IMF mitochondria. We had h~pothesized that COX 
! 
activity would be impaired due to previously reported defedts in mitochondrial 
I 
I 
respiration, and elevated ROS production in isolated mitochondria 1rrom skeletal muscle 
of KO animals (18; 24; 26). The results of this experiment, thqugh contrary to our 
I 
I 
expectations, are not necessarily contradictory to defective ~espiration rates, as 
I 
I 
mitochondrial oxidative phosphorylation is the culmination of the activity of the entire 
I 
I 
ETC, whereas COX activity reflects the function of complex IV '1 isolation from the 
I 
I 
other complexes. In the current study, we also noted no difference I in the expression of 
I 
representative ETC subunits in p53 KO muscle SS and IMF mitochd
1
ndria. However, this 
I 
I 
does not preclude any changes in the activity of the native ETC c9mplexes in the KO 
I 
I 
animals, which could be evaluated using complex-specific enzymatic assays or through 
I 
BN-PAGE in gel activity techniques. I 
I 
I 
The COX complex is composed of 13 subunits, two copper! centers, two hemes 
I 
and several cytochromes. The assembly of COX is thought to be a l~near process which 
I 
initiates around a seed formed by subunit I, subsequently assist~d by a number of 
I 
I 
nuclear-encoded ancillary factors (33). The process involves four su9-complex assembly 
intermediate stages, and the final mature complex (S4) dimeriz~s to result in the 
I 
functional COX holoenzyme. To date, most disorders that involve tox deficiency are 
I 
I 
I 
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I 
I 
I 
I 
attributed to mutations in ancillary factors such as COXlO and1 COX15, which are 
I 
I 
important for heme A biosynthesis (1; 36), LRPPRC (21) and TAC,01 (38) that mediate 
i 
the expression of COX subunits, Surfl, essential for formatio~ of early assembly 
I 
I 
intermediates (41), and SCOI/2 which are required for COX copper metallation (15; 23; 
! 
i 
35). Interestingly, despite documentation of p53-SC02-dependent rdgulation of oxidative 
I 
! 
capacity in liver and cancer cell lines, SCO 1 /2 levels do not decrease in the absence of 
I 
I 
p53 in skeletal muscle, and may be relatively unimportant for the observed mitochondrial 
I 
I 
defect present.in skeletal muscle of p53 KO animals, as shown rec~ntly (24). Thus, we 
I 
analyzed the expression of the assembly factor Surfl, which conbins a putative p53 
I 
response element in its promoter region (at nucleotide position -8d9) as revealed by in 
i 
silico analysis done on the promoter region of the mus musculus Surfl gene using the 
I 
I 
Patch Software (http://www.gene-regulation.com/cgi-
1 
bin/pub/programs/patch/bin/patch.cgi). Furthermore, Surfl has been11 shown to be vital in 
I 
the biogenesis of complex IV ( 41 ). Our results show that surfl expression was 
I 
significantly decreased in the IMF mitochondria of KO animals. This~ decrement occurred 
! 
in tandem with a decrease in the assembly of complex IV (S4) in the 1 same mitochondrial 
I 
I 
I 
pool. It is intriguing to speculate whether this delayed assembly process contributes to the 
I 
I 
oxidative defect present in mitochondria from p53 KO muscle, in spite of the unaffected 
I 
I 
i 
I 
complex activity and import kinetics. 
I 
I 
In summary, while p53 plays an indispensible role in determining oxidative 
I 
I 
capacity and mitochondrial function, the absence of the protein does little to impair 
I 
matrix-destined mitochondrial protein import. The reduced assembly !of complex IV may 
I 
I 
·1 
70 
be another course by which p53 determines the oxidative potential of mitochondria. 
However, more research is needed to comprehensively elucidate the mechanistic grid 
underlying the decrease in several components of the import an~ assembly pathway, 
culminating in reduced COX assembly in the absence of p53. 
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Figure Legends 
I 
I 
Figure 1. Effect of p53 on expression of Protein Importl Machinery (PIM) 
I 
I 
components in SS and IMF mitochondria. Representative wes~em blots of Tom20, 
I 
Tim23, mtHsp70, mtHsp60 and cpnlO in SS (A, C) and IMF (B, D) mitochondria 
I 
I 
isolated from muscle of p53 wildtype (WT) and knockout (KO) mice, with the respective 
- I 
I 
graphical representation below. VDAC was unchanged between th~ two genotypes and 
was used as a lo~ding control. Values are expressed as fold changes (KO/WT) ± SEM. *p 
I 
I 
< 0.05, KO vs. WT, N= 4-9. 1 
I 
I 
Figure 2. Expression of cytosolic chaperones in p53 WT : and KO animals. 
'1 
I 
Representative western blots of Hsp70, Hsp90, and MSF (A) and the1 respective graphical 
I 
representation below (B). Aciculin content was unaffected betwee+ the two genotypes 
I 
and was used as a loading control. Values are expressed as fold dhanges (KO/WT) ± 
I 
I 
SEM, N = 3-6. ! 
i 
I 
Figure 3. Mitochondrial protein import of matrix-destined OCli protein in SS and 
I 
I 
IMF mitochondria. Representative autoradiograms of protein fmport in the two 
I 
mitochondrial populations from p53 WT and KO mice (A). Quantification of protein 
I 
import was determined as a ratio of mature OCT (mOCT) to total dcT [precursor OCT 
(pOCT) + mOCT] (B). TL, 5µ1 of translation lane product that was! not incubated with 
77 
any mitochondria was run with each import reaction and used tb verify translational 
I 
efficiency. *p < 0.05, SS vs. IMF mitochondrial sub-fraction, N = 6-~. 
I 
I 
Figure 4. COX activity and expression of ETC protein componJnts in mitochondria 
from p53 WT and KO mice. COX activity was measured in ilsolated SS and IMF 
mitochondrial fractions from the two genotypes (A).Values are elpressed as means ± 
I 
SEM, N = 8. Representative western blots (left) and the co~esponding graphical 
I 
representation (right) of components of ETC complexes in S~ (B) and IMF (C) 
. I 
mitochondria from WT and KO samples. VDAC was used as a ladding control. Values 
I 
are expressed as means± SEM, N= 4. 1 
I 
Figure 5. Expression of Surfl and mitochondrial COX assembly. Western blots along 
with graphical summaries depicting the expression of Surf! J SS (A) and IMF 
mitochondria (C). VDAC was used as a loading control. Values are lpressed as means± 
I 
I 
SEM, *p < 0.05, WT vs. KO, N=5-7. BN-PAGE gels were used to analyze the assembly 
I 
of complex IV in SS (B) and IMF (D) mitochondria from WT vs. Kr animals. S4 refers 
to the final assembly product and densitometric analysis revealed it to be deficient in the 
IMF mitochondria from KO mice (p < 0.05), N = 4. 
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A 
0.45 
.-_0.40 
::J ~ < 0.35 
·c '-" 
"'O s:: 0.30 
s:: 0 
_g ·~ 0.25 
u Q) 
.s a 0.20 
~ ~ 0.15 
rJ) ......... 
rJ) ~ 0.10 
:::3 
rJ) 0.05 
Surfl 
~ 
,_.._, VDAC 
WT KO 
O.OOol-.._ __ _.__ 
WT 
B BN-PAGE 
LLJ 
~ 
J; WT~.~-
o 
Vl 
KO 
KO 
54 
c 
0.7 
$0.6 
~< :a '-" 0.5 
s:: s:: 
0 0 
..c ·;;; 0.4 
u Cl) 
0 Q) 
~ ao.3 
~~ 
:@ c 0.2 
- s-. a 0.1 
• 
-WT 
o.o ..... .__ __ ...__ 
WT 
;;.~ I~ "'.·;·l(,:::tJ.~ 
I. 
Sur fl 
VDAC 
* 
KO 
54 
-f'. 
I . 1_: 
83 
CHAPTERS: 
Acute Exercise induces p53 translocation to the mitochondria and promotes a p53-
I 
Tfam-mtDNA complex in skeletal muscle 
Ayesha Saleem1'2 and David A. Hood1'2 
I 
1 School of Kinesiology and Health Science and 2Muscle Health ResJarch Centre, York 
University, Toronto, Ontario, M3J 1P3, Canada [ 
I 
I 
Running title: Exercise and mitochondrial p53 
Keywords: acute exercise, mitochondrial biogenesis, p53, Tfam, ChlP 
Author Contributions 
AS and DAH conceived and designed the experiments, interpreted tHe data and wrote the 
I 
manuscript. AS collected and analyzed all the data. Both author~ approved the final 
version of the manuscript. 
This manuscript has been published in the Journal of Physiology (May 20 2013). The 
copyright policy automatically grants permission for authors reusing ~heir own published 
material from the Journal of Physiology in a thesis or dissertation. 
84 
Abstract 
The major tumor suppressor protein p53 plays an important role in maintaining 
mitochondrial content and function in skeletal muscle. p53 has been shown to reside in 
the mitochondria complexed with mitochondrial DNA (mtBNA), however the 
physiological repercussions of mitochondrial p53 remain unknown. We endeavoured to 
elucidate whether an acute bout of endurance exercise could mediate an increase in 
mitochondrial p53 levels. C57Bl6 mice (n=6/group) were randomly assigned to sedentary 
(SED), acute exercise (AE, 15m/min for 90mins) or acute exercise+3h recovery (AER) 
groups. Exercise concomitantly increased the mRNA content of nuclear-encoded (PGC-
la, Tfam, NRF-1, COX-IV, CS) and mtDNA-encoded (COX-I) genes in the AE group, 
and further by ~5-fold in AER group. Nuclear p53 protein levels were reduced in the AE 
and AER groups, while in contrast, the abundance of p53 was drastically enhanced by 
~2.4-fold and ~3.9-fold in subsarcolemmal (SS) and intermyofibrillar (IMF) 
mitochondria, respectively, in the AER conditions. Within the mitochondria, the 
interaction of p53 with mtDNA at the D-loop and with Tfam was elevated by ~4.6-fold 
and ~3.6-fold, respectively, in the AER group. In the absence of p53, the enhanced COX-
I mRNA content observed with AE and AER was abrogated. This study is the first to 
indicate that endurance exercise can signal to localize p53 to the mitochondria where it 
may serve to positively modulate the activity of the mitochondrial transcription factor 
Tfam. Our findings help us understand the mechanisms underlying the effects of exercise 
as a therapeutic intervention designed to trigger the pro-metabolic functions of p53. 
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Introduction 
I 
The concept of utilizing physical exercise as a viable therapbutic modality for the 
I 
I 
treatment and management of age-associated chronic diseases often defined by 
I 
I 
dysregulated metabolism such as obesity, type 2 diabetes, cardiovascular diseases, 
I 
I 
dementia and cancer, is fast gaining acceptance (Warburton et ~!., 2010). While the 
overall health benefits of exercise are undeniable, the underlying mblecular mechanisms 
I 
I 
mediating the protection conferred by exercise is only beginning to 9e amassed. Although 
I 
a multitude of cellular conduits are involved, a fundamental adaptat~on is the increase in 
the mitochondrial oxidative capacity post-exercise training. : This increase in 
mitochondrial biogenesis brought about by endurance exercise is orchestrated by a host 
I 
of transcriptional factors and co-activators that contrive together to coordinate 
. . .d . . I improvements m oxi atlve capacity. I 
Affectionately known as the 'Guardian of the Genome' for\ its role in inducing 
I 
cell-cycle arrest or cell death upon genotoxic stress signals, p53 is n~w reputed to play a 
I 
vital role during cell metabolism, growth and development, and can be activated by 
I 
I 
physiological stressors to elicit an adaptive response (Saleem 
1
et al., 2011 ). p53 
I 
participates in regulating metabolism, mobilizing cellular anti-oxidant defence against 
I 
I 
physiological oxidative stress, and orchestrating a balance between the anabolic and 
I 
! 
catabolic pathways within the cell (Vousden & Lane, 2007). Inter~stingly, the cellular 
I 
fate in response to p53 activation often hinges on its subcellul~r localization. For 
! 
I 
example, within the cytoplasm p53 inhibits autophagy, whereas in the nucleus it serves to 
activate autophagy through direct transcriptional activation of effector genes that promote 
I 
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I 
autophagy (Maiuri et al., 2010). Similarly, in vitro studies have sp.own that within the 
mitochondrial matrix, p53 specifically binds to mtDNA polymeras'.e y ensuring mtDNA 
I 
genomic integrity and maintenance (Achanta et al., 2005). p53 has also been purported to 
! 
I 
play a role in mtDNA transcription and translation by either binding directly (Heyne et 
I 
I 
al., 2004;Kulawiec et al., 2009) or indirectly via Tfam to mtDNA (Yoshida et al., 2003). 
p53 is not the only nuclear transcription factor to have been founq interacting with the 
I 
mitochondrial genome. Another important nuclear protein for mito?hondrial biogenesis, 
PPAR y co-activator-la (PGC-la), also reportedly resides within t~e mitochondria in a 
I 
complex with mtDNA, where it may be involved in facilitating rhtDNA transcription 
! 
(Aquilano et al., 2010;Safdar et al., 2011). In addition, retinoic acid X recepor (RXR) and 
I 
I 
estrogen receptors ERa/~ also localize to the mitochondria, and ha~e been implicated in 
i 
I 
mtDNA transcription (Casas et al., 2003;Chen et al., 2004). Clearly, ~he presence of bona 
I 
• I • • fide nuclear proteins within mitochondria warrants further mvestigation into the 
i 
I 
physiological role of these proteins stationed in this organelle. i 
i 
While much work has been done on p53 in cancer cell line~ and in response to 
I 
I 
cell damaging signals, the physiological function of p53 within sk~letal muscle and in 
i 
I 
response to physiologically-relevant signals such as exercise remains: unknown. We have 
I 
previously demonstrated an increase in p53ser15 phosphorylation cd
1
ntent in response to 
I 
I 
acute contractile activity (Saleem et al., 2009). Here, we further in~estigated whether a 
I 
physiological alteration in the cellular milieu, represented by an ac~te bout of exercise, 
could induce a change in the subcellular localization of p53 in murtne skeletal muscle. 
I 
Our findings indicate that p53 levels decreased substantially in the m~cleus with exercise 
I 
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and recovery. We further illustrate that exercise preferentially shuttled p53 into the 
skeletal muscle mitochondria where it forms a complex at the D-lobp region of mtDNA. 
These data suggest that the pro-metabolic/survival function of p53 L skeletal muscle can 
be differentially regulated in response to exercise. 
Methods 
Ethical Approval 
I 
I 
I 
C57Bl/6J mice, bred in an institutional central animal facility (Y 9rk University), were 
housed in micro-isolator cages in a temperature- and humidity- lontrolled room and 
maintained on a 12-h light-dark cycle with food and water ad libi~um. All animal care 
i 
protocols were submitted to the York University Animal Care CTommittee and were 
approved in accordance with the guidelines set forth by the Canadil Council on Animal 
I 
Care. Animals were sacrificed via cervical dislocation at the end of e~ch experiment. p53 
wild-type (WT) and knockout (KO) mice were acquired Jorn Taconic Labs 
I 
(Germantown, NY). I 
Animal breeding and Experimental Design. 
At 3 months of age, C57Bl/6J mice (N = 6/group), were matchetl for sex and body 
I 
weight, and randomly assigned to sedentary (SED), acute bout of exlrcise (AE), or acute 
exercise followed by three hours ofrecovery (AER) group. All mice Lere acclimatized to 
the treadmill two weeks prior to the beginning of the experiment. Thl animals in both the 
AE and AER groups were then selected and subjected to an acJe bout of treadmill 
I 
I 
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I 
running at 15 m/min for 90 min. All of the mice subjected to treadmill exercise were 
i 
I 
visibly exhausted at the end of the exercise as determined by their ability to withstand air 
and shock stimuli for greater than 5 seconds. The AE exercise 1!group was sacrificed 
immediately following exercise. The SED was euthanized by cervical dislocation at the 
I 
same time as the AER group. Quadriceps femoris muscle was extraqted from all mice and 
I 
,...., 70 mg was immediately snap frozen and stored at -80°C for subsequent mRNA 
I 
I 
expression. The remaining -200 mg of fresh quadriceps femoris w~s utilized for nuclear, 
I 
cytosolic and mitochondrial fractionation. To assess the importance
1 
of p53, WT and p53 
I 
I 
KO mice (N=4/group) were subjected to the same acute e~ercise challenge as 
I 
I 
documented above. Quadriceps femoris muscles were extracted and frozen for 
subsequent mRNA analysis. 
RNA Isolation. 
Total RNA was isolated from - 70 mg of frozen muscle using Tri1-reagent (Invitrogen) 
! 
I 
according to manufacturer's instructions. RNA concentration and tjuality was measured 
using Nanodrop 2000 (Thermo Scientific, Wilmington, DE, USA) and further verified 
I 
with RNA gels. 
mRNA Expression Analyses. 
The mRNA expression of peroxisome proliferator-activated recepto~ gamma co-activator 
I 
I 
1-a (PGC-la), mitochondrial transcription factor A (Tfam), nuclear: respiratory factor-1 
(NRFl), cytochrome c oxidase subunits I and IV (COX-I, COX-IV), citrate synthase 
I 
(CS), glyceraldehye phosphate dehydrogenase (GAPDH) and p53 ias quantified using 
! 
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I 
7500 Real-time PCR System (Applied Biosystems Inc., Foster City, CA, USA) and 
I 
SYBR® Green chemistry (PerfeCTa SYBR® Green Supermix, ROX, 1 Quanta BioSciences, 
I 
Gaithersburg, MD, USA). First-strand cDNA synthesis from 2 µ'g of total RNA was 
performed with primers using Superscriptlll transcriptase (Invi~rogen) according to 
manufacturer's directions. Forward and reverse primers (Table 1) f~r the aforementioned 
I 
genes were designed based on sequences • I available m GenBank 
I 
I (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) using the MIT 
1 
Primer 3 designer 
I 
software (http://wi.mit.edu/cgi- bin/primer3/primer3 _ www.cgi), and were confirmed for 
I 
I 
i 
specificity using the basic local alignment search tool (www.ncbi.nlm.nih. gov/BLAST/). 
i 
P-2 microglobulin was used as a control housekeeping gene, the ex~ression of which did 
I 
not alter between groups. All samples were run in duplicate simultanbously with negative 
I 
controls that contained no cDNA. Melting point dissociation curves generated by the 
I 
I 
instrument were used to confirm the specificity of the amplified product. Primer 
I 
efficiency curves were generated for each set to ensure 100±2% efficiency. 
Mitochondrial Fractionation. 
I 
Briefly, ,....,150 mg of skeletal muscle was minced, homogenized and subjected to 
~ 
I 
differential centrifugation as previously documented to yield subsa~colemmal (SS) and 
I 
I 
intermyofibrillar (IMF) mitochondrial fractions (Saleem et al., 2009). The mitochondria 
were re-suspended in a small volume of resuspension buffer (1 OQ1 mM KCl, 10 mM 
I 
MOPS, and 0.2% BSA, pH 7.4, supplemented with protease inhibito~ cocktail Complete, 
I 
ETDA-free [Roche Applied Science, Manheim, Germany]). All centrifugation steps were 
90 
I 
carried out at 4 °C. Mitochondrial homogenates were analyzed for protein content using 
I 
I 
the Bradford assay, and subsequently frozen at -80°C for further 1biochemical analysis 
I 
including mitochondrial co-immunoprecipitation assay, mitochondrial chromatin 
I 
immunoprecipitation (ChIP) assay and immunoblotting. 
Mitochondrial Co-lmmunoprecipitation Assay. 
I 
i 
I 
I 
Mitochondrial co-immunoprecipitation assay was performed 1
1 
on isolated IMF 
mitochondrial fractions using Pierce Co-Immunoprecipitation Kit (fierce, Rockford, IL, 
I 
USA) according to manufacturer's instructions. Briefly, mitochondrial fractions were 
homogenized in lysis buffer (0.025 M Tris, 0.15 M NaCl, 0.001 M EDTA, 1 % NP-40, 
I 
5% glycerol, pH 7.4) supplemented with protease inhibitor cockta~l Complete, ETDA-
1 
free (Roche Applied Science, Manheim, Germany). Mitochondrial protein fraction (1 
I 
I 
mg) was pre-cleared by incubation with control agarose resin to minimize non-specific 
binding. Anti-p53 (FL-393, Santa Cruz Biotechnology, Santa Cru2l, CA, USA, 40 µg) 
I 
i 
was covalently coupled onto an amine-reactive resin. The pre-cleared lysates were 
I 
i 
subsequently incubated with antibody-coupled beads overnight at 4 °C. Co-
l 
I 
immunoprecipitates were, washed, eluted and subsequently collecte~ by centrifugation, 
I 
I 
boiled in 50 µL of lane marker sample buffer, and used for immunoblot analysis for 
I 
Tfam. Anti-IgG antibody was used as a non-specific control. 
mtDNA Chromatin lmmunoprecipitation (Chf P) Assay. 
I 
ChIP assay was performed using an EZ-ChIPTM kit (Millipore, Billerica, MA, USA) 
! 
I 
according to manufacturer's instructions. Mitochondrial fractions (
1
 mg) were cross-
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linked in 1 % formaldehyde for 10 min at room temperature, and 1 OX glycine was added 
I 
I 
to stop fixation. Samples were then homogenized in 1 mL ~f SDS lysis buffer 
! 
supplemented with protease inhibitor cocktail Complete, ETDA-free (Roche Applied 
I 
Science, Manheim, Germany). Chromatin was sheared by sonicating each sample on ice 
I 
(output 20%, 4 times for 20 sec, with a 20 sec pause each time). Fol~owing centrifugation 
I 
at 10,000 x g at 4 °C for 10 min, the supernate containing 1 mg of protein was diluted to 
I 
1 mL with ChIP dilution buffer. Anti-p53 (FL393, Santa Cruz Biotechnology, Santa 
. I 
I 
Cruz, CA, USA, 10 µg) or anti-IgG antibody was added per s~mple and incubated 
I 
overnight at 4 °C. Anti-IgG antibodies were used as non-specific :controls. Protein G-
1 
agarose ( 60 µL) was added and the sample was mixed for 1 h at 1 4 °C with rotation. 
I 
Precipitated samples were washed, and then eluted in 100 µL of elution buffer, and cross-
1 
I 
I 
linking was reversed by the addition of 8 µL of 5 M NaCl per sample followed by 
I 
i 
incubation at 65 °C for 12 h. Co-immunoprecipitated DNA was purified according to the 
I 
manufacturer's instructions. mtDNA D-loop region (Table 1) was qhantified using 7500 
I 
I 
Real-time PCR System (Applied Biosystems Inc., Foster City, CA~ USA) and SYBR® 
I 
I 
Green chemistry (PerfeCra SYBR® Green Supermix, ROX, Quanta BioSciences, 
Gaithersburg, MD, USA). 
Nuclear and Cytosolic fractionation. 
I 
Nuclear and cytosolic fractions were prepared from freshly isolated skeletal muscle using 
I 
I 
a commercially available nuclear extraction kit (Pierce NE-PER, Rockford, IL, USA). 
I 
I 
Briefly, 50-75 mg of skeletal muscle was minced and homogenizfd in CER-1 buffer 
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containing protease inhibitor cocktail Complete, EDTA-free (Rocpe Applied Sciences, 
I 
I 
Manheim, Germany). After a series of wash steps, nuclear proteins were extracted in high 
I 
I 
salt NER buffer supplemented with protease-inhibitors. The cytosolic fraction was spun 
I 
at 100,000 x g at 4 °C for 60mins to obtain pure cytosolic fraction. 
Jmmunoblotting. 
I 
I 
Proteins were resolved on 8% or 12% SDS-PAGE gels dependiµg on the molecular 
I 
weight of the protein of interest. The gels were transferred onto ECL nitrocellulose 
I 
membranes, followed by blocking with 1-3% milk in TBST i overnight at 4 °C. 
I 
lmmunoblotting was carried out using mouse p53 (1 :20, pAb42 l, ki~d gift from Dr. Sam 
i 
Benchimol), rabbit Tfam antibody (1 :500, in house), rabbit p5!3ser15 (1 :500, R&D 
I 
I 
systems, AF2887) and rabbit PGC-la (1 :500, Millipore, AB3242). With regard to PGC-
1 
1 a, we have previously validated the use of this particular PGC-1 a a'.ntibody in myotubes 
I 
(U guccioni & Hood, 2011 ), and it has also been used by othei
1 
muscle physiology 
laboratories to detect PGC-la (Hancock et al., 2008; Philp et al., 201 l;Williams et al., 
I 
I 
2009). We also further ascertained the antibody specificity by ,performing western 
! 
I 
blotting analysis using quadriceps femoris muscle from PGC-1 a KO mice. Membranes 
were then incubated with the appropriate secondary antibody (~beam) coupled to 
I horseradish peroxidase (HRP) at room temperature for 2 hours. After incubation, 
membranes were washed three times in TBST, developed !with an enhanced 
I 
I 
chemiluminescence (ECL) kit, and quantified via densitometric analysis of the intensity 
I 
of signal with Sigma Scan Pro v.5 software (Jandel Scientific, San Rafael, CA). VDAC 
I 
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and Histone 2 B (H2B) were used as loading controls for mitochondrial and nuclear 
I 
I 
fractions, respectively. 
Statistical Analyses. 
I 
Data were analyzed using one-way analysis of variance (ANOV J\), except for Fig 5D 
I 
which was analyzed using a two-way ANOV A, using Graph Pad \4.0 software. For all 
1 • 
I 
one-way ANOVA analyses, a Tukey's post-hoc test was utilized to identify individual 
I 
differences when statistical significance was observed. Statisti~al significance was 
I 
I 
established at a P ~ 0.05. Data are presented as mean± standard error of the mean (SEM). 
! 
Results 
Purity of cellular fractions, antibody specificity, and cellular distribtition of p53. 
I 
I 
The purity of nuclear and mitochondrial fractions and specificity of1 p53 antibody are of 
I 
I 
extreme importance for the subsequent subcellular localization analyses of p53 carried 
out in this study. We have previously established that the isdlated mitochondrial 
subfractions are pure and functionally intact (Cogswell et al., 1993). tfo further assess the 
I 
! 
purity of the nuclear and mitochondrial fractions, we immtmoblotted for the 
I 
I 
mitochondrial protein cytochrome c oxidase IV (COX-IV, Fig 1k.) and the nuclear 
'1 
protein histone 2B (H2B, Fig lB). COX-IV and H2B were only detecfed in mitochondrial 
I 
and nuclear fractions, respectively. Furthermore, no cytosolic 1,contamination was 
apparent in the nuclear and mitochondrial fractions as measured by 1
1 
GAPDH (Fig 1 C). 
We also confirmed the specificity of p53 antibody against the protei~ by measuring p53 
I 
I 
94 
expression in whole muscle homogenates from wildtype (WT) an~ p53 knockout (KO) 
I 
mice (Fig ID). p53 was not detected in the muscle homogenates frqm KO mice (Fig ID) 
I 
illustrating the specificity of the p53 antibody utilized in this study. The subcellular 
I 
I 
distribution of p53 in skeletal muscle was measured by probing ifor p53 in cytosolic, 
mitochondrial and nuclear fractions (Fig 1 E). p53 content was hi~hest in the cytosolic 
I 
fraction, followed by the nuclear and mitochondrial compartments in muscle (Fig 1 E). 
I 
Validation of PGC-1 a antibody 
I 
To ascertain the specificity of the PGC-Ia antibody, we performed ihununoblotting using 
I 
I 
quadriceps femoris muscle from PGC-Ia KO (Fig. IF, lane I), and WT mice (Fig. IF, 
lane 2). We also included a soleus muscle homogenate as a positive pontrol (Fig. IF, lane 
I 
3), as it clearly depicts an increased abundance of PGC-Ia in a sJow, oxidative tissue 
such as soleus as opposed to a primarily fast glycolytic muscle. such as quadriceps 
I 
I 
femoris. The -94kDa band is absent in lane I confirming the antibqdy specificity. There 
I 
is slight immunoreactivity in lane I, but it is present at a higher mole~ular weight than the 
band in the WT lanes. We suspect it to be non-specific binding. 
mRNA content of genes related to energy metabolism increases follpwing an acute bout 
of endurance exercise. 
The transcript levels of nuclear DNA-encoded (PGC-Ia, Tfam, NRF-I, COX-IV, CS) 
I 
I 
and mtDNA-encoded (COX-I) genes involved in mitochondrial biogenesis increased 
I 
! 
immediately following an acute bout of exercise (p<0.05, Fig 2). This enhancement in 
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mRNA expression of these transcripts was maintained or further exacerbated after three 
I 
hours of recovery following the exercise (p<0.05, Fig 2). p53 ~A levels decreased 
I 
with acute exercise, whereas GAPDH transcript levels remained 1relatively unchanged 
I 
I 
with acute exercise (AE), and acute exercise with 3hrs recovery (AER, Fig 2). 
Acute exercise reduces nuclear, and enhances mitochondrial abundance of p53 
p53 content decreased steadily after exercise by 56% in the nuclear fraction from the 
I 
AER group (p<0.05, Fig 3A). In contrast, an elevation of PGC-la expression was evident 
in the nucleus in the AE and AER conditions (p<0.05, Fig 3B), ~n line with previous 
I 
literature (Wright et al., 2007). H2B served as a loading control and :remained unchanged 
I 
I 
with the exercise treatments. A gradual increase in p53 levels witHin mitochondria was 
I 
I 
observed by ,...,2.4-fold (p<0.05, Fig 4A) in the subsarcolemmal: (SS) mitochondrial 
fraction, and by "'3.9-fold (p<0.05, Fig 4B) in the intermyofibrillar (IMF) mitochondrial 
! 
I 
fraction. The increase in p53 content occurred concomitantly with~ gradual increase in 
p53ser15 phosphorylation in mitochondrial fractions (Fig 4C).'. Both the mtDNA 
I 
transcription factor Tfam, as well as VDAC expression remained 
1
unchanged with the 
exercise treatments (Fig 4D). 
I 
I 
Mitochondrial p53 forms a complex with Tfam and binds to mtDNA cit the D-loop region 
Given the apparent translocation of p53 to the mitochondria with ~xercise, we posited 
I 
I 
that acute exercise would positively enhance this association of p53 with Tfam and 
mtDNA. To test our hypothesis we performed co-immunoprecipitatiop assays with the SS 
96 
mitochondrial fraction from SED, AE and AER groups (Fig 5A). Congruent with 
I 
previous in vitro findings (Wong et al., 2009;Yoshida et al., 2003), fwe observed that p53 
forms a complex with Tfam in skeletal muscle mitochondria (Fig 5A). Since Tfam is 
I 
I 
primarily found in the mitochondrial matrix, this observation also confirmed the matrix-
specific localization of p53 in mitochondrial fractions (Fig 5A and'. B). Furthermore, we 
i 
I 
observed that the p53-Tfam complex increased progressively upon an acute bout of 
I 
exercise by --3.6-fold in the AER group (p<0.05, Fig 5A). We als9 performed mtDNA 
co-immunoprecipitation assays to determine if p53 was bound to th~ D-loop of mtDNA, 
I 
I 
and whether this interaction was positively modified by acute exercise. We observed that 
! 
in skeletal muscle mitochondria, p53 forms a complex with mtDNlt\ within the D-loop 
I 
I 
region, and that this association is enhanced by --4.6-fold in the iAER group in IMF 
! 
mitochondria (p<0.05, Fig 5B). 
I 
Increase in mtDNA-derived COX-I mRNA post-exercise is dependant upon p53 
expression 
The transcript levels of mtDNA-encoded COX-I subunit inc~eased immediately 
I 
I 
following an acute bout of exercise, and further with recovery in the WT mice (p<O.OS, 
I 
Fig SD) as shown earlier. Remarkably, this exercise-induced adaptatibn in COX-I mRNA 
was completely abolished in the p53 KO mice (p<0.05, Fig SD). 
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Discussion 
I 
The disruption of p53 expression carries grave physiolog~cal repercussions, as 
I 
evident by aberrant mitochondrial bioenergetic efficiency, r~1duced mitochondrial 
I 
biogenesis, greater fatigability and reduced exercise capacity observed in p53 KO 
I 
animals (Matoba et al., 2006;Park et al., 2009;Saleem et al., 2009). 11 If p53 plays a role in 
potentiating endurance exercise-induced mitochondrial adaptations, it is likely that p53 is 
I 
post-translationally modified in response to exercise which may differentially regulate its 
I 
I 
sub-cellular localization post-contractile activity. We and others ha~e previously reported 
I 
elevated p53serl 5 phosphorylation levels in response to acute contrdctile activity (Saleem 
I 
et al., 2009;Bartlett et al., 2012), a modification that is classically lipked to the increased 
I 
stability and activity of the protein. Interestingly, here we demo~strate that p53ser15 
I 
I 
phosphorylation levels increase progressively with AE and AER conditions in the 
mitochondrial fractions, in line with the enhanced phosphorylatibn status of p53 as 
previously reported in whole muscle homogenates (Saleem et al., l 2009;Bartlett et al., 
2012). It is entirely plausible that the measured increase in Ser15 phosphorylation is a 
I 
due to the combined effect of the activation of p38 MAPK and AMPK, both of which are 
bona fide exercise-activated kinases (Akimoto et al., 2005;Ljubicic & Hood, 2009) and 
• I 
are known to post-translattonally modulate p53 (Jones et al., 2005;S;he et al., 2000). In a 
recent paper, Bartlett et al. (Bartlett et al., 2013) provided further sukgestive evidence of 
a link between AMPK signalling and p53 phosphorylation in hJan skeletal muscle. 
I 
Furthermore, since p53 is subject to a host of other post-translational modifications such 
I 
as acetylation, ubiquitination, sumolaytion, and neddylation, it is possible that any of 
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these may assist in trafficking p53 out of the nucleus and into the mitochondria. In fact, it 
I 
I 
has been previously demonstrated that mono-ubiquitinated p53 is shuttled out of the 
nucleus in a CRMl-dependent manner (Lohrum et al., 2001). Sub*quent to this, mono-
1 
I 
ubquitinated p53 is rapidly trafficked to the mitochondria where it undergoes 
deubiquitination by resident deubiquitinases such as HA USP (Matchenko et al., 2007). 
I 
Additionally, proteomic analyses have revealed that a large numper of mitochondrial 
destined nuclear-encoded proteins lack canonical N-terminal mitochondrial targeting 
. I 
signal, but instead have cryptic internal signals. There is no discema:ple consistent pattern 
to the nature and location of these cryptic signals. Similar to many bther proteins such as 
i 
I 
PGC-la, RXR and ERa/~ that have been identified within mitochondria, p53 also does 
not contain a canonical mitochondrial targeting signal, but it appears to possess a cryptic 
I 
I 
signal (Boopathi et al., 2008). Clearly, further research is requirbd to carefully distil 
! 
I 
which post-translational modification is pivotal to the change in the sub-cellular address 
I 
of p5 3 and its subsequent import into the mitochondria. 
I 
AIF, SC02 and Tfam are important transcriptional targets ofp53 through which it 
I 
regulates cell metabolism. While AIF is known for its role in the infiuction of apoptosis, 
I 
during basal conditions AIF contributes to efficient oxidative : phosphorylation by 
promoting the proper assembly and function of mitochondrial re,spiratory complex I 
(Stambolsky et al., 2006). SC02 has been shown to be vital for th~ proper assembly of 
subunit I of the mitochondrial cyctochrome c oxidase complex, and re-expression of 
I 
SC02 quickly rescued the oxidative impairment in p53 KO cells in ~ancer cells (Matoba 
et al., 2006). A multitude of studies (Bourdon et al., 20Q7;Kulawiec et al., 
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2009;Lebedeva et al., 2009;Park et al., 2009; Yoshida et al., 2003) have demonstrated that 
! 
I 
the presence of p53 is a determinant of both Tfam expression and 11}.tDNA content. Since 
I 
p53 clearly targets the promoter regions of these genes and positivbly up-regulates their 
expression, we posited that p53 levels would increase in the nuclyus upon an exercise 
I 
stimulus in an effort to increase the transcription of the aforementioned gene targets. 
I 
I 
However, p53 content reduced drastically with exercise, and even more so in the 
I 
recovery period in the nuclear fraction. This is at odds with the expression pattern of the 
I 
I 
classic activator of mitochondrial biogenesis, PGC-1 a, wherein th~ content of PGC-1 a 
steadily increased with exercise and recovery in the nuclear fraction as shown here, and 
I 
by others (Wright et al., 2007). We hypothesize that the decrease in p53 content occurred 
so as to remove p53 from the vicinity of the plethora of gene target$ that can induce cell 
I 
death, or senescence, reactive outcomes often dictated by p53 : in times of stress. 
Additionally, a recent study (Sahin et al., 2011) has indic~ted that p53 can 
I 
I 
transcriptionally suppress PGC-1 a and PGC-1 ~ expression, co-activators that are known 
I 
I 
to induce mitochondrial biogenesis. Therefore it is possible that the decrease in nuclear 
p53 content ensures that p53 does not suppress the activation of PG\C-la/~, so as not to 
impede the process of mitochondrial biogenesis. 
I 
It should also be noted that despite the apparent exodus of p5~ from the nucleus, a 
basal level of p53 is still present in nuclei post-exercise which may qe sufficient to carry 
I 
on its pro-metabolic role. Moreover, the idea that p53 is a transcriptional inhibitor of 
I 
I 
I 
PGC-la is not universally accepted. A recent study reported p53 binqs to the promoter of 
! 
PGC-1 a and up-regulates its expression during times of mild oxid*ive and nutritional 
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stress (Aquilano et al., 2012). Thus, the interaction between p53 and PGC-la appears to 
I 
be specific to the cellular milieu, and it remains to be seen ho~ exercise affects this 
relationship. 
Another intriguing finding was the decrease in the mRNA leyel of p53, which was 
in vivid contrast to the significant elevations in the transcripts of other genes involved in 
I 
~ 
mitochondrial biogenesis such as Tfam, NRF-1, PGC-la, CS, CO~ I and COX IV. This 
I 
could be due to the exquisite control exerted by p53 on its own rriRNA expression. As 
I 
I 
illustrated previously (Mosner et al., 1995), with increasing p53 pro~ein expression, there 
is a subsequent decrease in its mRNA expression as p53 binds tp the 5' untranslated 
I 
region (UTR) of its own mRNA and causes it to be degraded. Thus the decrease in 
mRNA expression that was observed in this study could simply be due to the ability of 
! 
p53 to fine-tune its own expression. 
I 
The binding of p53-Tfam, and p53 with mtDNA post-exhcise is an exciting 
: 
finding. It is possible that p53 acts as an accessory factor that :may augment Tfam 
I 
activity, an association highly dependent on altered energy dem~nds such as during 
exercise. Tfam primarily exists as a mitochondrial transcription factbr, but also functions 
I 
I 
to maintain mtDNA integrity and repair. We observed increasing amounts ofTfam bound 
I 
I 
to p53 in the mitochondria with exercise and 3hrs recovery, despit~ a lack of change in 
the amount of total Tfam in the mitochondria. It is known that the majority of Tfam 
within the organelle is closely associated with mtDNA (Park & Lars'.son, 2011), at the D-
1 
I 
loop region to allow Tfam to regulate mtDNA transcription (Larssbn et al., 1998). We 
I 
I 
have previously shown that chronic contractile activity results in increased Tfam binding 
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to mtDNA D-loop region, indicative of the ability of chronic exerc~se to modify mtDNA 
transcription (Gordon et al., 2001). Interestingly, p53 has been shown to increase the 
I 
binding of Tfam to damaged DNA (Wong et al., 2009;Yoshida ~t al., 2003) and it is 
entirely plausible that it potentiates binding of Tfam to the D-loop as well. We also 
observed an elevated amount of p53 bound to the D-loop of mtDNA, either directly or via 
Tfam, in the mitochondrial fractions following exercise and recovery. Therefore, we 
I 
hypothesize that p53 may function as a mitochondrial transcription factor, positively 
I 
modulating mtDNA-encoded gene expression either directly, or via modulation of Tfam 
activity at the D-loop region. To assess the plausibility of this hypothesis, we subjected 
! 
I 
the D-loop region 15400bp-16299bp of the mus musculus mitochondrial genome (NCBI 
reference number: NC 005089.1) to a patch analysis using the Consite software 
- I 
I 
http://asp.ii.uib.no:8090/cgi-bin/CONSITE/consite. Bioinformatic analysis revealed 
putative p53 response elements (RE), which were identified and plotted against the 
I 
mtDNA D-loop sequence. This is in line with previous studfos documenting the 
I 
interaction of p53 with mtDNA (Heyne et al., 2004;Kulawieq et al., 2009), and 
I 
corresponds with several reports that have identified common ~uclear transcription 
I 
factors and co-activators such as SIRTl, ERa/~, retinoid X receptor and PGC-la that also 
reside in the mitochondria, and are involved in regulating riitDNA transcription 
(Aquilano et al., 2010;Casas et al., 2003;Chen et al., 2004;Safdar ~t al., 2011). Further 
I 
support for a significant role of p53 in regulating mtDNA transcri~tion can be acquired 
I 
from observing the large increase in COX-I mRNA expression in wild-type mice, which 
i 
was completely abrogated in the p53 knockout animals. This indic~tes that the increase 
102 
I , 
m intra-mitochondrial p53 with exercise is indeed functional m facilitating mtDNA 
transcription. In addition, p53 can mediate mtDNA genomic sta9ility directly, via its 
inherent base excision repair activity, and indirectly by 1) promoting the binding of Tfam 
I 
I 
to damaged mtDNA, and 2) by enhancing the function of mtDNA ~olymerase y, the sole 
I 
mtDNA repair enzyme (Saleem et al., 2011 ). Therefore, it is possible that exercise 
induces p53-Tfam-mediated maintenance and repair of mtnNA, exclusively or 
I 
I 
concomitantly with enhanced mtDNA transcription. 
I 
Thus, the nuclear depletion and mitochondrial accumulation '
1
of p53 subsequent to 
I 
an acute bout of exercise highlights the fascinating diverse transcriptional and non-
transcriptional modes of regulating oxidative metabolism as comm~deered by p53 in a 
I 
physiological setting. Clearly, the action of p53 on the mitoch~ndrial genome may 
I 
represent an important conduit by which it facilitates the coordinated expression of the 
I 
nuclear and mitochondrial genomes in promoting mitochondrial bidgenesis and mtDNA 
I 
stability in muscle. The tumor suppressor protein p53 plays an 'ndispensible role in 
i 
halting tumorigenesis, is important in mediating oxidative metabolism, and as indicated 
! 
I 
by our data, responds to an exercise stimulus. Together with the current awareness of 
!, 
exercise as a feasible, cost-effective and safe therapy to reduce the incidence and 
I 
progression of cancer (Friedenreich & Orenstein, 2002;Warburton el; al., 2010) and other 
! 
metabolic diseases, our results may carry important clinical implichtions. Further work 
I 
! 
that delineates the signalling mechanisms involved, and that focus~s on elucidating the 
i 
effect of exercise training on p53 function and regulation is clearly warranted. 
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Tables 
Table 1. Primer sequences based on gene transcripts available in GenBank. 
Gene Forward primer (5' -+ 3') Reverse primer (5' -+ 3') 
PGC-la TTCCACCAAGAGCAAGTAT CGCTGTCCCATGAGOTATT 
I • 
Tfam GAAGGGAATGGGAAAGGTAGA AACAGG~CATGGAAAGCAGAT 
i 
NRF-1 ATCCGAAAGAGACAGCAGACA TGGAGGGTGAGATGCAGAGTA 
I 
p53 CCGACCTATCCTTACCATCATC TTCTTCTGTACGGCGGTCTC 
I 
COX-I CTAGCCGCAGGCATTACTAT TGCCCAlAA.GAATCAGAACAG 
COX-IV CTCCAACGAATGGAAGACAG TGACA~CCTTCTTAGGGAAC 
cs GCATGAAGGGACTTGTGTA TCTGGCACTCAGGGATACT 
i 1 
GAPDH AACACTGAGCATCTCCCTCA GTGGGTGCAGCGAACTTTAT 
~-2 II 
GGTCTTTCTGGTGCTTGTCT TATGTTCGGCTTCCC~TTCT 
microglobulin I 
I 
I 
I 
mtDNA D-loop AGCCCATGACCAACAT AACTG AGACTGTGTGCTGTCCTTTCA 
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Figures and legends 
I 
Figure 1. Sub-cellular fraction purity, cellular distribution o( p53, and antibody 
specificity of p53 and PGC-la. (A) COX-IV, (B) Histone 2B and (C) GAPDH were 
I 
used as indicators of the purity of mitochondrial, nuclear and cytosolic fractions, 
i 
respectively. (D) Specificity of p53 antibody as demonstrated 1 by measuring p53 
I 
I 
expression in whole muscle homogenates from p53 wild-type (WT) and knockout (KO) 
mice. (E) Sub-cellular pattern of p53 expression in cytosolic (C), m
1
itochondrial (M) and 
nuclear (N) fractions. (F) PGC-1 a expression in KO quadriceps femoris (KO-Q, lane 1 ), 
I 
I 
WT quadriceps femoris (WT-Q, lane 2) and WT soleus (WT;-S, lane 3) muscle 
I 
homogenates. The molecular weight in kDa is shown on the left for (p), (E), and (F). 
Figure 2. Changes in nuclear and mitochondrial DNA-encoded mRNA transcripts. 
I 
Transcriptional regulators of mitochondrial biogenesis (PGC-la, 1NRF-l and Tfam), 
components of the electron transport chain (COX-IV and COX-q, and mitochondrial 
enzyme citrate synthase (CS) mRNA expression increased in '1the AE and AER 
I 
conditions. Glycolytic enzyme GAPDH did not change and p53 ~A levels decreased 
I 
with the experimental conditions. ~2-microglobulin was used as a house keeping control 
I 
gene. *p<0.05 AE vs. SED, tp<0.05 AER vs. SED. Data are present~d as a fold-increase 
I 
over SED mice. Error bars represent SEM values, N=6/group. 
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I 
Figure 3. Alterations in nuclear expression of p53 and PGC-la1 with acute exercise. 
i 
Nuclear content of (A) p53 steadily decreased, and that of (B) ~GC-la progressively 
increased in the AE and AER animal groups. Histone 2B was used as a loading control 
I 
and did not change during the conditions. *p<0.05 AE vs. SED, tB<0.05 AER vs. SED. 
I 
I 
ifp<0.05 AER vs. AE. Data are presented as mean± SEM, N=6/grotip. 
Figure 4. Changes in mitochondrial Tfam and p53 content upon acute exercise. p53 
I 
content in (A} SS mitochondria and (B) IMF mitochondria increas~s significantly in the 
AER group. (C) p53 phosphorylation at serine 15 displayed a gradu~l increase in AE and 
I 
I 
AER conditions in SS mitochondria compared to SED control (rep~esentative blot from 
I 
n=2). (D) Tfam content did not alter immediately after AE, and ntjr in the AER group. 
VDAC was used as loading control and did not alter between the experimental 
I 
I 
conditions. *p<0.05 AER vs. SED. ifp<0.05 AER vs. AE. Data are presented mean ± 
I 
SEM values, N=6/group. 
Figure 5. Acute exercise enhances the association of p53 with Tfam inside the 
mitochondria and promotes p53-mtDNA D-loop complex formation. (A) p53 was 
I 
immunoprecipitated (IP) followed by immunoblotting (IB) foli Tfam in isolated 
mitochondrial fractions from SED, AE, and AER mice. p53-Tfarri complex increased 
significantly in the AER group. *p<0.05 AER vs. SED. lgG was used as a non-specific 
I 
control for the co-immunoprecipitation assay. VDAC was used tb ensure that equal 
I 
I 
amounts of mitochondrial fractions were used for co-IP experiments 1 from each group of 
I 
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mice. Data is presented as a fold-increase over SED values. Error bars refer to SEM 
values, N=6/group. (B) There is a significant increase in the p53 complexed at the D-loop 
i 
region of the mtDNA in the AER group. *p<0.05 AER vs. SED. Anti-IgG antibody was 
used as a non-specific control. Real-time amplification of signal :from lgG group was 
below detectable limit. Data is presented as a fold-increase over SED values. Error bars 
refer to SEM values, N=6/group. (C) Schematic illustrating the 1 D-loop sequence of 
I 
mtDNA and putative p53 response elements (RE). The position of the forward (F') and 
I 
reverse (R') primers used in mtDNA-ChIP analysis is identified, and the sequences of the 
three putative p53 RE within the amplicon amplified by the PCR re~ction are shown. (D) 
mRNA content of mtDNA-encoded COX-I subunit in wild-type (WT) and p53 knockout 
I 
(KO) mice in SED, AE and AER conditions. ~2-microglob~lin was used as a 
I 
housekeeping control gene. *p<0.05 WT vs. KO, tp<0.05 AE and AER vs. SED in WT 
mice. Data are presented as a fold-increase over SED mice. Error: bars represent SEM 
values, N=4/group. 
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Figure 5. 
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Abstract 
I 
An acute bout of exercise activates downstream signaling cascades' that ultimately result 
I 
I 
in mitochondrial biogenesis. In addition to recruitment of factors that lead to net 
mitochondrial synthesis, endurance exercise also triggers the removal of damaged 
cellular material via autophagy, and of dysfunctional mitochondri~ through mitophagy. 
Here we investigated the necessity of p53, an important regulator of mitochondrial 
I 
content/function, oxidative capacity and autophagy, to the changes; that transpire within 
the muscle upon an imposed metabolic and physiological challenge such as a bout of 
I 
endurance exercise. We randomly assigned age and gender-matchecl C57BL6 (wildtype, 
WT) and p53 knockout (KO) mice (N=6 each) to control, acute exercise (90mins at 
15m/min, AE) and acute exercise + 3hr recovery (AER) gr~up, and measured 
downstream alterations in markers of mitochondrial biogene~is, autophagy and 
mitophagy. In the absence of p53, exercise-induced activation bf p38 MAPK was 
I 
abolished, whereas CAMKII and AMPK phosphorylation levels di~ not increase in the 
I 
AE group, but displayed an attenuated enhancement in the AER grdup compared to WT 
I 
mice. The translocation of PGC-1 a to the nucleus was diminished ~nd only observed in 
the AER group, and the subsequent increase in mRNA tra;nscripts related to 
mitochondrial biogenesis with exercise and recovery was absent in tpe p53 KO animals. 
Whole muscle autophagic and lysosomal markers did not respond to ~xercise irrespective 
of the genotype of the exercised mice, with the exception of increased ubiquitination 
I 
observed in KO mice with exercise. Since non-exercised p53 KO 'muscle displays an 
I 
I 
impaired ability to undergo autophagy in basal conditions, this could. be a compensatory 
I 
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response to elevate autophagy back to WT levels. Markers of mitophagy were elevated in 
I 
response to AE and AER conditions in both WT and p53 KO runners. The data suggest 
that p53 is important for the exercise-induced activation of mitoch<lmdrial synthesis, and 
I 
is integral in regulating autophagy during control conditions, but not in response to acute 
exercise. 
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Introduction 
Skeletal muscle is a highly adaptable tissue that undergoes numerous metabolic 
and morphological adaptations in response to regular physical ~ctivity. In particular, 
endurance exercise training has been illustrated to induce beneficial physiological 
alterations that help extend life expectancy, reduce morbidity in disease states such as 
obesity, cardiovascular disease, type 2 diabetes, metabolic syndrome, cancer, as well as 
physical disability in later life (33). While an extensive amoufit of information is 
available on the benefits of exercise, complete insight into the molecular mechanisms 
underlying these changes is lacking. Elucidating the causes and: molecular signaling 
events behind the adaptations in response to endurance exercise carries great significance 
for the treatment of physical inactivity-related diseases. 
Muscle contraction results in rapid cellular changes that subsequently activate 
I 
downstream signaling kinases. Upon each bout of muscle contraction, there are variations 
I 
in the AMP:ATP ratio, increases in intracellular calcium (Ca2+):, and generation of 
reactive oxygen species (ROS) that can activate AMP-activated protein kinase (AMPK, 
(36), Ca2+/calmodulin-dependent protein kinase II (CaMKII (23)~ and p38 mitogen-
I 
activated protein kinase (p3 8 MAPK, ( 1 ), respectively. These 1 bonafide exercise-
responsive signaling kinases then initiate more widespread changes in the muscle by 
recruiting regulators of mitochondrial biogenesis such as pero*isome proliferator-
activated receptor gamma co-activator 1-a (PGC-la). PGC-la is a transcriptional co-
activator and a critical regulator of the transcription of nucl~ar genes encoding 
mitochondrial proteins, and it has been implicated as a master mediator of the adaptive 
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response to exercise in skeletal muscle (18; 22). Both acute and 'chronic exercise can 
activate PGC-la and cause it to localize to the nucleus (35) where it can directly or 
indirectly control the transcription of its target genes including nuclear respiratory factor 
1 (NRF-1 ), cytochrome c oxidase subunit IV (COX IV), mitoc~ondrial transcription 
factor Tfam among others (32), and thus enhancing mitochondrial bfogenesis. 
In addition to triggering the synthesis of mitochondria, exercise has recently been 
I 
recognized to play a part in the removal of damaged or dysfunctional mitochondria, 
I 
thereby maintaining mitochondrial homeostasis ( 1 O; 11; 15). Autpphagy refers to the 
I 
process where damaged cellular materials are marked, encapsulated and delivered to the 
lysosomes for degradation. Mitophagy is the selective degradation of dysfunctional 
mitochondria often tagged by enhanced ubiquitination of mitochondrial proteins, a 
consequence of elevated ROS accumulation, or dissipation of the mitochondrial 
membrane potential (9). A multitude of proteins have been identified to be a part of this 
I 
process, including Beclinl, Atg7, p62, and LC311 that participate atthe various stages in 
the process of autophagy(8; 9; 12). Beclinl and Atg7 are involved ~n vesicle nucleation 
and LC3 maturation, p62 and LC311 recognize ubiquitinated proteiq.s, and LC311 is now 
commonly used as a marker of autophagy as it necessary for the construction of the 
autophagosome (3). 
The tumor suppressor protein p53 has an established role m modulating 
mitochondrial content, and subsequently oxidative capacity :(20; 26; 27). Its 
I 
transcriptional control over many vital factors involved in mitochondrial biogenesis such 
I 
as PGC-1 a, Tfam, and synthesis of cytochrome c oxidase 2 (S~02), an important 
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I 
I 
I 
I 
assembly factor in mitochondrial electron transport chain coq:iplexes, renders the 
I 
expression of p53 to be of significance with respect to mitochondrial adaptations in 
! 
response to exercise training (27). However, it is unknown, whether p53 is necessary for 
I 
the physiological changes that occur subsequent to an acute bout of exercise. Incidentally, 
I 
p53 also serves as a dual regulator of autophagy, a positive enfor~er via transcriptional 
'1 
regulation of genes that induce autophagy (19), and a negative moderator when it is 
I 
present in the cytoplasm through a hitherto uncharacterized mechani1sm (31 ). Considering 
I 
I 
the role of p53 in mediating oxidative capacity, autophagy and its r~cognition as a target 
I 
of AMPK and p38 MAPK (16; 29), we hypothesized that the absenc~ ofp53 will result in 
I 
a diminished adaptive cellular response to exercise. 
Methods 
Animal Breeding 
I 
p53 mice (5) were obtained from Taconic labs (New York, USA). Heterozygous p53 
I 
I 
mice were bred and treated experimentally in accordance with principles of the York 
I 
Animal Care Committee. Each progeny of the breeding pair was gbnotyped as follows. 
I 
I 
An ear clipping obtained from each animal was used to produce a !crude DNA extract. 
I 
\ 
Extracted DNA was added to a PCR tube containing DNA Taq \Polymerase (Sigma 
I 
Jumpstart REDtaq Ready Mix PCR Reaction Mix) and forward and reverse primers for 
i 
I 
the wild-type (WT), or the knockout (KO) p53 gene. Differences in the genome were 
I 
I 
detected using polymerase chain reaction (PCR) amplification. The reaction products 
i 
I 
I 
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were separated on a 2% agarose gel at 90 volts for 2-2.5 hours and ~isualized with the use 
I 
of ethidium bromide. 
Exercise Performance Test 
WT and KO mice were subjected to a graded treadmill exerdse test to determine 
maximum exercise capacity. Mice were acclimatized to the treadmill one week prior to 
I 
the test. Animals commenced running at 5 m/min on a 0% incline for 5 mins, followed by 
I 
I 
10 m/min for 10 min. Running speed was increased by 1 m/min ~very min until mice 
reached exhaustion, defined as the point whereby mice remained at the back of the 
I 
I 
treadmill on an electric shock pad for 5s. The Work performed 'Yas calculated by the 
formula where, Work (J) = Force [body weight (kg) X 9.8 m/sec2~ X Vertical distance 
[speed (m/min) x time (min)] (21). 
Experimental Design 
As no differences were observed in the endurance capacity of the two genetic strains of 
mice, p53 WT and KO mice (N = 6/exercise condition, 18/genotype) at ,....,2 months of age 
I 
I 
were matched for sex and body weight, and randomly assigned to control (CON), acute 
I 
exercise (AE), or acute exercise followed by three hours of recovery (AER) groups. All 
I 
mice were acclimatized to the treadmill one week prior to tHe beginning of the 
experiment. The animals in both the AE and AER groups were then selected and 
I 
I 
subjected to an acute bout of treadmill running at 15 m/min for 90 min. All of the mice 
I 
subjected to treadmill exercise were visibly exhausted at the end of the exercise, as 
I 
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determined by their ability to withstand air and electrical shock stimuli for greater than 5 
seconds. The AE exercise group was sacrificed immediately following exercise. The 
animals in the CON group were euthanized by cervical dislocation at the same time as the 
I 
I 
AER group. Quadriceps femoris muscle was extracted from all mice, and ,...., 70 mg was 
immediately snap frozen and stored at -80°C for subsequent mRNA expression and whole 
I 
muscle western blotting purposes. The remaining ,...., 200 mg of fresp quadriceps femoris 
I 
was utilized for nuclear, and mitochondrial fractionation. Frozen rpuscle samples were 
pulverized into a powder with a stainless steel mortar cooled to the ~emperature of liquid 
nitrogen. Powdered tissue was resuspended in RIPA buffer, sonicated, centrifuged, and 
I 
stored in liquid nitrogen until further use. The protein content of extracts was determined 
using the Bradford method (4). 
RNA Isolation. 
Total RNA was isolated from ,...., 70 mg of frozen muscle using Trirreagent (Invitrogen) 
according to manufacturer's instructions. RNA concentration and quality were measured 
using Nanodrop 2000 (Thermo Scientific, Wilmington, DE, USA)! and further verified 
with RNA gels. 
mRNA Expression Analyses. 
The mRNA expression of PGC-la, Tfam, NRFl, COX-IV, and s:co2 was quantified 
using 7500 Real-time PCR System (Applied Biosystems Inc., Foster :City, CA, USA) and 
SYBR® Green chemistry (PerfeCTa SYBR® Green Supermix, ROX, Quanta BioSciences, 
I 
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Gaithersburg, MD, USA). First-strand cDNA synthesis from 2 µg of total RNA was 
performed with primers using Superscript III transcriptase (lnvitrogen) according to 
manufacturer's directions. Forward and reverse primers (Table 1) for the aforementioned 
genes were designed based on sequences available m GenBank 
(http://www.ncbi.nlm.nih.gov/entrez/query .fcgi) using the MIT : Primer 3 designer 
I 
software (http://wi.mit.edu/cgi- bin/primer3/primer3 www.cgi), and were confirmed for 
- I 
specificity using the basic local alignment search tool (www.ncbi.nl*1.nih. gov/BLAST/). 
P-2 microglobulin was used as a control housekeeping gene, the expression of which did 
I 
I 
not change between groups. All samples were run in duplicate :simultaneously with 
negative controls that contained no cDNA. Melting point dissociation curves generated 
I 
by the instrument were used to confirm the specificity of the amplified product. Primer 
efficiency curves were generated for each set to ensure 100±2% effic~ency. 
Mitochondrial Fractionation. 
Briefly, ,...., 150 mg of fresh skeletal muscle was minced, homogenized and subjected to 
I 
I 
differential centrifugation as previously documented to yield the subsarcolemmal (SS) 
mitochondrial fraction (26). The mitochondria were re-suspended itj a small volum.e of 
resuspension buffer (100 mM KCl, 10 mM MOPS, and 0.2% BSA, pH 7.4, supplemented 
I 
with protease inhibitor cocktail Complete, ETDA-free [Roche Applied Science, Manheim, 
Germany]). All centrifugation steps were carried out at 4 °C. Mitochondrial homogenates 
were analyzed for protein content using the Bradford assay, and subsequently frozen at -
80°C for further biochemical analysis. 
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i 
Nuclear fractionation. 
Nuclear fractions were prepared from freshly isolated skele~al muscle usmg a 
commercially available nuclear extraction kit (Pierce NE-PER, Rockford, IL, USA). 
Briefly, 50-75 mg of skeletal muscle was minced and homogeni~ed in CER-1 buffer 
containing protease inhibitor cocktail Complete, EDT A-free (Rocfye Applied Sciences, 
Manheim, Germany). After a series of wash steps, nuclear proteins 'Yere extracted in high 
salt NER buff er supplemented with protease-inhibitors. 
lmmunoblotting 
Proteins were resolved on 8% or 12% SDS-PAGE gels dependi~g on the molecular 
I 
weight of the protein of interest. The gels were transferred onto ECL nitrocellulose 
membranes, followed by blocking with 1-3% milk in TBST 'overnight at 4 °C. 
I 
Immunoblotting was carried out using rabbit PGC-1 a (Millipore), phospho and total 
AMPK, p38 MAPK, CaMKII (Cell Signalling), lysosomal markers: cathepsin-D (CTS-D, 
Santa Cruz), lysosomal-associated membrane protein2 (lamp2, Abeam), autophagy 
markers: ubiqutin (Uh, Assay Designs), p62 (Sigma), light chain 3 II (LC311, Cell 
Signalling), autophagy-related protein 7 (Atg7, Sigma), and Beclirl (Cell Signalling. 
Membranes were then incubated with the appropriate secondary antibody coupled to 
horseradish peroxidase (HRP) at room temperature for 2 houd. After incubation, 
membranes were washed three times in TBST, developed with an enhanced 
chemiluminescence (ECL) kit, and quantified via densitometric analysis of the intensity 
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I 
of signal with Sigma Scan Pro v.5 software (Jandel Scientific, San ~afael, CA). Aciculin, 
I 
voltage-dependent anion channel (VDAC, Mitosciences) and Hisfone 2 B (H2B, Cell 
I 
I 
Signalling) were used as loading controls for whole muscle, mitochondrial and nuclear 
i 
I 
fractions, respectively. I 
Statistical analysis 
I 
Data were analyzed using Graph Pad 4.0 software and values are re~orted as means± SE 
I 
unless otherwise indicated. Data were analyzed using a two-way ANOV A and Bonferroni 
i 
post-tests. All other data were analyzed using Student's t-test. Sig~ificance levels were 
set at p < 0.05. 
I 
Results I 
I 
Maximum treadmill exercise capacity is similar in WT and p53 KO rhice. 
I 
To estimate the maximum aerobic running potential of p53 KO mi~e, we subjected p53 
I 
WT and KO mice to an acute bout of graded treadmill exercise to lexhaustion. p53 KO 
I 
animals attained a maximum speed comparable to that of their WT counterparts (Table 2), 
I 
I 
as reported by Park et al. previously (21). Interestingly, p53 KO mice, though previously 
I 
I 
demonstrated to have impaired respiration (20; 21; 26) and exerp ise performance in 
I 
wheel running (26) and swimming tests (20; 21 ), displayed no ~eficits in maximum 
I 
distance run, or work performed (Table 2). Thus, both p53 WT !and KO mice were 
I 
I 
subjected to the same acute exercise protocol for 90 minutes at 1 fon/min, as no basal 
I 
differences in exercise capacity were apparent. 
128 
Exercise-induced kinase activation is suppressed in p53 KO animals .. 
While a plethora of signals are triggered upon exercise, the transient activation of p38 
I 
I 
MAPK, AMPK and CaMKII in skeletal muscle are known modifiqations in response to 
contractile activity. As expected, there was a large increase in p38 MAPK 
I 
phosphorylation in the AE group, which returned to control levels ~ith recovery in WT 
mice (Fig. lA). In contrast, p38 MAPK phosphorylation upon exercise was abolished in 
p53 KO mice (Fig. lA). Similarly, AMPK (Fig. lB) and :CaMKII (Fig. lC) 
phosphorylation was enhanced by "'2.5-fold in AE and AER gro~ps in WT mice. As 
opposed to this, p53 KO mice displayed a delayed activation of AMPK and CaMKII 
I 
phosphorylation subsequent to endurance exercise. AMPK phosphorylation increased by 
"'2-fold (Fig. lB), and CaMKII activation was elevated by ,.., 1.5-fold (Fig. 1 C), but this 
I 
only occurred in the AER group in p53 KO mice. Interestingly, while no differences were 
documented between the basal phosphorylation status of p3 8 MAPK and AMPK in non-
1 
I 
exercised muscle, levels of CaMKII phosphorylation tended to be higher in the KO mice 
when compared to their WT counterparts in the CON condition (p=OJ09, data not shown). 
Nuclear translocation of PGC-1 a with acute exercise is attenuated in p53 KO mice. 
PGC-la, considered to be an important transcriptional co-factor, pas been previously 
illustrated to rapidly translocate to the nucleus upon an exercise bout (35). We assessed 
I 
the accumulation of PGC-1 a in the nuclear fractions isolated froµi sedentary control 
I 
(CON), acute exercise (AE) and acute exercise with 3 hours recovery (AER) group from 
p53 WT and KO mice (Fig. 2A). PGC-la increased by 1.5-2-fold ~n WT animals with 
I 
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AE and AER (Fig. 2A). In contrast, PGC-la nuclear content was not elevated in p53 KO 
mice in the AE group, and displayed only a slight increase in the AER group. The level 
I 
of nuclear PGC-1 a content in KO mice under non-exercised, basal: conditions tended to 
be lower than that of WT, but this did not reach statistical significan9e. 
mRNA levels of genes related to energy metabolism increase following acute exercise in 
I 
p53 WT, but not KO mice. 
I 
The transcript· levels of genes involved in mitochondrial biogenesis such as PGC-1 a, 
Tfam, NRF-1, and COX-IV increased immediately following an acute bout of exercise in 
I 
the WT mice (Fig. 2B, 3). The enhancement in mRNA expression of these transcripts 
was maintained, or further increased, after three hours of recovery following the exercise 
I 
in WT animals (Fig. 2B, 3A-C). Surprisingly, the only transcript which increased as a 
result of exercise or recovery in p53 KO mice was PGC-1 a (Fig. 2B). The response of 
I 
other transcripts to exercise, and exercise with recovery, remained relatively unchanged 
in the KO animals (Fig. 3A-C). The mRNA levels of SC02, a well .. known target of p53 
that was initially illustrated to be pivotal for p53-mediated mitochondrial biogenesis in 
cells in culture, did not respond to the acute exercise stimulus in either WT or KO 
animals (Fig. 3D). 
Muscle autophagic and lysosomal markers are unchanged in respo'!se to acute exercise 
in p53 WT and KO mice. 
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I 
We immunoblotted for lysosomal and autophagic proteins intimately associated with the 
induction of the autophagic process. Basal levels of Cts-D and larpp2 in non-exercised 
muscle were lower in KO animals compared to their WT littermate controls (Fig. 4B), 
I 
suggesting a lower lysosomal capacity in p53-deficient animals. 1 In contrast, LC3-II 
content was similar, and p62 expression was enhanced in the KO animals compared to 
WT controls. Thus, p53 exerts specific effects on the expression of autophagy and 
lysosomal proteins in muscle. Exercise and recovery had no effect qn the level of any of 
these proteins in muscle. Beclinl, and Atg7 levels were comparable 11in WT and KO mice 
I 
at rest, and also did not respond to the exercise stimulus (Fig. 4A). Ubiquitination, a post-
translational modification that most commonly earmarks cellular material for 
I 
proteosomal or autophagic degradation, was also measured in whole 'muscle homogenates 
i (Fig. 4B, C). Steady-state levels ofubiquitination were reduced in p53 KO mice (Fig. 4B), 
and while WT ubiquitination levels remained unchanged with exercise, the KO animals 
displayed a significant increase in ubiquitinated proteins in the AE and AER groups when 
compared to WT controls (Fig. 4C, D). This effectively raised the level of ubiquitination 
I 
in KO tissue back to the level observed in WT animals. 
Mitophagy signaling is activated by acute exercise in p53 WT and KO mice. 
I 
We measured the amount of lipidated LC3, p62, and ubiquitination m isolated 
I 
mitochondrial fractions from WT and KO mice as indicators of J?itophagy (Fig. 5). 
Levels of mitochondrial LC3-II (Fig. 5B inset) were increased (p < 0.05), as well as 
organelle ubiquitination (p=0.06, Fig. 5D inset) in the KO mice, whe'n compared to their 
I 
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WT counterparts in control non-exercised conditions, suggesting a: heightened drive for 
mitophagy in the KO muscle. Basal p62 levels remained unchanged :in mitochondria from 
KO compared to WT animals (data not shown). A significant main effect of exercise and 
recovery on all three mitophagy indicators was evident in both WT and KO animals (Fig. 
5). 
Discussion 
Steady-state mitochondrial content is determined by th~ interplay between 
mitochondrial biogenesis and mitophagy. We, and others, have extensively characterized 
the synthesis arm of mitochondrial turnover, but there are only a few studies that have 
investigated exercise and its effects on mitophagy. Thus, the purposes of this study were 
to explore how mitochondrial biogenesis and mitophagy are regu:lated in response to 
acute endurance exercise in skeletal muscle, and the role executed by1 p53 in this context. 
I 
PGC-1 a is intimately involved in regulating mitochondrial ~iogenesis, due to its 
ability to rapidly translocate to the nucleus and co-activate the transeription of numerous 
I 
downstream mediators of mitochondrial biogenesis upon an e*ercise signal ( 18). 
Interestingly, p53 exerts a significant degree of control over the transcription of PGC-la. 
We had earlier identified a putative p53 response element in PG<S-la promoter (13), 
I 
which was subsequently demonstrated to both suppress (25), and activate transcription of 
PGC-1 a (2). Clearly, the interaction is dependent on the cellular milieu, and the 
I 
experimental model in which it is investigated. We here report that while there is no 
effect on basal nuclear PGC-1 a localization between the two genotyp~s, the kinetics of its 
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movement into the nucleus upon exercise are impaired in the absence of p53. This is 
important as the delayed increase in nuclear PGC-1 a may stippress the onset of 
I 
mitochondrial biogenesis. Indeed, the expected augmentation in t~e transcript levels of 
PGC-la, Tfam, NRF-1 and COX-IV that occurs with exercise and recovery in WT 
animals, was either attenuated or abolished in the KO mice. It is quhe possible that there 
is an eventual increase in the mRNA content of the different transcripts in the p53 KO 
animals, requiring either a longer recovery period (> 3 hours), br multiple bouts of 
I 
exercise to gain the same adaptation as WT mice. It is important to note that the p53-
transcribed gene SC02, involved in the assembly of complex IV of the electron transport 
chain, was unresponsive to exercise in either WT or KO mice. 
To understand the mechanisms of reduced PGC-1 a translocation to the nucleus, 
we measured the activation of upstream kinases. p38 MAPK directly phosphorylates 
PGC-1 a at three sites which releases it from its repressor binding protein known as p 160 
and leads to its stabilization (6). AMPK activates PGC-la by phosphorylating it on the 
threonine-177 and serine-538 residues (14). Our data indicate that the absence of p53 
results in a lack of, or delay in the phosphorylation of p38 N1APK, and AMPK, 
I 
respectively, in KO mice subjected to acute exercise. This may be the underlying reason 
behind the sluggish response of PGC-1 a translocation into the nucl~us upon exercise in 
p53 KO animals. 
The diminished AMPK activity in the KO mice is not likely attributed to reduced 
I 
levels of the allosteric activator AMP in the muscle of p53 KO animals during exercise. 
This is because muscle of p53 KO animals have a reduced oxidati~e capacity, and thus 
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more likely to increase cellular AMP levels, as well as the activ~tion of AMPK (17). 
I 
However, p53 KO cells have been shown to maintain comparable cellular ATP levels 
basally, and higher ATP levels during conditions of metabolic stress such as glucose 
deprivation when compared to WT cells (20; 31 ). It is possible t~at the lower AMPK 
activity may be due to the transcriptional control exerted by p53 qver the ~ 1 accessory 
subunit of the AMPK complex (7). AMPK exists as a heterotrimeric complex, with one 
I 
catalytic a subunit, and two regulatory ~' and y subunits. The ~ s~bunit functions as a 
scaffold for the other two, and has been shown to modulate AMPK localization and 
activity (34). Thus it is likely that, in the absence of p53, reduced ,~ subunit expression 
I 
somehow manifests as a delayed increase in AMPK activity upon acute exercise. 
p38 MAPK can be activated by a plethora of different oxidative, DNA damage, 
I 
and inflammatory stress stimuli, and is a bona fide activator of p53, as well as being 
subject to negative regulatory feedback regulation by p53-inducible genes (30). p38 
MAPK phosphorylation in response to acute exercise was completely abrogated in the 
I 
KO mice, although basal levels were unchanged. We expected higher basal p38 MAPK 
activity in the KO mice, having previously reported elevated reaqtive oxygen species 
levels in these animals (26), and also because of the negative correlation that exists 
between oxidative capacity and activation of p38 kinase activity (17). We do not know 
why p38 activation is attenuated in control non-exercised muscle from p53 KO mice, but 
given that p38 MAPK is an integral component of many cellula.r processes, further 
research is warranted to investigate this observation more closely. 
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The effect of p53 on autophagy is potentially ambiguous, depending on its 
cellular location. Cytoplasmic p53 can inhibit autophagy during :non-stressful cellular 
conditions, whereas the accumulation of nuclear p53 upon a cellular insult results in the 
I 
I 
p53-mediated transcriptional up-regulation of autophagy genes including AMPK ~1, 
death associated protein kinase 1 (DAPK-1 ), damage-regulated autophagy modulator 
(DRAM), proapoptotic Bcl-2 proteins (e.g. Bad, Bax, Bnip3, and Puma), sestrin 2, and 
tuberous sclerosis protein 2 (TSC2, (19; 27). In this study we have totally abrogated p53 
I 
activity and expression, and examined the consequence on the exp,ression of autophagy 
and autophagy-related proteins. Our results revealed attenuated lysosomal capacity as 
illustrated by lower CtsD and lamp2 protein expression in the KO animals at rest. 
Concomitantly, there was decreased ubiquitination, and an accumulation of p62 
indicative of a lower autophagy flux in the resting muscle of KO mice. LC311, Beclinl 
and Atg7 expression remained unchanged in the absence of p53. Interestingly, the 
I 
mitochondrial localization of LC311 and ubiquitin content was, higher in the KO, 
compared to the WT animals, indicative of an underlying basal drive to remove 
dysfunctional mitochondria during non-exercised conditions, but! limited by a lower 
! 
lysosomal capacity for degradation. Consistent with this, it has been shown that liver, 
kidney and pancreas from p53 KO mice had higher basal levels: of LC3 puncta and 
autophagosomal accumulation in whole cell homogenates (31 ), : characteristic of an 
impaired autophagic process in the absence of p53. 
Since both autophagy and mitophagy have been recently implicated to be 
activated in response to acute endurance exercise in muscle (1 ~; 11; 15), we next 
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investigated whether this avenue of mitochondrial turnover is dependent on the presence 
of p53. He et. al (11) previously reported an increase in the autophagosomal membrane-
I 
associated lipidated form of LC311, and degradation of autophagy substrate p62 with 
I 
acute exercise in WT mice. We investigated of a number of autophagy and lysosomal 
markers, and did not observe any changes in the WT mice with the exercise protocol 
I 
employed, despite the considerable induction of gene expression.1 It is likely that our 
I 
exercise protocol, while commonly used to successfully invoke mitochondrial synthesis 
I 
(24; 35), and physiologically equivalent to running at - 75% V02 max (28), is not as 
I 
intense or long enough as that used by others (11) to induce macroautophagy in WT mice. 
Indeed, a recent study showed the up-regulation of autophagy proteins in humans that 
could be observed after an ultra-endurance exercise bout of exercise:lasting 24 hours (15). 
I 
Clearly, exercise dosage is of paramount importance as it dictates the magnitude of the 
downstream activation of autophagic signaling. The increase' in whole muscle 
I 
ubiqutination evident only in p53 KO mice may play a therapeutic role in raising the 
attenuated level of this process up to healthy, control levels in the absence of p53. 
I 
Exercise-induced ubiquitination is commonly used to tag cellular debris for removal by 
the proteosome or for selective autophagy, therefore it is possible that this change in 
ubiquitin content is upstream of an activation of the autophagic process in the KO mice. 
With respect to mitophagic signaling initiation, both WT and KO animals displayed an 
I 
equal propensity to enhance mitochondrial LC311, p62 and ubiquitin content with 
exercise. Thus, acute exercise promotes mitophagy by enhanced tai:geting of LC311 and 
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p62 to the mitochondria, and by ubiquitinating mitochondrial proteins even when p53 is 
absent. 
This study documents a comprehensive analysis of the ~ecessity of p53 for 
exercise-induced changes in cellular signaling and gene expression in skeletal muscle. 
i 
Exercise has been touted as a viable means to decrease the incidence and progression of 
cancer, as well as many inactivity-related pathologies such as obe~ity, type 2 diabetes, 
and cardiovascular disease. We have previously identified that enqurance exercise can 
directly activate and re-localize p53 to the mitochondria where it ~ffects mitochondrial 
DNA (mtDNA) transcription (Saleem, J Physiol 2013, in press). Here, we demonstrate 
that the presence of p53 is requisite for the activation, and subsequent initiation of 
mitochondrial biogenesis after an acute bout of exercise. In addition, ~ack of p53 seems to 
be important for the basal expression and recruitment of autophagic 'proteins, but has no 
effect on the induction of mitophagic signaling after an acute bout :of exercise. Further 
i 
research is warranted in order to fully appreciate the interplay between autophagy and 
mitophagy, and the dependence of these cellular processes on p53 expression in skeletal 
muscle after exercise. These findings add considerably to the li~erature on muscle 
adaptations to exercise, and they suggest that individuals with decreased or ablated p53 
expression, may require a greater exercise dose in order to benefit from the mitochondrial 
adaptations which normally accompany the pursuit of a regular p.i;ogram of physical 
activity. 
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Table 1. Primer sequences used for RT-PCR analysis. 
Gene Forward primer (5' -+ 3') Reverse primer (5' -+ 3') 
PGC-la TTCCACCAAGAGCAAGTAT CGCTGTCCCATGAGGTATT 
I 
Tfam GAAGGGAATGGGAAAGGTAGA AACAGG~CATGGAAAGCAGAT 
NRF-1 ATCCGAAAGAGACAGCAGACA TGGAGGOTGAGATGCAGAGTA 
I 
COX-IV CTCCAACGAATGGAAGACAG TGACAACCTTCTTAGGGAAC 
I 
SC02 TCCCTICACCCITCGCTGMC CAGTAGCATCGTGGACCTGM 
~-2 
GGTCTTTCTGGTGCTTGTCT TATGTTCGGCTTCCCATTCT 
microglobulin 
Table 2. Body weight and treadmill exercise performance. 
Genotype Body Weight Speed Distance Work (kJ) 
(g) (m/min) (km) I 
WT 
17.6 ± 1.52 42.2 ± 1.44 0.99 ± 0.06 172.4 ± 24.04 
(N=4) 
KO 
19.6±0.17 44.0 ± 1.73 1.06 ± 0.08 204.1±13.0 
(N=3) 
I 
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Figure and Table legends 
Table 1. List of forward and reverse primer sequences used for real time PCR. 
Table 2. Body weight and treadmill exercise performance. p53 WT and KO mice 
were subjected to a graded treadmill exercise challenge until exhaustion. No difference 
was observed in maximum speed attained, distance covered or work performed between 
the WT and KO mice. N=3-4. 
Figure 1. Exercise-induced activation of signaling kinases. (A) p38 MAPK 
phosphorylation increased significantly with exercise and recovery in the WT mice, and 
not in the KO animals (p<0.05). (B) AMPK phosphorylation levels were enhanced by ,..,2 
- 2.5-fold in AE and AER conditions in WT mice, respectively (p<0.05). p53 KO group 
displayed a delayed "'2-fold elevation in phosphorylated AMPK in the AER group 
(p<0.05). (C) Phospho-CaMKII content was higher by "'2.5-fold in WT mice in AE and 
AER, and by ,.., 1.5-fold in AER condition in the KO counterparts (p<0.05). tp<0.05 main 
effect of AE and AER vs. CON, *p<0.05 main effect of WT vs~ KO, ifp<0.05 main 
interaction effect. Data are presented as a fold-increase over CON values. Error bars 
represent SEM values. N=6/exercise condition. 
Figure 2. Alterations in expression of PGC-la protein and mRNA. (A) PGC-la 
nuclear content increased by 1.5 - 2-fold in WT mice with AE and AER (p<0.05), and 
this effect was nearly absent in the KO mice. Histone 2 B was used 1 as a nuclear loading 
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control (B) As expected, a large up-regulation of PGC-la mRNA was evident in WT 
mice with exercise and recovery. On the other hand, p53 KO exercised mice displayed an 
attenuated increase in PGC-la mRNA content. tp<0.05 main effect of AE and AER vs. 
I 
CON, *p<0.05 main effect of WT vs. KO. Data are presented as a fold-increase over 
CON values. Error bars represent SEM values. N=6/exercise condition. 
Figure 3. Changes in mRNA transcripts related to mitochondrial biogenesis. The 
I 
transcript levels (A) Tfam, (B) NRF-1, and (C) COX-IV increased immediately following 
acute exercise, and was further elevated in recovery in the WT mice (p<0.05). This 
increase in mRNA levels was abolished in the KO mice. (D) SC02, a transcriptional 
target of p53 involved in maintaining mitochondrial function, did not respond to exercise 
in the WT mice, and its levels decreased in the absence of: p53 (p<0.05). ~-2 
microglobulin was used as an internal housekeeping gene. tp<0.05 main effect of AE and 
AER vs. CON, *p<0.05 main effect of WT vs. KO. Data are present~d as a fold-increase 
over CON values. Error bars represent SEM values. N=4/exercise condition. 
Figure 4. Response of whole muscle autophagic and lysosomal markers to acute 
exercise. (A) lmmunoblots depicting the expression of lysosomal (~TSD, Lamp2) and 
autophagic (p62, LC311, Beclinl, ATG7) markers in WT and KO samples in CON, AE 
and AER conditions. No changes in protein content were observed in either genotype 
with exercise. (B) Non-exercised control levels of LC311 were unchanged, CTSD, Lamp2 
and ubiquitin levels were lower, and p62 content was higher in p53 KO mice compared to 
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I 
littermate WT controls (p<0.05). AU refers to arbitrary units. *p<0.05 WT vs. KO. Data 
is presented as mean ± SEM values. (C) Representative western ~lot for ubiquitinated 
I 
proteins and (D) its graphical illustration illustrates an exercise-:induced elevation of 
ubiqutin content in p53 KO mice only (p<0.05). Aciculin was used as a loading control. 
I 
*p<0.05 main effect of WT vs. KO. Data is presented as a fold-increase over CON values. 
Error bars represent SEM values. N=6/exercise condition. 
I 
I 
Figure 5. Activation of mitophagy signaling post-acute boµt of exercise. (A) 
Lipidated LC3, p62, and ubiquitination in isolated mitochondrial fr~ctions from WT and 
KO mice. VDAC was used as a loading control. Graphical illustration depicting an 
I 
increase in (B) LC311, (C) p62, and (D) ubiquitinated protein expression with exercise in 
I 
I 
mitochondria isolated from both WT and p53 KO mice. (B, inset) ~ncreased amounts of 
I 
I 
LC311 (p<0.05), concomitantly with (D, inset) higher ubiqutination (p=0.06) were 
I 
documented in the mitochondria from mice with p53 ablation. tp<0'.05 main effect of AE 
I 
and AER vs. CON, *p<0.05 main effect of WT vs. KO. Data are presented as a fold-
! 
I 
increase over CON values. Error bars represent SEM values. AU refers to arbitrary units. 
I 
N=6/exercise condition. 
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CHAPTER 7: 
SUMMARY AND CONCLUSION 
p53 is a transcription factor that is well-known for its ability to respond to a 
multitude of extrinsic and intrinsic challenges to the cell including DNA damage, 
oxidative and UV stress, oncogene activation and hypoxia (15). It cap regulate pleiotropic 
pathways in the cell ranging from cell cycle arrest, cell death, autophagy, senescence, 
metabolism, fertility, DNA repair, pro-/anti-oxidant response and angiogenesis depending 
on the type and severity of stress and the host tissue (3). Until about few years ago, 
I 
majority of the research had investigated the role of p53 in the context of cancer cell 
models, understandably because of the pivotal role of p53 in halting tumorgenesis. With 
metabolic aberrations being recognized as a stalwart feature of cancer, and more 
importantly as a viable target for therapeutics, research has intensified on delineating the 
mechanisms by which p53 regulates mitochondrial function. There is however a dearth in 
literature in examining the function of p53 in skeletal muscle, a gross oversight as 
skeletal muscle is the largest organ system in the body, arid impaired muscle 
mitochondrial function is linked with a variety of pathological conqitions such as type 2 
diabetes, obesity, cancer, and aging. Previously, we and others have shown that the 
I 
absence of p53 results in a lower mitochondrial content, reduced mitochondrial 
respiration and poor endurance performance in animals (7; 8; 12; 13). Thus my doctoral 
work focused on investigating the mechanisms by which p53 induces mitochondrial 
biogenesis, and to attest the necessity of p53 for exercise-induced metabolic adaptations. 
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Objective 1: We first investigated the role of p53 in regulating mitochondrial 
protein import and complex IV or cytochrome c oxidase (COX) assembly. It has been 
previously demonstrated that lack of p53 results in reduced COX activity (7; 8; 12). Like 
I 
many other complexes of the electron transport chain in the mitochondria, COX is made 
up of both mtDNA- and nuclear DNA-encoded mitochondrial proteins, which mandates 
the process of protein import to be important for the formation , of this holoenzyme. 
I 
Consequently, we hypothesized that the lower COX activity observ~d in p53 KO animals 
was a result of defective rates of protein import leading to inefficient assembly, and 
hence function of the complex. Additionally, p53 had been shown to be a transcriptional 
regulator of SC02 (7), a factor involved in assembly of COX. Isolat~d mitochondria from 
p53 KO mice had lower expression of many important components of the protein import 
machinery such as Tom20, Tim23, mtHsp70, and mtHsp60. The content of cytosolic 
chaperone proteins in p53 KO mice was unaltered, leading us to postulate that reductions 
in the protein import machinery constituents would impact import kinetics. However, 
results from our in vitro import assay showed no difference between the WT and p53 KO 
mice. We measured COX activity and markers of ETC complexes in isolated 
mitochondrial sub-fractions and again noted that p53 KO samples remained unchanged 
from their WT counterparts. Lastly, we assessed complex IV assembly using BN-PAGE 
and the protein levels of Surfl, another assembly co-factor, and found both to be 
decreased in the absence of p53. Thus, p53 has no effect on the import of matrix-destined 
proteins, but lack of the protein impaired the assembly of the COX .complex. This may 
imply that there is a compensatory increase in the COX activity of KO mice to maintain 
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levels comparable to WT in the face of this impairment in COX 
1
assembly. This study 
provides further mechanistic insight into how p53 regulates mitochondrial function in 
skeletal muscle. 
Objective 2: Next we examined whether an acute bout of exercise activates p53. 
We randomly divided WT mice in to sedentary, acute exercise (AE) and acute exercise 
plus 3 hour recovery (AER) groups, and subjected the AE and AER groups to 90mins of 
I 
treadmill running at 15m/min. We evaluated the transcript and protein content of p53, 
I 
and documented that both p53 mRNA and nuclear p53 protein levels decreased upon AE 
compared to control conditions. A small pool of p53 has been reported to reside in the 
mitochondria (1), hence we measured p53 content in SS and IMF mitochondrial fractions 
and observed striking -4-fold increases in p53 protein in the organelles with exercise. 
Furthermore, mitochondrial p53 was phosphorylated at Ser15 with e,xercise, indicative of 
improved protein stability, and an enhanced amount of p53 was imniunoprecipitated with 
I 
Tfam. p53 was also found in a complex with mtDNA at the D-loop region, directly or 
indirectly through Tfam, and this interaction increased substantially in AER conditions. 
We also identified putative p53 response elements in the D-loop region of mtDNA using 
in silica analysis, hence leading us to posit that p53 may be invol;ved in co-regulating 
mtDNA transcription in collaboration with Tfam, the mtDNA transcription factor. Indeed 
the increase in mtDNA-transcribed COX subunit I with exercise and ,recovery was nearly 
abolished in p53 KO mice giving credence to our hypothesis. This study is the first to 
document how exercise reshuffles p53 to the mitochondria wherein it is involved in 
modulating mtDNA transcription and/or mtDNA integrity. This st'1dy also establishes 
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p53 as a bona fide transcription factor activated in response to endurance exercise in 
skeletal muscle. 
Objective 3: Since exercise modified p53 expression and sub-cellular localization 
so drastically, it was intuitive to subsequently explore the necessity of p53 for exercise-
1 
mediated adaptations. Specifically, we wanted to delineate whether p53 is crucial for the 
post-exercise changes in cellular kinase activation, mRNA response, transcriptional 
I 
regulation and autophagic/mitophagic induction. We subjected p53 WT and KO animals 
to a similar ef(ercise paradigm as in objective 2, and measured doW11stream activation of 
signalling kinases. In the absence of p53, p38 MAPK phosphorylation was abolished, and 
CaMKII and AMPK activity was attenuated with exercise and recovery. The 
translocation of one of the main regulators of mitochondrial biogenesis, PGC-1 a to the 
nucleus was impeded in the KO mice. Concomitantly, increase in the levels of mRNA 
transcripts commonly associated with an initiation of mitochondrial biogenesis was 
absent in p53 null animals. Markers of autophagy did not fluctuate with the exercise in 
either mice genotypes, however the induction of the mitophagic programme was evident 
in both WT and KO mice. This suggests that while p53 is crucial to the activation of the 
mitochondrial synthesis arm, and necessary for baseline levels of autophagy, it is likely 
not required for the exercise-mediated mitophagy/autophagy. 
All together our data further cement the role of p53 as a legitimate regulator of 
mitochondrial biogenesis, and one that is responsive to endurance, exercise, in skeletal 
muscle. Reversing the metabolic impediments in cancer is a viable means to treating 
some cancers, along with using exercise as a cancer therapy. Since p53 is involved in 
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regulating both oxidative capacity, and can be recruited by exer9ise to localize to the 
I 
mitochondria, our work carries important therapeutic repercussions. Indeed, p53-
mediated control of mitochondrial respiration and function may underlie the Warburg 
I 
effect that is characteristic of cancer cells - an increase in glyc0lytic metabolism, in 
tandem with a decrease in oxidative phosphorylation. Coupled witp the fact that p53 is 
one of the most often mutated proteins in tumorgenesis, focusing on treating cancer by 
I 
I 
effectively aiming to ameliorate the metabolic dysfunction in p5~ mutant/KO cancers 
seems to be a viable therapeutic initiative that needs to be urgently addressed. More work 
I 
needs to be done to fully elucidate the mechanisms by which pS3 is directed to the 
I 
I 
mitochondria upon exercise, and to decipher the underpinnings of the diminished effects 
seen in the absence of p53 in activating mitochondrial biogenesis. 
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CHAPTERS: 
FUTURE DIRECTIONS 
I 
Based on our observations from the three studies summarized earlier, it is evident that 
I 
p53 is implicitly involved in regulating baseline and endurance exercise-mediated 
I 
mitochondrial biogenesis. Several interesting research questibns arise from our 
I 
I 
observations which will form the basis of scientific studies our lab, could be undertaking 
in future. These are detailed below: 
1) Does p53 impact the rate of protein import into mitochondrial sub-compartments? 
The decrease in the expression of Tom20, Tim23, and the 'chaperone proteins in 
the KO mice could be the result of a direct transcriptional regulation of these proteins by 
I 
p53, or via an indirect method. While we were surprised by the unaltered matrix protein 
I 
I 
import, it is likely that import into sub-mitochondrial destinations such as the inner or 
I 
outer mitochondrial membrane, or intermembrane space is impaire:d. Conducting further 
i 
import experiments using radiolabelled precursor proteins destined for these sub-
I 
mitochondrial compartments will be valuable in answering this queey. 
Moreover, while we discerned no differences in cytosolic '.chaperones, there are 
I 
instances where mitochondrial import is not different between two '!treatment groups, but 
i 
when pre-incubated with cytosol from the respective treatment group, import kinetics 
I 
were altered (16). Further work must be conducted to preclude thi~ eventuality that may 
I 
have been missed in our import study. 
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2) What are the upstream signalling pathways that target p53 to the mitochondria, 
and the subsequent post-translational modifications that the protein undergoes, in 
response to exercise? 
Additional time course experiments need to be performed to elucidate the 
'dosage' of exercise needed to re-direct p53 to the mitochondrion, and/or deplete the 
nuclear p53 content. Plus, it will also be of interest to subject mice to different modalities 
of exercise i.e., endurance vs. resistance vs. interval training. Since p53 does not have a 
I 
canonical mitochondrial targeting sequence, research into investigating the molecular 
mechanisms (most likely post-translational modifications that dictate its mitochondrial 
transport) via which endurance exercise exerts its effect on p53 sub-cellular shuttling is 
also warranted, along with measuring protein import kinetics of p53 into the 
mitochondria upon exercise. Immunoprecipitating the p53 protein from different sub-
fractions of the cell post-exercise, and then subjecting it to mass spectroscopy techniques 
will help identify the post-translational modification(s) to p53 with exercise. 
We have preliminary evidence that indicates mitoch0ndrial p53 to be 
phosphorylated at Ser15. The most likely candidates for this post-translational 
modifications are AMPK and p38 MAPK. We can elicit the contributions by the kinases 
by acutely administering inhibitors of these kinases (compound C for AMPK, and 
SB203580 for p38 MAPK) and subsequently subjecting the mice to an acute bout of 
acute exercise. Accumulation of p53 in the mitochondria and p53Ser15 status can then be 
analyzed. The next step would be to address the importance of phosphorylation at Ser 15 
to mitochondrial p53 translocation. Transfecting p53 KO mice with vectors expressing 
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p53 mutated at Ser 15, and subsequently allowing the mice to run an acute bout of 
treadmill exercise, would help decipher how important this post-translational 
modification is. 
Furthermore, another intriguing question is what attracts p53 to the mitochondria 
upon exercise. Sablina et al. (10) once floated an interesting hypothesis that levels of 
ROS regulate p53 activity as the tumor suppressor protein is highly susceptible to any 
changes in oxidative status. It has been known for some time tha~ exercise can briefly 
increase levels of oxidative stress ( 4; 6). It is intriguing to speculate that mitochondrial-
derived ROS can serve as part of a retrograde signalling pathway that may serve to 
recruit p53. Treating mice with cytosolic- or mitochondrial-directed antioxidants prior to 
acute exercise challenge will help delineate the role of oxidative stress in directing p53 
and its sub-cellular address. 
3) What is the precise role of exercise-induced p53 ac~umulation in the 
mitochondria? 
We believe that mitochondrial p53 may be 1) improving mtDNA integrity via its 
inherent base excision repair capacity, and/or by working in conjunction with 
mitochondrial polymerase gamma (poly), or 2) involved in mediating mtDNA 
transcription. Our data support p53-mediated mtDNA transcriptional control, but it is 
possible that p53 is executing both of these functions. To examine thi~ question we would 
need to employ a cell culture technique where primary muscle cells from p53 KO mice 
are differentiated and allowed to form myotubes. Recombinant p537flagged protein can 
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then be transfected along with mtDNA D-loop based reporter constructs, and cells 
contracted in vitro to mimic exercise. Alternatively, since mtDNA transcription is 
impaired in myotubes from p53 KO mice, transient expression of p53 may rescue it. This 
would provide further insight into whether p53 can affect mtDNA transcription. To 
delineate whether p53 is playing a part in fixing mtDNA errors, p53 KO myotubes will 
be treated with pro-oxidants followed by mitochondrial fractions isolation. One would 
I 
hypothesize that in absence of mitochondrial p53, these myotubes ~ill accumulate more 
mtDNA mutations/lesions in response to pro-oxidants (such as H202) treatment. The 
isolated mitochondrial fraction from p53 KO myotubes vs, control; myotubes (with and 
without pro-oxidant treatment for both) can be analyzed for levels of mtDNA mutations 
using Next Generation Sequencing. To show that p53 is involved in repairing this defect, 
mitochondrial fractions from these cells can be incubated with recombinant p53 followed 
by mtDNA sequencing to ensure that mtDNA gets repaired. 
4) How does the absence of p53 impair cellular signaling in response to exercise? 
First, a comprehensive assessment of the upstream regulatory components that 
control the activity of exercise-responsive kinases is warranted in p53 WT vs. KO muscle, 
including metabolites and upstream activators of AMPK and p38 MAPK such as LK.Bl 
and p38 MAPKK. A time-course experiment needs to be conducted.to ascertain whether 
the activity of kinases, expression of PGC-1 a, and mRNA transcript levels eventually 
catch up to WT levels in the recovery phase post-exercise in p53 KO mice. Second, the 
relation between PGC-la and p53 is a fascinating one and needs to be fully investigated. 
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Both proteins have been shown to exert transcriptional control ov~r the other (2; 5; 11; 
12). The decreased exercise-induced aggregation of PGC-la to :the nucleus in mice 
I 
without p53 as shown in objective 3 of this dissertation could be due to inefficient post-
translational modifications of PGC-1 a. To further inspect this, we' can subject WT and 
p53 KO mice to an acute bout of exercise, and immunoprecipitate nuclear and cytosolic 
PGC-1 a protein from the respective sub-cellular components. The precipitates can 
thereafter be probed for the classic phosphorylation and deacetyla~ion sites on the co-
factor using "immunoblotting, or subjected to mass spectroscopy, to. assess the gamut of 
post-translational modifications of PGC-la. Lastly, the attenuated increase in mRNA 
levels of genes related to mitochondrial biogenesis in the KO mice· could be an indirect 
effect through the reduced transactivation by PGC-1 a, or more directly via changes in 
mRNA stability. p53 can bind to RNA (9) and certainly possesses the ability to regulate 
the stability of its own mRNA. Also, RNPCl, an RNA-binding protein is a transcriptional 
target of p53 (14), which could be repressed in mice with no p53. Expression of RNPCl, 
and other mRNA binding proteins could be evaluated using primary myotubes derived 
from p53 WT and KO animals. Furthermore, using this cell culture model, we can 
subsequently treat the cells with actinomycin D, a transcriptional inhibitor, and RNA 
extracted over a time course post-treatment to gauge mRNA stability. 
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APPENDIX A 
ADDITIONAL DATA & GENOTYPING PROTOCOL 
I 
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STUDY 1 
REGULATION OF p53 mRNA EXPRESSION & STABILITY 
Figure 1. 
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Figure 1. p53-dependent increase in COX activity and basal and AI CAR-induced expression of p53 
mRNA. (A) COX activity increased in C2C12 myoblasts with AICAR (A, lmM) treatment for 1, 2 or 4 
days (lD, 2D, 4D). With the addition of 15µM ofpifithrin-a (P), a specific inhibitor of p53, the AICAR-
mediated increase in COX activity was diminished. n=3-8, *p<0.05, **p<0.05 effect of pifithrin-a. (B) 
The main two isoforms of p53 mRNA in muscle. Variant 1 (varl) is expressed:at 60% higher levels than 
variant 2 (var2) in myoblasts and at 90% higher levels in myotubes. n=3-6, *p<0.05. (C) mRNA 
expression of both p53 variants decreases in C2C12 myoblasts after 3 days of AI CAR (lmM) treatment. 
~-actin and ~-2-microglobulin were used as loading control. n=3, *p<0.05, **p<0.05, main affect of 
splice variant. 
167 
Figure 2 
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Figure 2. Acute and chronic stimulation-mediated expressfon of p53 mRNA 
variants. (A) 1 hour of acute stimulation at 1 OHz reduced the ~A levels of var 2, 
whereas 3 hours of acute stimulation (lOHz) of C2C12 myotubes resulted in a 
significant increase in p53 mRNA for both transcript variants. n=5, *p<0.05, 
**p<0.05, main effect of time. (B) mRNA expression of p53 de~reased or remained 
unchanged, as opposed to other regulators of mitochondrial bioge,nesis such as PGC-
1 a, Tfam, and NRF-1 with 4 days of chronic stimulation (3hrs/day at lOHz). SC02 
expression also decreased in tandem with p53. *p<0.05 vs. non~stimulated control. 
Values are expressed as stimulated over control. n=5-13, **p<~.05, main affect of 
splice variant. ' 
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Figure 3 
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5'ctcccatcacttcatccctccccttttctgtcttcctatagctacctgaagaccaagaagggccagtctacttcccgccataaaaa 
aacaatggtcaagaaagtgggacctgactcagactgactgcctctgcatcccgtccccatcaccagcctccccctctccttgctgt 
cttatgacttcagggctgagacacaatcctcccggtcccttctgctgccttttttaccttgtagctagggctcagccccctctctgag 
tagtggttcctggcccaagttggggaataggttgatagttgtcaggtctctgctggcccagcgaaattctatccagccagttgttgg 
accctggcacctacaatgaaatctcaccctaccccacaccctgtaagattctatcttgggccctc~tagggtccatatcctccagg 
gcctactttccttccattctgcaaagcctgtctgc~ff!tccaccccccaccctgtctccctc~f~ttr~~acccctttttata 
tatcaatttcctmcaataaaattttgttatcacttaaaaaaaaaa 3' 564bp 
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Figure 3. 3' UTR constructs of p53 var 2 and mRNA stability. (A) Schematic illustrating the 
pRL-CMV vector (Invitrogen) that has a CMV promoter driving the expression of luciferase 
reporter construct ligated to the 3' UTR of the SV 40 virus. (B) The putative full length 3' UTR 
of p53 var 2 (p53-564bp). The highlighted nucleotides form the AU-rich elements (ARE) that 
RNA-binding proteins can bind to and affect stability of mRNA. The italicized nucleotides 
represent the poly-adenylation signal. The first underlined region is ~he smaller construct (p53-
109bp). The bolded region including one ARE is the second construct (p53-474bp). We are still 
attempting to amplify the full length 3'UTR (p53-564bp). The other constructs were ligated into 
the pRL-CMV vector and transfected into C2C12 myoblasts. (C) The predicted secondary 
structure of the 3'UTR of p53 var 2 identifying the variety of stem-loop structures that offer 
another modicum of regulating mRNA stability, in addition to ARE regions. (D) Luciferase 
I 
activity at 1 day post-transfection in C2C12 myoblasts in the empty vector (pRL-CMV), 3' 
UTR construct (p53-470bp) and shorter 3' UTR construct (p53-109bp), n=5, **p<0.05 vs. pRL-
CMV. (E) Luciferase activity of the two constructs over 3 days of transfection, ·n=l-5. (E) 
Luciferase activity in myoblasts treated with lmM AICAR for one day, n=3. *p<0.05, main 
affect of AICAR. (F) Luciferase activity in myoblasts treated with l
1
mM AICAR for two days, 
n=l. (G) Luciferase activity in myoblasts treated with lmM AICAR for three days, n=2-5. All 
values are expressed as percent of control (pRL-CMV). 
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Figure 4. p53 variant 1 3' UTR constructs and mRNA :stability. (A) 
Schematic illustrating the pRL-CMV vector (lnvitrogen) that, has a CMV 
promoter driving the expression of luciferase reporter construct ligated to the 3' 
UTR of the SV40 virus. (B) The putative full length 3' UTR !of p53 var 1 
(p53vl-441 hp). The highlighted nucleotides form the AU-rich elements (ARE) 
that RNA-binding proteins can bind to and affect stability of, mRNA. The 
italicized nucleotides represent the poly-adenylation signal. The first underlined 
region is the smaller construct (p53vl-366bp). We are still attempting to amplify 
the full length 3'UTR (p53vl-441 bp ). The p53vl-366bp was ligated into the 
pRL-CMV vector and transfected into C2C 12 myoblasts. These cells were 
subjected to 4 days of differentiation. The fully formed C2C12 n}yotubes were 
then acutely stimulated at 2hrs (AS) and AS + 2hrs recovery (C) 1The predicted 
secondary structure of the 3'UTR of p53 var 1 identifying the variety of stem-
loop structures that offer another means of regulating mRNA stability, in 
addition to ARE regions. (D) p53vl-366bp-mediated mRNA stability does not 
change with AS or AS+recovery. Luciferase activity of p53~1-366bp was 
expressed as a ratio of pRL-CMV activity, and the resulting RFUs were 
presented as fold over control non-stimulated myotube values, n=6.: 
I., 
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STUDY2 
TISSUE-SPECIFIC EFFECTS OF p53 
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Figure 1. Basal ROS generation in mouse embryonic fibroblasts (MEFs) 
isolated from p53 WT and KO mice. MEFs were stained with H2DCFDA 
(50µM) that binds to cellular reactive oxygen species, for 30 mins. Cells were 
then isolated and a F ACS flow cytometer was used to count the cells, and 
measure green fluorescence. (A) Representative flow cytometer read outs for 
p53 WT (left) and KO (right) MEFs. (B) quantification of the DCF staining for 
all experiments illustrated that p53 KO mice produce higher level$ of ROS, n=7-
8, *p<0.05. 
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Figure 2. NAO fluorescence as a measurement of mitochondrial mass in p53 
WT and KO MEFs. MEFs were stained with nonly-acridine orange (50µM) 
that binds to the inner mitochondrial membrane, for 45 mins. Cells were then 
isolated and a F ACS flow cytometer was used to count the cells, and measure the 
fluorescence. (A) Representative flow cytometer read outs for p53 WT (left) and 
KO (right) MEFs. (B) quantification of the NO staining for all experiments, n=4. 
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Figure 3. Protein expression of mitochondrial-related proteins, COX 
subunit I and COX activity in WT and p53 KO MEFs. (A-G) Graphical 
representation of PGC-1 a, PGC-1 ~' COX subunit I, Tfam, AIF, Bax and 
cytochrome c in p53 WT and KO MEFs, (I) with the representative 
immunoblots. (H) COX activity in whole cell homogenates from WT and KO 
MEFs. 
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STUDY3 
ESTABLISHING PRIMARY MYOBLAST ISOLATION PROCEDURE 
Animal Sacrifice and tissue collection: 
(Use 1 week old mice - 1 mouse/well in a 6-well plate when culturing and about 6 
mice with each mouse undergoing the procedure below. The myoblasts can then be 
pooled at the end to increase yield given the mice were all of the same genotype) 
1. Euthanize mouse by cervical dislocation. Spray liberally with 70% ethanol. 
2. Remove skin and excise all muscle from mouse and place in a well containing 
2mls of Ham's F-10 (with 1 % penicillin/streptomycin and 1 % 
antibiotic/antimycotic ). Clean the muscle of any fat, skin etc. 1 Be quick. 
Collagenase treatment: 
1. In the cell culture hood, transfer muscle to a new well 1-3mls of Ham's F-10 
(with peni/strep and ab/amyc) and mince thoroughly. 
2. Add 1.5ml of 0.2% type II collagenase/dispase made in Ham's F-10. Use freshly 
prepared collagenase/dispase. Incubate at 3 7 °C for 30mins. 
3. Triturate slurry with 25ml, add 0.5ml of collagenase/dispase solution, and 
incubate at 37 °C again for 30mins. 
4. Triturate again with 25ml, then 1 Oml and 5ml pipettes. 
5. Add 2ml of stop media (5% FBS in DMEM) to stop collagenase/dispase reaction. 
Filtration: 
This is what the slurry should look 
like be/ ore filtration. 
1. Place a BD Falcon 70µm nylon cell strainer in a Falcon tube and wet strainer with 
lml 5% FBS in DMEM. 
2. Add lml PBS to cell suspension and transfer all to strainer. Use lml PBS to rinse 
well and add to strainer. 
3. Pipette on strainer until solution has mostly gone through. 
4. No wet a 40um BD Falcon strainer with PBS and pipette the slurry again. 
5. Centrifuge at 1500rpm for 15mins. 
6. carefully pipette out supemate and discard. Do not disturb the pellet. 
7. Add 3-4mls of Ham's FlO growth media. 
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Ham's FlO Growth Media (GM): 
40%Ham 
20%FBS 
1%P/S 
2% chick embryo extract (CEE) 
Pre-plate, overnight plating. Initial culture (approx 2 weeks): 
1. Pre-plate for 1 hour on a non-coated well. 
2. Then remove supernatant and put in a collagen coated dish/well overnight. 
3. Change media after 24hours 
4. Pre-plate and then change media every 2 days as described above. 
5. Use partial trypsinization every 2 days when plates are changed - i.e. add trypsin 
for 30sec and then tap once to see most of the myoblasts floating immediately 
whereas the fibroblasts remain stuck .. This will help purify the colony. 
Growing conditions: 
1. After about 2 weeks, remove CEE from growth media and add lOOng/µl bFGF 
(lnvitrogen) fresh to 50ml aliquots of Ham's GM. 
2. Stop pre-plating. 
3. Use only collagen coated dishes/wells from here onwards. 
4. Continue to use partial trypsinization- works very well to keep selecting 
myoblasts against fibroblasts. 
5. Plates can be changed on a weekly basis. 
Collagen coating: 
1. To coat, add 2-3ml to a well or plate. Make sure it covers the surface evenly. 
Incubate at 37 °C for lhr. 
2. Pipette off liquid and return to stock bottle. It can be reused many times. 
3. Dry the plate in the flow hood (overnight or 8 hours - do not use UV). 
4. Plates can be wrapped in a bag and stored at 4 °C for many months. 
Collagen: 
1. Autoclave 0.2% acetic acid in ddh20. Use water NOT PBS. 
2. Final solution is 0.01 % collagen in 0.2% acetic acid. 
3. Resuspend rat tail collagen type I (Sigma, C3867) in the bottle from the 
manufacturer before diluting into a larger volume. Vortex to resuspend. 
4. Store collagen solution at 4 °C for many months - if kept sterile. 
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A 
B 
Figure 1. Proof-of-concept that the primary myoblast isolation procedure yields 
pure myoblast population. (A) Isolated myoblasts were allow,ed to reach 90-95% 
confluency and then differentiated for 5 days. The myoblasts readily formed elongated 
premature muscle cells or myotubes. (B) To further ascertain, purity of isolation, 
myotubes were stained with skeletal muscle marker desmin, and nuclear dye DAPI. The 
image clearly depicts all differentiated and even the non-differentiated myoblasts in the 
background to be skeletal muscle cells. 
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STUDY 4 
EFFECT OF MEDIA CHANGE POST-STIMULATION IN C2C12 MYOTUBES 
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C2C 12 myotubes were stimulated at 1 OHz for 3h/day for 4 days with or without a 
change in media after each stimulation bout. Representative light microscopy pictures of 
myotubes after (A) 1 day post-stimulation, (B) 2 days of stimulation, (C) 3 days of 
stimulation and (D) 4 days post-stimulation. Changing the media after a bout of in vitro 
electrical stimulation improves myotube viability, especially evident during days 2 - 4. 
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Figure 2. Total protein, RNA yield and COX activity with or ~ithout media change 
post-stimulation for 4 days. 
C2C 12 myotubes were stim~lated at 1 OHz for 3h/day for 4 days with or without a 
change in media after each stimulation bout. (A) Total protein yield (n=3), (B) total 
RNA yield (n=3-7) and (C) COX activity (n=4) from control/non-stimulated, and 
stimulated C2C12 myotubes with or without a change of m,edia post-stimulation. 
Changing the media results in an improved protein and RNA1 yield, but carries no 
repercussions for the adaptation in mitochondrial biogenesis qbserved after chronic 
contractile activity that mimics endurance exercise training in V:itro. *p<0.05, con vs. 
stim, **p<0.05, stim vs. stim with media change. 
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PROTOCOL 
GENOTYPING P53 MICE USING PCR 
Background: This protocol is designed to detect sequences in the murine genome that 
differ between p53 wild-type and null animals using polymerase chain reaction 
amplification. PCR is a rapid, inexpensive and simple way of copying specific DNA 
fragments from minute quantities of source DNA material. There are basically 3 
procedural steps involved in PCR: 
1) Denaturation: DNA is heated to high temperature to separate the DNA double helix 
to single strands making them accessible to primers. During denaturation (94° C, 30sec), 
the DNA strands separate to form single strands. 
2) Annealing: The reaction mixture is cooled down. Primers anneal to the 
complementary regions in the DNA template strands, and double strands are formed 
again between primers and complementary sequences. During annealing (60°C, 30sec) 
one primer binds to one DNA strand and another binds to the complementary strand. The 
annealing sites of the primers are chosen so that they will prime DNA synthesis in the 
region of interest during extension. 
3) Extension: The DNA polymerase synthesizes a complementary strand. The enzyme 
reads the opposing strand sequence and extends the primers by adding nucleotides in the 
order in which they can pair. During extension (72°C, 45sec), DNA synthesis proceeds 
through the target region and for variable distances into the flanking region, giving rise to 
long fragments of variable lengths. The whole process is repeated over and over. 
The DNA polymerase, known as Taq polymerase, is named after the hot-spring 
bacterium Thermus aquaticus from which it was originally isolated. The enzyme can 
withstand the high temperature needed for DNA-strand separation. The cycle of heating 
and cooling is repeated over and over, stimulating the primers to bind to the original 
sequences. and to newly synthesized sequences. The enzyme will continue to extend 
primer sequences. This cycling of temperatures results in copying and then copying of 
copies, leading to an exponential increase in the number of copies of specific sequences. 
Because the amount of DNA placed in the tube at the beginning is very small, almost all 
the DNA at the end of the reaction cycles are copied sequences. 
The reaction products are then separated by gel electrophoresis and visualized with the 
use of ethidium bromide. 
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Reagents 
Lysis Buffer (pH=8.0) 
10 mM Tris HCl (0.121g/100ml) 
150 mM NaCl (0.8766g/100ml) 
20 mM EDTA (0.744g/100ml) 
Autoclave for 30min and store at room temperature. 
Supermix 
Sigma Jumpstart REDtaq Ready Mix PCR Reaction Mix (P0982) 
Product contains 20 mM Tris-HCl, pH 8.3, lOOmM KCl, 4 mM MgC12, 0.002% gelatin, 
0.4 mM each dNTP (dATP, dCTP, dGTP, TTP), inert dye, stabilizers, 0.06 unit/µl Taq 
DNA polymerase, JumpStart Taq antibody. 
Primers 
Forward and Reverse for WT and Null Stock Concentration 500 pmol/µl 
Working Concentration of Primers (lOX dilution): 50 pmol/ul 
To make up 50 pmol/µl: use 5 µl of 500 pmol/µl stock and add 45µ1 of sterile water 
Proteinase K 
ProK- concentration of 1 mg/ml 
Reagents for Agarose Gel Electrophoresis of PCR product 
Agarose 50XTAE 
50 X TAE 242 g TRIS 
lX TAE (dilute SOX TAE with stH20) 500ml dH20 
1 Omg/ml EtBr 1 OOml 0.5M EDT A (pH 8.0) 
Sterile water 57.lml Glacial Acetic Acid 
Make up to 1 L and autoclave 
DNA Extraction from ear clippings 
1. Make (fresh) 10: 1 mixture oflysis buffer to ProK (@concentration of lmg/ml-fresh) 
2. Add 20 µl of this mixture to a 1.5 ml sterile eppendorf tube. 
3. Obtain ear clipping from animal, add to tube and vortex (ensure ear clipping is 
immersed in solution). 
4. Incubate in a 55 °C water bath (no higher than 60 °C) for 30min, vortexing every 15 
minutes. 
5. Add 180 µl sterile distilled water. 
6. Place in boiling water for 5 minutes (use hot plate) and then vortex. 
7. Store at -20°C, or use immediately for PCR 
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PCRmethod 
1. Make mastermix for each of the primers you will be using. 
Mastermix contains: 25 µl of Supermix sample 
1 µl of Forward Primer per sample 
1 µl of Reverse Primer per sample 
Enough sterile distilled water for a volume per sample of 50 µl. 
2. For each sample use 48 µl of mastermix and 2 µl of template DNA extracted from 
procedure described above. Add 1 drop of mineral oil to each PCR tube to prevent 
evaporation of sample during cycling. 
3. Cycling times: Initial Denaturation 
35 cycles: Denaturation 
Annealing 
Extension 
Final Extension 
Hold 
Running PCR product on gel 
1. Loading buffer is already included in Supermix. 
94°C 2min 
94°C 30sec 
60°C 30sec 
72°C 45sec 
72°C 5min 
4°C 
2. Preparation of a 1.2% agarose gel. For large gel system: 3.6g Agarose, 6 ml SOX TAE 
and volumed up to 300 ml with sterile H20. Mix solution and note weight followed by 
boiling in microwave. Remove periodically to mix during boiling procedure in 
microwave. Upon complete dissolving of agarose and a homogenous and releatively 
clear agarose solution, weigh solution and replace lost amount of evaporated H20. Add 
25µ1 of EtBr (lOmg/ml), slightly cool solution in room temperature (S-lOmin), then pour 
into caster. 
For small gel system: 1.92g Agarose, 3.2 ml SOX TAE, and 1S6.8ml st H20; follow same 
procedure as noted above. Only add 8 µl of EtBr (1 Omg/ml). 
Electrophoresis Running Buffer: IX TAE: 40 ml of SOX TAE made up to 2L with H20. 
3. Run 10 µl of PCR product reaction on either a small or large 1.2% agarose gel for 1 hr 
@ approximately 90V. 
Example of Experimental Setup/Procedure for PCR Genotyping (15 mice) 
1. Make up mastermix for both wild-type and null primers for the number of animals 
required for genotyping. 
18S 
Mastermix(proportions) 
A) WT Mastermix 
25 µl Supermix 
1 µl Forward Primer WT 
1 µl Reverse Primer WT 
23 µl Sterile Water 
50µ1 Total 
B) Null Mastermix 
25µ1 Supermix 
lµl Forward Primer Null 
1 µl Reverse Primer Null 
23µ1 Sterile Water 
50µ1 Total 
X 17 reactions (over estimate, since 15 animals required) 
Total Mastermix 
A) WT Mastermix 
425µ1 Supermix 
1 7 µl Forward Primer WT 
1 7 µl Reverse Primer WT 
3 91 µl Sterile Water 
850µ1 Total 
B) Null Mastermix 
425 µl Supermix 
17µ1 Forward Primer Null 
17µ1 Reverse Primer Null 
391µ1 Sterile Water 
850µ1 Total 
1. Label PCR tubes with 1 N and 1 W to represent each animal and each mastermix, 
respectively. 
2. Place 48 µl of null mastermix in PCR tubes with N designation and 48 µI of wild-type 
mastermix in PCR tubes with W designation. 
3. Add 2µ1 of DNA template from animals into the appropriate PCR tubes i.e. DNA 
isolated from animal #1 into 1Nand1 W. 
4. Include negative controls using dH20 instead of DNA template with both Null and 
wild-type mastermix i.e. 2 µl of dH20 into PCR tubes with 48 µl of WT mastermix and 2 
µl of dH20 into PCR tubes with 48 µl of Null mastermix. 
5. Add 1 drop of mineral oil to each tube and place tubes into thermocycler for 3 5 cycles. 
Use file# 29 on thermocycler for the initial 2 min denaturation then STOP this program. 
Use file# 30 for repeated cycles. Scroll through the settings in File# 29 and change the 
settings to achieve: 
Denaturation 94 °C 30sec 
Annealing 60°C 30sec 
Extension 72 °C 45sec 
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Then link this file (#29) to file #33 which is the final extension of 72°C for 1 Omin 
(protocol states 5min but 1 Omin does not make a difference). This will be followed by a 
hold cycle at 4 °C. Samples can be left holding overnight if necessarx. 
6. Prepare either large gel or small gel or both depending on number of samples. Load 
PCR products onto gel and run for 1-1.5 hours. ' 
7. Visualize PCR products using UV lightbox in the molecular core facility. Null PCR 
product should be about 600bp whereas WT PCR product will be about 300bp. If animal 
#1 displays a band for both the Null and the WT, the animal is a heterozygote. If animal 
# 1 exhibits only a Null band but no WT band then the animal is a h~mozygous null. If 
the animal displays a wild-type but no Null band then the animal is, homozygous wild-
type. 
Fig.1: Typical agarose gel displaying PCR products and animal genotypes. 
Genotype 
30A-hetero 
33C-hetero 
32A-hetero 
31A-null 
31B-hetero 
31C-hetero 
31D-hetero 
31E-hetero 
30B-hetero 
34-hetero 
32B-hetero 
32C-hetero 
33A-wild-type 
33B-hetero 
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